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ABSTRACT 
Nanofiber-Based Scaffold for Integrative Rotator Cuff Repair 
Xinzhi Zhang 
 
 Functional integration of bone with soft tissues such as tendon is essential for joint motion and 
musculoskeletal function. This is evident in the rotator cuff of the shoulder, which consists of four muscles 
and their associated tendons that connect the humerus and scapula.  The cuff functions to stabilize the 
shoulder joint, and actively controls shoulder kinematics. Rotator cuff injuries often occur as a result of 
tendon avulsion at the tendon-bone interface, with more than 250,000 cuff repair surgeries performed 
annually in the United States. However, these procedures are associated with a high failure rate, as re-
tears often occur due to the lack of biological fixation of the tendon to bone post-surgery. Instead of 
regenerating the tendon-bone interface, current repair techniques and augmentation grafts focus on 
improving the load bearing capability of the repaired rotator cuff. Biologically, the supraspinatus tendon 
inserts into bone via a biphasic fibrocartilaginous transition, exhibiting region-dependent changes in its 
compositional, structural and mechanical properties, which enables efficient load transfer from tendon to 
bone as well as multi-tissue homeostasis. Inspired by the native tendon-bone interface, we have 
designed and evaluated a biomimetic bilayer scaffold, comprised of electrospun poly (lactide-co-glycolide) 
(PLGA) nanofibers seamlessly integrated with PLGA-hydroxyapatite (HA) fibers, in order to engineer 
tendon-bone integration. 
 The objective of this thesis is to explore the key design parameters that are critical for integrative 
tendon-bone repair using this biphasic scaffold as a model. Specifically, intrinsic to the scaffold, effects of 
fiber alignment, fiber diameter, mineral distribution, and polymer composition on integrative rotator cuff 
tendon-bone healing were evaluated in vivo using a rat model. Results indicated that an aligned, 
nanofiber-based scaffold with a distinct order of non-mineralized and mineralized regions will lead to 
insertion regeneration and integrative tendon-bone repair. Additional tissue engineering design 
parameters such as healing time and animal model were also tested. It was observed that the biphasic 
scaffold exhibited a stable long term response, as the mechanical properties of rat shoulders repaired by 
this scaffold remained comparable to that of the control at 20 weeks post-surgery. This scaffold was also 
evaluated in a large animal model (sheep), in which a clinically-relevant rotator cuff repair procedure was 
implemented with the biphasic scaffold. Results demonstrated the scaffold lead to integrative rotator cuff 
repair through the regeneration of the enthesis in both small and large animal models.   
 In summary, through a series of in vivo studies, the work of this thesis has identified the critical 
tissue engineering parameters for integrative and functional rotator cuff tendon repair. More importantly, 
the design principles elucidated here are anticipated to have a broader impact in the field of tissue 
engineering, as they can be readily applied towards the regeneration of other soft-hard tissue interfaces.  
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1.1 Specific Aims 
The rotator cuff consists of four muscles: infraspinatus, supraspinatus, teres minor and 
subscapular1 and their associated tendons surrounding the ball-and-socket joint formed by the humerus 
and scapula. These muscles and tendons function in synchrony to stabilize the glenohumeral joint, 
control shoulder kinematics and enable the range of motion essential for daily activities2. Rotator cuff 
tendon tears are among the most common injuries of the shoulder, accounting for more than 4.5 million 
physician visits annually4;5. Most full-thickness tears involve rupture of the supraspinatus tendon from the 
humerus at or near the tendon-bone insertion site, a fibrocartilaginous region through which the tendon 
attaches to the bone. These injuries do not heal spontaneously6-8. As a result, clinical intervention is 
required for treating rotator cuff tears. More than 250,000 rotator cuff repair surgeries are performed 
annually in the U.S.9. Currently, primary repair, in which the torn tendon is re-attached to the humeral 
head, followed by extensive rehabilitation is the treatment of choice10. However, this treatment is often 
associated with tendon re-tear, with failure rates ranging from 20 to 94%11;12. The leading cause of the 
failure is the lack of biological fixation of the tendon to bone. Current surgical techniques and rotator cuff 
augmentation grafts focus on improving the initial mechanical properties of the repaired tendon-bone 
insertion or biological healing of the tendon. However, they do not lead to the regeneration of the native 
tendon-bone insertion, which is the key to biological fixation. Therefore, there is an unmet clinical need for 
an integrative rotator cuff tendon-bone repair approach. 
Due to the limited intrinsic ability of the insertion to regenerate, tissue engineering approaches 
have been taken to enhance this process. The native tendon-bone insertion is a heterogeneous tissue 
that consists of non-mineralized and mineralized fibrocartilage with aligned collagen fibers13-18 and 
connects the tendon and bone within a span of several hundred micrometers19. This heterogeneity results 
in the variation of mechanical properties within this tissue15;20;21, which contributes to its function of 
minimizing stress concentration, thus enabling complex load transfer between the tendon and 
bone13;15;22;23. Therefore, in addition to biocompatibility and biodegradability, the ideal tissue scaffold for 
this application should be multiphasic mimicking the two fibrocartilage layers, in order to simultaneously 
regenerate the heterogeneous insertion and achieve biological fixation. 
2
With these criteria in consideration, a structurally continuous yet compositionally distinct scaffold 
has been developed to mimic the fibrocartilage by incorporating the distinct organization and mineral 
distribution profile in the design. This scaffold is fabricated via electrospinning and consists of two layers: 
Phase A of the scaffold consists of aligned poly (lactide-co-glycolide) (PLGA) nanofibers, mimicking the 
non-mineralized fibrocartilage, and Phase B consists of aligned PLGA nanofibers loaded with 
hydroxyapatite (HA), mimicking the mineralized fibrocartilage24. Scaffold structure and composition were 
previously determined from a series of in vitro studies that evaluated interface-relevant cell response on 
individual phases25;26. Results showed that when chondrocytes were seeded, the scaffold supported 
formation of distinct regions of non-mineralized and mineralized fibrocartilaginous tissue in vitro, and in 
vivo in a subcutaneously athymic rat model27. In addition, osteointegration between host bone and the 
biphasic scaffold was enabled by Phase B. The biphasic scaffold was used to repair acute rotator cuff 
injury in a rat model, and results demonstrated that compared to single phased scaffolds, this scaffold 
supported tendon-bone integration through the regeneration of an organized fibrocartilaginous tissue24. 
Collectively, these pioneering studies demonstrated the feasibility of enhancing rotator cuff tendon-bone 
healing with a biomimetic biphasic scaffold that consists of aligned PLGA and PLGA-HA nanofibers, 
laying the ground work for the studies presented in this thesis.  
This thesis continues on exploring the potential of this biphasic scaffold for integrative rotator cuff 
repair. The objective of this thesis is to identify key parameters that contribute to the in vivo efficacy of 
the biphasic scaffold on rotator cuff tendon-bone insertion regeneration. First, the effects of parameters 
that are dependent on the scaffold, including fiber properties, mineral distribution, and polymer 
composition are evaluated in a rat model. Then, the effects of parameters that are independent of the 
scaffold, such as healing time and selection of animal model are evaluated in rat and sheep models, 
respectively. Ultimately, this thesis will help to identify strategically biomimetic scaffold-dependent and 
scaffold-independent parameters that are essential for the in vivo formation of a fibrocartilaginous, 
insertion-like tissue at the tendon-bone junction for integrative rotator cuff repair.  
This thesis is guided by the working hypothesis that the in vivo regeneration of the tendon-bone 
insertion with the biphasic scaffold is the result of certain key parameters, either dependent or 
independent of the scaffold design. It is anticipated that when a key parameter is removed, the biphasic 
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scaffold will become less effective, as a fibrous, unorganized scar-like tissue will form at the insertion 
instead of a fibrocartilaginous, organized insertion-like tissue. To test this hypothesis, this proposal 
consists of the following specific aims: 
Aim 1:  
 
Investigate the effects of scaffold-dependent properties on rotator cuff tendon-
bone healing. 
Hypothesis: Scaffold fiber alignment, fiber diameter, mineral distribution and polymer composition 
all contribute to the formation of a fibrocartilaginous, insertion-like tissue at rat rotator 




Investigate the effects of scaffold-independent factors on rotator cuff tendon-
bone healing. 
Hypothesis 1: Integrative rotator cuff repair by the scaffold is maintained over the long term. 
Hypothesis 2: Effect of the biphasic scaffold on integrative rotator cuff repair is independent of 
animal model 
 
Specifically, Aim 1 focuses on identifying scaffold-dependent organizational (Chapters 2 and 3) 
and compositional (Chapters 4 and 5) parameters. Rat is selected as the animal model for studies in this 
aim, because of the similarity in shoulder structural between human and rat rotator cuff28. The surgical 
procedure will be the same for all chapters included in Aim 1. In these studies, the rat supraspinatus 
tendon will be sharply detached from its insertion on the greater tuberosity of the humeral head, scaffolds 







Aim 2. Effects of 
scaffold-independent 
factors on rotator cuff 
tendon-bone healing
Aim 1. Effects of 
scaffold-dependent 
properties on rotator 





with different structural or compositional properties will be placed at the tendon-bone insertion to augment 
the repair, followed by tendon re-attachment to the humeral head via the tranosseus bone tunnel 
method29. Rats will be sacrificed at week 5 post-surgery for all studies and the supraspinatus-humerus 
complex will be harvested and processed for analyses. Healing will be assessed, and the tissue formed at 
rat rotator cuff repaired by biphasic scaffolds with different design parameters will be characterized and 
compared.  
For scaffold fiber properties, it was demonstrated that both scaffold fiber alignment and diameter 
modulate in vitro matrix deposition of rotator cuff fibroblasts25;30. As a result, these two structural 
parameters are selected for in vivo evaluation. In Chapter 2, the in vivo effect of fiber alignment of the 
biphasic scaffold will be investigated since it was observed in vitro that rotator cuff tendon cells produced 
a physiologically relevant matrix consisting of aligned collagen fibers when seeded on aligned PLGA 
scaffolds, while an unorganized, scar-tissue like matrix was produced on unaligned PLGA scaffold25. 
Nanofiber-based biphasic scaffold consisting aligned or unaligned fibers on both phases will be used to 
repair the rat rotator cuff. It is expected that the in vitro effect of fiber alignment will be translated in vivo, 
as the collagen fiber organization of the regenerated tissue will follow that of the scaffold. As a result, the 
aligned biphasic scaffold will lead to the formation of tissue with organized fibers, and the unaligned 
biphasic scaffold will lead to the formation of scar-like tissue with unorganized collagen fibers. The 
average fiber diameter of the current biphasic scaffold is 680 nm in the PLGA phase and 340 nm in the 
PLGA-HA phase24, both of which are within the range of native collagen fibrils31. It was reported that in 
vitro, rotator cuff fibroblasts increased cell proliferation and production of fibrocartilaginous tissue on 
nano-sized PLGA fibers (320±100 nm) when compared to micro-sized fibers (1.8±0.16 μm)30. Therefore, 
effect of scaffold fiber diameter will be investigated in Chapter 3. Aligned biphasic scaffolds consisting of 
either nanofibers or microfibers will be used to repair rat shoulder defects. It is expected that more matrix 
deposition at the tendon-bone insertion will be observed in the nanofiber scaffold repaired shoulders. The 
effects of scaffold composition will be investigated from the perspectives of mineral distribution within the 
scaffold and polymer composition of the scaffold. Chapter 4 evaluates the effect of biphasic scaffold 
mineral distribution on insertion fibrocartilage formation. In the first study, the biphasic scaffold will be 
placed at the tendon-bone junction with either the proposed (PLGA phase contacting tendon, PLGA-HA 
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phase contacting bone) or reversed orientation. Since the biphasic scaffold is designed to provide phase-
specific cues for non-mineralized and mineralized fibrocartilage formation, it is expected that only when 
the biphasic scaffold is placed with the correct phase order will the physiologically-relevant 
fibrocartilaginous tissue form at the insertion. In this chapter, the effect of a mineral gradient throughout 
the thickness of the biphasic scaffold will also be investigated. It was long believed that the non-
mineralized and mineralize regions are distinguished by the well-defined tidemark13. Recently, it has been 
reported that within the insertion, mineral content increases in a linear, rather than an abrupt manner17;32. 
Although the current biphasic scaffold does not have a mineral gradient within the PLGA-HA layer, it still 
led to the formation of an insertion-like tissue, indicating scaffold mineral gradient might not be critical 
towards achieving in vivo efficacy. Therefore, a gradient scaffold with step-wise change in mineral content 
through the thickness of the scaffold, which better mimics the mineral distribution profile of the native 
tissue than the biphasic scaffold does, will be fabricated and used to repair rat rotator cuff. It is expected 
that no difference will be observed between tissue formed in shoulders repaired by the biphasic and the 
gradient scaffold. Finally, in Chapter 5, scaffold polymer composition will be changed to modulate 
scaffold degradation rate. Specifically, poly (ε-caprolactone) (PCL) will be mixed with PLGA to fabricate a 
biphasic scaffold with a slower degradation rate. The in vivo efficacy of this scaffold will be compared to 
that of PLGA-based biphasic scaffold. It is expected that the slower degradation rate of the PCL/PLGA 
blend will prevent new matrix deposition; therefore, insertion-like tissue will not form at the tendon-bone 
junction of PCL/PLGA scaffold repaired shoulder.  
While Aim 1 focuses on identifying structural and compositional properties of the biphasic scaffold 
that contribute to insertion regeneration, Aim 2 focuses on investigating the effects of scaffold-
independent factors on rotator cuff tendon-bone interface regeneration. In Chapters 2-5, all rats used will 
be sacrificed at 5 weeks post-surgery, which is adequate for providing insight to short term scaffold 
performance. However, the newly formed fibrocartilaginous tissue needs to continue develop and 
remodel in vivo from short to long term to achieve integrative rotator cuff repair. Therefore, in Chapter 6, 
the effect of healing time will be investigated by extending the healing period to 20 weeks post-surgery. It 
is expected that the use of the biphasic scaffold optimized in Aim 1 will improve the mechanical properties 
of repaired shoulders both in the short and the long term, as they will be significantly higher than those of 
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the shoulders repaired without scaffold at the same time point. The ultimate goal of the biphasic scaffold 
is to achieve integrative rotator cuff repair in the clinic. Although promising results have been observed in 
the rat model, its supraspinatus tendon is much smaller than that of human. It is important to ensure that 
the biphasic scaffold can be scaled up for clinical practice, as well as confirming that the efficacy of the 
biphasic scaffold is repeatable in another animal model. To this end, a sheep model is chosen because of 
the similarity in size of rotator cuff tendon between sheep and human33, as well as it being a readily 
accepted animal model for rotator cuff repair34. Therefore, in Chapter 7, performance of biphasic scaffold 
will be evaluated in a sheep model. It is expected that the biphasic scaffold can be scaled up and 
successfully implanted in sheep using current clinical techniques, and the biphasic scaffold will promote 
the formation of insertion-like fibrocartilaginous tissue. 
In summary, several strategic steps are proposed in this thesis to identify key parameters that 
contribute to the in vivo efficacy of the biphasic scaffold. First, the effects of scaffold organizational and 
compositional properties will be investigated. Then, effects of scaffold-independent factors including 
healing time and selection of animal model on in vivo tendon-bone insertion regeneration will be 
investigated. It is expected that with these studies key parameters of the biphasic scaffold that lead to its 
efficacy in regenerating the rotator cuff tendon-bone insertion will be identified. Findings from this thesis 
will provide guidelines for strategically biomimetic scaffold design for regenerating the rotator cuff tendon-
bone insertion. Furthermore, design principles can also be applied to other complex tissues such as the 
ligament-bone and osteochondral interfaces. 
 After Chapter 1-7 lay the foundation for a scaffold that has the potential for clinical use, in 
Chapters 8-11, exploratory work will be performed to determine if the scaffold performance could be 
further enhanced, and to explore working mechanism of the scaffold from the cells’ perspective. 
Specifically, Chapter 8 will explore the potential of mesenchymal stem cells (MSCs) on integrative rotator 
cuff repair. Chapters 9 and 10 will explore the potential of biomechanical and biochemical stimulus on 
MSC differentiation toward fibrochondrogenic lineage, with a focus on approaches to incorporate them 
into the scaffold system. In Chapter 11, the mechanism of the scaffold will be explored, by investigating 
the effect of cell interaction distance on fibrocartilage formation on the scaffold.  
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1.2 Background and Significance 
1.2.1 Rotator Cuff Tears 
The rotator cuff consists of four muscles: infraspinatus, supraspinatus, teres minor and 
subscapular1 and their associated tendons that surround the ball-and-socket joint formed by the humerus 
and scapula (Figure 1.2). These tendons connect the corresponding muscles to the greater tuberosity of 
the humerus through a direct tendon-bone insertion, and together they connect the upper arm to the 
scapular. The muscles and tendons of the rotator cuff 
function in synchrony to stabilize the glenohumeral joint, 
actively controlling shoulder kinematics and enabling the 
range of motion essential for daily activity2. Within the 
shoulder, the rotator cuff is situated below the 
coracoacromial arch of the scapula. In the same space, 
the subacromial burse acts as a lubricant to allow the 
rotator cuff to move freely and smoothly when the upper 
arm moves1. 
 Rotator cuff tendon tears are among the most common injuries of the shoulder, accounting for 
more than 4.5 million physician visits annually4;5. The origin of the injury can be intrinsic or extrinsic28;35;36. 
Intrinsic injuries are caused by tendon overload, degeneration due to age, or other insults such as trauma 
to the tendon28;36;37. Extrinsic injuries are the results of pressure to the tendon from surrounding tissue, 
such as bone impingement28;38. Despite various causes, the majority of the rotator cuff tears are caused 
by cuff tendon degeneration, as evidenced by pathologic analysis35;39-41. Multiple clinical studies have 
shown that degeneration is age-related, as a higher rotator cuff tendon tear rate is observed in older 
populations42-44, with an almost 100% occurrence rate in people who are 70 years of age or older45. Out 
of the four tendons, the supraspinatus tendon is the most commonly impacted46, as it is located directly 
underneath the coracoacromial arch and has a high chance of experiencing impingement from the bony 
structure, leading  to tendinitis and eventual rotator cuff tear47. Rotator cuff tears can be classified as 
partial- or full-thickness depending on if the tear propagates through the whole thickness of the tendon. In 









Figure 1.2. Human rotator cuff anatomy 
(adapted from the MMG group) 
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each with different classification criteria, such as size, shape or extent of the tear, are currently in use48;49. 
This lack of a universal classification system leads to interobserver disagreement and complicates the 
diagnostic and treatment procedure49. Usually, partial-thickness tears are classified according to their 
location: they can be articular-sided, bursa-sided, intratendious, or a combination of these50. To treat 
these tears, typically acromioplasty or debridement of the lesion is performed, leading to satisfactory 
results51;52. Full-thickness tears occur across the whole depth of the tendon and can be further classified 
based on their size: small (tears < 1cm), medium (tears between 1-3 cm), large (tears between 3-5 cm) or 
massive (tears >5 cm)53.  
Most full-thickness tears involve the rupture of the supraspinatus tendon54;55 from the humerus at 
or near the tendon-bone insertion site, a fibrocartilaginous region through which the tendon attaches to 
the bone13;56. These injuries do not heal spontaneously as the combined effects of the complex shoulder 
anatomy, extended range of joint motion and weakening of the cuff tendons post-injury6-8 limit the intrinsic 
healing capacity of injured tendon. As a result, clinical interventions are required for treating rotator cuff 
tears. More than 250,000 rotator cuff repair surgeries are performed annually in the U.S.9. Currently, 
primary repair, in which the torn tendon is re-attached to the humeral head, followed by extensive 
rehabilitation is the treatment of choice10. The aim of the surgery is to restore the anatomic attachment of 
the tendon to the original footprint on the humerus57. However, this treatment is associated with tendon 
re-tear, with failure rates ranging from 20% to 94%11;12. The high failure rate is attributed to factors such 
as severity of the tear, degenerative and poorly vascularized tendons, poor quality of the bone of humeral 
head and muscle atrophy, leading to the lack of tendon-bone healing33;55;58-64. Therefore, strategies that 
have been developed to decrease the failure rate focused on improving tendon-bone healing. Gerber et al. 
proposed that an ideal rotator cuff tendon-bone repair should provide high initial tendon fixation strength, 
allow minimum gap formation between fixed tendon and bone and maintain mechanical stability 
throughout the tendon-bone healing process33;45;65. Surgical techniques and devices have been modified 
and/or designed to achieve this goal, as discussed in the following sections. 
 
1.2.2 Repair Techniques 
 Repair techniques typically focus on providing high initial mechanical properties as well as 
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increasing the contact area and pressure between the tendon and bone45;66. It is proposed that a larger 
contact area will increase the size of the newly formed insertion, thus improving tendon-bone healing45. 
Traditionally, open surgery is performed to repair rotator cuff injury67-69. In this procedure, an incision is 
made over the shoulder and the deltoid is detached for better access to the torn tendon70. Recently, less 
invasive procedures, such as arthroscopic-based surgery and mini-open surgery have been used for 
rotator cuff repairs.  
To re-attach tendon to bone, in open or mini-open surgeries, the transosseus suture repair 
technique has been used59;71-73. In this method, bone tunnels are drilled on the humeral head and sutures 
are passed through these tunnels to fix tendon to bone. It has been shown that the suture 
configuration73;74 and tendon grasping method33 can impact the mechanical properties of the fixed tendon. 
However, regardless of the suture approach, this repair does not provide sufficient mechanical strength to 
the shoulder and re-tears often occur. Since the transosseus suture repair cannot be performed in 
arthroscopic-based approaches, the gold standard in rotator cuff repair75, new techniques to fix tendon to 
bone have been developed for their use in the arthroscopic approach. Initially, the single-row suture 
anchor method was used76-78. In this technique, one or two anchors preloaded with sutures are arranged 
in a row and placed laterally to the tendon footprint on the humeral head. To repair the torn tendon, the 
sutures are passed through the tendon from articular to bursal side, pulled to reattach the tendon to the 
footprint and tied back to the anchor(s) to secure the fixation. However, studies have shown that 
compared to the transosseus method, the single-row suture anchor technique does not restore the 3-D 
anatomy of the supraspinatus footprint45, with the restored footprint smaller and thus placing less 
pressure on the cuff79, resulting in more tendon-bone interface motion71, indicating inferior performance of 
the single-row suture anchor repair method. To improve the arthroscopic performance of suture anchors, 
the double-row suture anchor fixation technique was developed. In this method, two anchors preloaded 
with sutures are placed to the medial aspect of the footprint in a row and the other row of two anchors is 
placed to the lateral aspect of the footprint. To repair the torn tendon, sutures from the medial row are 
passed through the tendon from articular to bursal side, pulled to re-attach tendon to the footprint and tied 
to the corresponding lateral row anchor to secure the fixation. Compared to the transosseouses tunnel 
method, the double-row anchor fixation method increases tendon-bone contact area and pressure80, as 
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well as leading to a higher initial mechanical strength66. On the other hand, it was also reported that the 
double-row suture anchor method leads to a higher stress concentration inside the tendon compared to 
the transosseous method, which could be the cause of the often observed high re-tear after arthroscopic 
rotator cuff repair using suture anchors69;81.  
Combining the benefits of both transosseous tunnel 
and double-row suture anchor techniques, the 
transosseous equivalent anchor fixation technique has 
been developed for the arthroscopic approach82. This 
technique can be seen as a combination of the double-row 
suture anchor fixation and suture bridge technique, thus it is 
referred to as the double-row suture-bridge technique. In 
this technique, as in the double-row approach, a medial row 
of anchors preloaded with sutures and a lateral row of 
anchors are used. To repair the torn tendon, first the medial 
row of anchors are placed into the humeral head, two of the 
sutures from these are then passed through the medial 
aspect of the torn tendon from articular to bursal side, the suture tails are then passed into the eyelets of 
the two lateral anchors respectively, in a cross pattern, which are inserted into the lateral aspect of the 
footprint76;83(Figure 1.3). This configuration leads to increased compression between tendon and bone, 
optimizes tendon-bone contact dimension, provides sufficient initial strength to withstand immediate 
postoperative rehabilitation, and allows a more even pressure distribution compared to double-row suture 
anchor fixation82;84;85. Biomechanical tests have shown that rotator cuffs repaired with this method 
resulted in higher yield load and ultimate failure load than those repaired by the single- or double-row 
techniques57;86, leading to a higher healing rate and a lower re-tear rate57;77;83. This method has quickly 
gained popularity and has been widely used in arthroscopic rotator cuff repair surgeries76. 
 
1.2.3 Augmentation Grafts 
A B
C D
Figure 1.3. Schematic of double-row 
suture-bridge technique. A: placement of 
the medial row of anchors, B: reattach 
tendon to bone through sutures, C: 
placement of the lateral row of anchors D: 
finished look demonstrating the two rows of 
anchors and crossed sutures 
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Another approach to improve the mechanical strength of repaired rotator cuff is to augment the 
repair with grafts. These grafts are often used to repair massive rotator cuff tears, in which the tendon is 
detached from the humeral head, leaving a gap between tendon and bone, or when there is more than 
one tendon involved in the tear. The grafts are applied to the repair site in an “onlay” or interposition 
configuration, in which the graft is sutured to cover the tendon and bridge the gap between tendon and 
bone. They serve the function of improving the physical strength of the repair through mechanical 
reinforcement and/or improving the biological healing response10;87-91. Based on the materials, these 
grafts can be categorized as biologic or synthetic. Currently, rotator cuff repair augmentation grafts from 
both types of materials are commercially available. 
1.2.3.1 Biological grafts 
Biological grafts are based on allogeneic or xenogenic extracellular matrices (ECM) such as small 
intestinal submucosa (SIS) and dermis8;92-96. To minimize patient immune response, these grafts are 
decellularized through a series of treatments including lysis, enzymatic treatment and physical removal of 
the cells from ECM97;98. Through the decelluarization processes, the grafts maintain the 3D structure of 
the native ECM, and have been shown to have similar hydroxyproline99 and chondroitin/dermatan 
sulfate93 content as in the native tendon99. Therefore, in addition to providing initial mechanical strength, 
they are believed to provide chemical, structural and biological cues to host cells via their natural 
composition and remodeling byproducts90;92;100-105, prompting a cell response in favor of tissue healing. It 
has been shown that graft-augmented rotator cuff tendons have improved mechanical properties in 
cadaver shoulders106, in addition, improved histological appearance, mechanical properties and 
incorporation of the graft to host tissue have been reported in variety of animal models including rat107-109, 
sheep95;110, and even in primate102. However, when used in clinical studies, the biological grafts lead to 
mixed results.  
The performance of SIS-based grafts is far from satisfactory. Two clinical studies reported that 
they caused an acute inflammatory response, leading to additional irrigation and debridement procedures 
to mitigate the adverse response111;112. In the long term, use of SIS-based graft did not decrease the re-
tear rate of cuff repair surgeries96 and did not increase the functional outcome scores at follow up 
compared to the repair performed without graft agumentation94;96. In one study, the use of SIS scaffold 
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even led to lower functional scores compared to control112. As a result, SIS grafts were not recommended 
for augmenting massive rotator cuff tears94;112. Compared to SIS grafts, dermis-based grafts showed 
better performance. Most of the clinical studies have used GraftJacketTM. It has been used in open rotator 
cuff surgery to repair massive tears113. It has also successfully been used in arthroscopic augmentation of 
massive114, irreparable tears115-117 and tears involve two tendons118. Augmentation with GraftJacketTM led 
to high patient satisfaction116, improvement in post-op shoulder functional scores compared to control 
repair118 or before surgery114-117;119. The PermacolTM grafts demonstrated biocompatibility and graft 
incorporation in humans105, as well as improved shoulder functional scores post-surgery120. Similarly, the 
Zimmer patch also demonstrated efficacy when used in repairing massive rotator cuff tears, as significant 
improvements of patient’s functional outcomes have been observed at post-op87. However, in a case 
study where four patients underwent repair of massive rotator cuff tears augmented with this graft, it was 
reported that all of them showed early complications such as reduced range of motion and increase in 
pain, one showed signs of inflammation, and the surgeon did not recommend use of Zimmer patch for 
irreparable massive rotator cuff tears121. In addition to inconsistent performance, the efficacy of any 
biologic grafts on rotator cuff repair augmentation has yet to be demonstrated in a prospective, controlled 
clinical study122. 
Three main reasons are proposed to explain the inconsistent performance of biological grafts. 
The first reason is the less than ideal efficacy of the deceullarization process. Although much effort has 
been spent on removing cells from the original tissue, a study in 2004 showed that the Restore graft 
contains several layers of residual cells and caused inflammatory reaction in rabbits and mice when 
implanted subcutaneously123. The potential incomplete decelluarization could lead to the reported immune 
response from patients. Secondly, systematic studies that compare mechanical properties of the 
biological grafts showed that the majority of them have inferior mechanical properties such as maximum 
tensile loads91;124 and shear modulus125 compared to those of the native rotator cuff tendon20;93;126, even 
for the ones cross-linked to increase mechanical properties. Finally, it is possible that the effectiveness of 
the grafts is impacted by the size of the tears, as a clinical study showed a significant correlation between 
size of tendon gap and the pain and functional scores of patients, when the tear is less than 2 cm, better 
outcomes have been observed127, while in most of the clinical studies, the biological graft was used to 
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augment massive rotator cuff tears.  
1.2.3.2 Synthetic grafts 
Synthetic grafts have been developed with the goal of providing initial mechanical reinforcement 
as well as lasting physical stabilization of the repaired rotator cuff90. An ideal synthetic graft should be 
biocompatible to minimize inflammation when used in surgery and biodegradable to allow for infiltration of 
newly grown tissue128. Polymers such as polyglycolic acid129, polylactic acid130-132, chitin fabric133, 
polycarbonate and polyurethane122, polytetrafluoroetilene134 and polyethyleneterephthalate135 have been 
investigated for this purpose. Currently, there are four commercially available synthetic grafts for rotator 
cuff repair: SportMesh (polyurethane-urea), X-Repair (polylactic acid), Biomerix RCR-Patch 
(polycarbonate and polyurethane-urea), and Gore-Tex patch (polyethyleneterephthalate). Biocompatibility 
of synthetic scaffolds have been confirmed in animal models122;130. Mechanical properties, such as 
stiffness, ultimate load130 and shear modulus136 have been measured and shown to be comparable to that 
of the native rotator cuff tendon125. It has been demonstrated in a cadaveric model that augmentation with 
synthetic graft increased shoulder mechanical properties137. Furthermore, the synthetic grafts showed 
promising results when tested in animal models, as X-Repair increased stiffness and strength of initial 
repair compared to the non-augmented repair in a canine model130, Biomerix RCR-Patch demonstrated 
an increase in failure load compared to non-augmented repair in an ovine model138 and Gore-Tex patch 
increased the ultimate force and stress of repaired sheep shoulders at three months post-surgery, 
compared to repair without it139. 
Compared to biological grafts, when used in clinical settings, synthetic grafts showed better 
performance. In most of the clinical studies, Gore-Tex has been used. In short term, when used to 
augment massive irreparable tears, the Gore-Tex graft led to excellent healing at one and 12 weeks, with 
improvement in pain, strength and impingement signs140. In another study, at one year follow up of 
augmentation of massive rotator cuff tear, in addition to improvement in outcome scores, histology 
showed a tight connection of the scaffold to bone and a smooth attachment to the tendon without 
inflammation141. The promising performance is also seen at long term follow-up, as it was reported that 
Gore-Tex significantly improved the functional outcome scores at 44 months compared to pre-
operation135, and at 10 years, healing of patch material to tendon in 4 out of 5 patients and to bone in all 5 
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patients was observed142. Similarly, it has been reported that X-Repair led to low re-tear rate at 12 and 42 
month follow ups and improved shoulder function143. Biomerix scaffold caused no adverse reaction, 
resulted in low re-tear rate and improvement in functional scores at 12 month post-surgery144. Although 
no surgical case in rotator cuff repaired using SportMesh has been reported, it showed low re-tear rate 
when used to repair subscapularis tendon tear145, indicating a promising result for rotator cuff repair. 
These results indicate the potential of augmenting rotator cuff repair with synthetic grafts. However, 
additional clinical studies, especially ones comparing healing with and without augmentation will be 
needed before a definitive conclusion can be drawn.  
To combine the advantages of biological and synthetic grafts, approaches have been taken to 
create hybrid grafts. In one study, polymer braids were used to reinforce a fascia patch and was shown 
effectively improve the mechanical properties of the patch to be equivalent or better than that of the 
rotator cuff tendon146. Compared to other types of grafts, the hybrid graft is relatively new and there is 
only one that is commercially available(OrthADAPT PR Bioimplant by Pegasus Biologics, made with 
equine pericardium with non-woven polymer) and no animal or clinical studies using it have been 
reported90.  
In summary, to improve tendon-bone healing, surgical techniques have been refined in order to 
develop methods that result in stronger initial mechanical properties, increased contact area and pressure 
between tendon and bone. Augmentation grafts have also been developed, but only achieved limited 
success as they often show inferior mechanical properties to native tendon, and no consensus has been 
reached regarding the functional efficacy of such grafts. Therefore, there is a significant clinical need for a 
method that would lead to integrative rotator tendon-bone repair. Due to the functional significance of the 
native tendon-bone insertion, regeneration of this interface is a pre-requisite for biological fixation, the key 
to integrative rotator cuff repair. One potential solution is the tissue engineering approach, in which the 
tendon-bone insertion will be regenerated post-surgery. Specifically, in this approach, a repair scaffold will 
be placed at the tendon-bone interface, and its structural and compositional cues will recruit host cells to 
infiltrate, differentiate and produce a matrix that is similar to that of the native tendon-bone insertion, 
leading to its eventual regeneration. Details of this approach will be discussed in subsequent sections. 
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To better understand what scaffold cues are necessary for a biomimetic scaffold design, details of 
the native tendon-bone insertion, including its structure-function relationship, development and healing 
are discussed in the following section.  
 
1.2.4 Tendon-Bone Insertion: Structure-Function Relationship, Development and Healing 
1.2.4.1 Insertion structure-function relationship 
 Rotator cuff tears often result from avulsion 
of the supraspinatus tendon at the tendon-bone 
insertion site147. Connecting tendon to bone, two 
tissues with different properties, the insertion has 
developed unique, controlled heterogeneity in 
compositional, organizational and mechanical 
properties to perform its function, which is to 
minimize stress concentration and ensure a smooth 
transition of load between tendon (Young’s modulus 
in the range of several hundred MPa20;126;148) and 
bone (Young’s modulus usually in the range of 10-30 GPa149;150) 
 Compositionally, different from tendon, which consists of aligned fibers rich in collagen I, with a 
main cell type of fibroblasts35;151 and bone, which consists of organized fibers rich in collagen I and 
mineral, with three different types of cells (osteoblasts, osteoclast and osteocytes)152;153, the tendon-bone 
insertion is fibrocartilaginous and can be divided into non-mineralized and mineralized regions(Figure 1.4). 
The non-mineralized fibrocartilage consists of a collagen I, II and a glycosaminoglycan (GAG) rich ECM 
populated by fibrochondrocytes, while the mineralized fibrocartilage, in addition to collagen I, II and GAG, 
also contains collagen X and mineral (hydroxyapatite, HA) with the predominant cell type being 
hypertrophic fibrochondrocytes13-15;154. In terms of organization, the orientation of collagen fibers change 
at different locations within the insertion: collagen fibers exhibit a well aligned, parallel pattern in the 
tendon, but progressing towards the non-mineralized region, fibers become slightly less aligned and the 




Figure 1.4. Rotator cuff tendon-bone 
insertion3. H&E stained, NF: non-mineralized 
fibrocartilage, MF: mineralized fibrocartilage, TM: 
tidemark, AC: articular cartilage. 
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mineralized region15;17;18. These heterogeneities in tissue composition and organization lead to the 
controlled variation in mechanical properties across the insertion. Generally, an increase in the mineral 
content of collagen fibers leads to the stiffening of them in the tissue, and this effect becomes significant 
when mineral volume fraction becomes higher than a certain threshold (≈0.5), at which a continuous 
network of mineralized collagen forms. On the other hand, decreased collagen fiber orientation reduces 
the stiffness of the tissue17. Therefore, progressing from tendon proper to bone, the initial decrease in 
fiber alignment within the non-mineralized fibrocartilage results in a more complaint region compared to 
tendon15;20;21. Approaching towards the bone end, collagen fibers become stiffer as the result of 
increasing mineral content. Eventually the mineral content is higher than the threshold for the formation of 
continuous network of mineralized collagen fibers, and the increase in fibrocartilage stiffness overcomes 
the decrease caused by less aligned fibers, leading to an overall increase in the stiffness of the insertion 
at the bone end15. These unique and controlled heterogeneous mechanical properties of the insertion 
ensure efficient load transfer from tendon to bone13;15;22;23. 
1.2.4.2 Insertion development  
Development of the insertion is a well-orchestrated process lasting from fetal to postnatal stages. 
It has been shown in mice that the formation of the insertion occurs by endochondral ossification during 
fetal development, in which cartilage mineralizes to form bone, followed by the development of a 
fibrocartilaginous region between tendon and bone155. This region is indistinguishable from tendon and 
bone, until 7 days postnatal. The collagen fibers and mineral in this region continue to remodel until a 
mature, well-organized, transitional tissue is formed19. The mature fibrocartilaginous insertion is not 
formed until 21-days postnatal, at which time the four distinct zones (tendon, non-mineralized 
fibrocartilage, mineralized fibrocartilage and bone) can be seen on the mineralized humeral head156. 
Biological cues are important for this process. For example, expression of insertion-related ECM genes is 
controlled both spatially and temporally during insertion development, as indicated by a study that 
monitored the expression of collagen I, II and X at the four regions from postconception up to 56 days 
postnatal in mice. It was found that at the tendon region, only collagen I was expressed by fibroblasts 
throughout the duration of the study. In the non-mineralized fibrocartilage, both collagen I and II were 
expressed by chondrocytes. Collagen I expression persisted until day 56, while collagen II expression 
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lasted to day 21. In the mineralized fibrocartilage, collagen II was expressed from day 7 to day 56, 
collagen X was expressed from day 14 to day 56, corresponding with the onset of mineralization in the 
bone region, in which collagen II was expressed postconception only until day 14, after which the bone 
was completely mineralized156. Mechanical loading is also critical for insertion development as indicated 
by a study that investigated effect of supraspinatus muscle loading on fibrocartilage formation and bone 
mineralization during insertion development in mice. It was reported that although no effect was observed 
at day 14 postnatal, from day 21 to 56, fibrocartilage development was delayed and bone mineralization 
was decreased in the group where muscle loading was completely removed by Botox injection157. These 
studies demonstrate that insertion development is the result of the combined effects of spatially and 
temporally controlled biological and mechanical cues. 
1.2.4.3 Insertion healing 
Since the ultimate goal of tissue engineering is to augment the healing process of injured tissue 
towards the regeneration of native tissue rather than scar tissue, understanding of the tendon-bone 
insertion healing is critical. Using animal models, a significant amount of knowledge has been obtained 
regarding the healing process of rotator cuff tendon-bone insertion. 
Similar to insertion development, healing is modulated by both biological and mechanical cues. 
Using a rat rotator cuff acute injury model, expression of ECM genes in the healing supraspinatus tendon-
bone insertion was investigated up to 8 weeks post-injury158. A distinct expression profile was observed in 
the healing tissue. Specifically, compared to uninjured tissue, expression of collagen I was elevated both 
at the insertion site and tendon region while expression of collagen X was decreased in the insertion 
region. Growth factors known to be important for tendon healing, such as basic fibroblast growth factor, 
insulin-like growth factor 1 and transforming growth factor-β (TGF-β) were expressed in a controlled 
manner during the insertion healing158-160. However, the expression profile of genes and growth factors in 
tendon healing is different from that of tendon development. One example is the expression profile of the 
TGF-β isoforms, which are associated with scar formation in wound healing161;162. Specifically, fetal 
scarless healing in tendon is characterized by low expression levels of TGF-β1 and high expression 
levels of TGF-β3, while in adult healing, a predominate expression of TGF-β1 is reported during scar 
tissue healing162-165. Correspondingly, it was found that during fetal development of the insertion, TGF-β3 
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is predominately expressed at the early stage and TGF-β1 is predominately expressed at the late stage156. 
During adult insertion healing, however, high expression levels of TGF-β1 were observed at the insertion 
and no TGF-β3 expression could be detected166, leading to the formation of scar tissue and loss of 
functionality of the native insertion. 
 The effect of mechanical loading on insertion healing has also been investigated. Using animal 
models, it was shown that adequate loading is needed to reappose the torn tendon to bone after repair167. 
Immobilization, which removes the extrinsic loading from active shoulder movement, led to better healing 
with improved tendon collagen fiber organization and mechanical properties compared to normal cage 
activity or exercise9;168;169. On the other hand, it has shown that when Botox injection is used to remove 
intrinsic loading from muscle to the tendon-bone insertion, it is detrimental to the insertion healing12. 
These differences in biological and mechanical factors between insertion development and healing 
contribute to the ineffectiveness of insertion site regeneration after injured. Compared to the well-
organized, fibrocartilaginous, functional native insertion which contains a controlled heterogeneity of 
properties, the repaired insertion is comprised of fibrovascular, disorganized tissue with inferior 
mechanical properties158;169;170 that is inefficient in transferring loads, leading to the high re-tear rate of 
tendon-bone repairs. 
 
1.2.5 Current Tissue Engineering Strategies for Rotator Cuff Tendon-Bone Insertion Regeneration 
 The pre-requisite for integrative rotator cuff repair is the regeneration of the tendon-bone insertion, 
which is limited due to the low intrinsic healing capacity of the native tissue, but might be achieved by the 
tissue engineering approach. In this approach, through the use of scaffolds that mimic the native tissue 
and/or modulate the microenvironment of the injury site, cells, applied externally or recruited from native 
tissue, are guided to produce native tissue-like ECM, ideally with comparable organizational, 
compositional and mechanical properties, achieving tissue regeneration. All three components, the cell, 
the microenvironment and the scaffold are critical to this process. Therefore, this section will focus on 
them and discuss how they are used in integrative rotator cuff repair. 
1.2.5.1 Mesenchymal stem cell-based approach 
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The tendon-bone healing process involves multiple cell types including fibroblasts in the tendon, 
fibrochondrocytes in the tendon-bone insertion region, and osteoblasts in the bone region. However, 
these are all primary cells, which are differentiated and have limited capability of self-renewal and matrix 
production. To overcome this hurdle, a stem cell based approach is considered. For regenerating 
orthopedic tissues, MSCs are widely used171-178 as they can be obtained from bone marrow or adipose 
tissue through simple procedures179-181. For rotator cuff repair, MSCs are intrinsic to the procedure, as 
they can be isolated from the marrows obtained through the anchor tunnels during arthroscopic rotator 
cuff repair182. Furthermore, it has been demonstrated that the MSCs can differentiation into 
fibroblastic183;184, chondrogenic180;185-188 and osteogenic188-191 linages with appropriate stimuli, making 
them suitable for regenerating the heterogenous tendon-bone insertion. A significant amount of work has 
been performed to investigate the efficacy and working principle of MSCs in animal rotator cuff repair 
models.  
Using the rat model, Gulotta et al. performed a series of experiments to investigate the use of 
MSCs to augment acute full thickness rotator cuff repair. In all studies, MSCs were pre-seeded on a fibrin 
carrier, and the repair was assessed at weeks 2 and 4 post-surgery. In the first study, directly isolated 
MSCs without any modifications were used. Although the cells were metabolically active, they did not 
improve the structure, composition or strength of the healing tendon192. This failure was thought to be due 
to the lack of guided differentiation of MSCs. In the following three studies, MSCs transduced with 
membrane type 1 matrix metalloproteinase (MT1-MMP, upregulated during development of tendon-bone 
insertion)193, scleraxis (Scx, related to tendon development)194 or bone morphogenetic protein-13 (BMP-
13, related to chondrogensis and tendon formation)195, were used for repair. Results showed that both 
MT1-MMP and Scx induced MSCs enhanced tendon-bone insertion development as more fibrocartilage 
formation with increased mechanical properties were observed compared to control repair. On the other 
hand, BMP-13 induced MSCs did not lead to improvement in tendon-bone healing compared to control. 
These studies showed that there are certain differentiation pathways of the MSCs that are more effective 
for regenerating the tendon-bone insertion. When used in a rabbit model, MSCs led to more fibrocartilage 
formation and improved insertion mechanical properties129. With the promising results from animal studies, 
MSCs were used in human surgeries. In one case report, MSCs were used to augment full-thickness 
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rotator cuff tear with localized injection. Follow-up at 1 year post-surgery showed no adverse sign of using 
MSCs and improvement of shoulder functional scores compared to pre-surgery196. However, due to the 
lack of comparison to a control group where no MSCs were used for repair, it cannot be concluded that it 
was the MSCs led to the positive outcome.  
In summary, although theoretically MSC is the ideal cell source for augmenting the tendon-bone 
insertion, its application is still under investigation. Currently, there is only limited support in the literature, 
due to the general lack of testing in large animal models and prospective, comprehensive clinical studies. 
As a result, a considerable amount of efforts is needed before the routine use of MSCs in rotator cuff 
augmentation.  
1.2.5.2 Microenvironment modulation 
 Since the microenvironment provides biological and mechanical cues to guide cell behavior, they 
have been tested in the tissue engineering approach of regenerating the tendon-bone insertion. For 
biological cues, effects of individual growth factors have been tested in animal models and clinical 
settings. While animal studies showed positive outcomes both histologically and mechanically with the 
addition of growth factors such as TGF-β3197;198, fibroblast growth factor-2199;200, growth differentiation 
factor-5201, bone morphogenetic protein-2202 and-12203, cartilage-derived morphogenetic protein 2204 and 
platelet-derived growth factor-BB205;206, their application in clinical settings has been hindered for several 
reasons. First of all, the growth factor needs to be present and active at the repair site during healing. 
Although coating it on suture or using a carrier matrix helps to retain the growth factor, its activity may be 
altered. Secondly, it is critical to control the amount of growth factors applied to the insertion. On the one 
hand, the concentration needs to be high enough for the growth factors to be effective, on the other hand, 
it has been reported that too high a concentration can be detrimental to tissue healing207;208. Currently, no 
optimal concentration for clinical application has been determined for any of the growth factor tested in 
animal models. Finally, as mentioned in the previous sections, insertion development and healing are 
achieved through organized temporal expression of localized growth factors, not the result of a single 
growth factor. Because of these disadvantages of single growth factors, platelet-rich plasma (PRP), which 
contains a mixture of growth factors that are important for tendon healing209 is frequently used in clinical 
settings for rotator cuff repair. PRP is obtained from the patient’s blood via centrifugation and currently 
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there are several commercially available systems for on-site PRP preparation. Compared to the 
application of a single type of growth factor, PRP has been extensively tested in human rotator cuff 
surgeries. Despite the popularity, to date, there is no scientific consensus that supports its efficacy. 
Animal studies and early clinical studies demonstrated that PRP improved shoulder functionality 
compared to pre-augmentation, most of the recent studies showed PRP did not improve the shoulder 
function or integrity compared to the repair without it. This inconsistency in performance can be explained 
by several factors. First of all, there is no universal quality control of the PRP, as multiple vendors provide 
different systems and procedures for PRP isolation, resulting in differences in growth factor concentration 
in the RPP210. In addition, the potency of the PRP is determined by the platelet count of the blood, which 
can vary widely among individuals, or even within the same patient at different times211;212. Secondly, in 
different studies, PRP was applied differently, from direct injection213;214 to a matrix formulation215-218. The 
lack of a standard method of application adds another variable that could impact PRP’s efficacy. Finally, 
the severity and chronicity of the rotator cuff tears are not controlled in different studies, and PRP might 
be most effective when treating a specific type of injury.  
 Compared to biological cues, application of mechanical cues to the tissue engineering of tendon-
bone insertion has not been widely tested or advanced. Currently, most of the efforts have been spent to 
test the efficacy of mechanical loading on scaffolds for tendon regeneration219-222. Compared to tendon, 
which experiences uniaxial tensile loading most of the time, the fibrocartilaginous tendon-bone insertion 
experiences both tensile and compressive loading223;224. To test the effects of compressive loading on 
fibrocartilage formation, Thomopoulos et al. designed a bioreactor that is able to apply compressive and 
tensile loading simultaneously. Study of MSCs showed that although compressive loading changed cell 
morphology from spindle to round, change in expression profile of fibroblastic and chondrogenic genes 
was not observed, unless external TGF-β3 was supplemented in addition to compressive loading225.  
 From the current studies that investigate effect of microenvironments, including growth factors 
and mechanical loading on the rotator cuff tendon-bone interface regeneration, it can be concluded that 
they have achieved limited success. 
1.2.5.3 Scaffold design  
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 In tissue engineering, a scaffold that mimics the native tissue is often used to support the 
infiltration, proliferation and matrix production of either pre-laden cells or host cells. Ideally, the scaffold is 
biomimetic in terms of its composition, organization and mechanical properties. For its application in 
tendon-bone regeneration, the focus of scaffold design is to recapitulate the heterogeneity across the 
insertion. Several groups have worked on creating such scaffolds and their designs are discussed in 
detail below.  
 One major feature of the insertion is the change in mineral content as it progresses from the non-
mineralized region to the mineralized region. Since this change is critical for the unique mechanical 
properties of the insertion that are essential to its function, a scaffold with a region-dependent change in 
mineral content will be highly advantageous for tendon-bone repair226. Dickerson et al. harvested bovine 
cancellous bone, decellularized it and selectively removed the mineral in the bone to create a scaffold 
that consists of a non-mineralized region and a mineralized region. When used in the sheep model to 
repair rotator cuff, the scaffold led to the formation of fibrocartilage between tendon and bone. However, 
compared to the native insertion, this fibrocartilage region is thicker, likely due to the large size of the 
scaffold used227. Although results were promising, the method of scaffold harvesting and preparation is 
challenging for application in clinical settings. Therefore, selective mineralization methods have been 
tested on synthetic scaffolds for this purpose. Li et al. immersed PLGA and PCL scaffolds in 10x 
simulated body fluid. By changing the immersion time of different sections of the scaffold, a gradient of 
mineral was created on the surface of the scaffold. It was reported that this gradient led to controlled 
modulation of stiffness across the length of scaffold. Furthermore, it was observed that MC3T3 cells 
proliferated more at the high mineral end of the scaffold, indicating that it might be possible to guide cell 
behavior with changes in mineral content228. Using the same method, Liu et al. created scaffolds with 
mineral gradient and showed that the scaffold spatially controlled the osteogensis of seeded adipose-
derived stem cells, with higher activity on areas of higher scaffold mineral content229. To further increase 
the stiffness of mineral coated scaffold, a different soaking solution, as well as scaffold surface 
modification was used. This modification led to the formation of a dense coat of small mineral crystals, 
compared to plate-like mineral formed with the original soaking method. This change led to an order of 
magnitude increase in stiffness, resulting a scaffold that is more suitable for tendon-bone tissue 
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engineering230. Another method to create the change in mineral content of the scaffold is to pre-fabricate 
the non-mineralized and mineralized regions respectively, followed by integration of these regions. 
Weisgerber et al. fabricated collagen-GAG scaffolds with and without CaP, and then integrated the two 
regions with lyophilization. This multi-compartment scaffold remained intact, and its elastic modulus and 
porosity were shown to be controlled by the non-mineralized and mineralized regions, respectively231.  
Another change in property across the tendon-bone insertion is fiber alignment, as the fibers change from 
aligned at the tendon end to unaligned at the bone end18. As an attempt to mimic this change, Xie et al. 
electrospun an “aligned-to-random” nanofiber scaffold that with the fibers in the aligned region mimicking 
that of tendon and fibers in the unaligned region mimicking the less organized collagen fibers in bone. In 
vitro study utilizing rat tendon fibroblast demonstrated that cell morphology followed that of the underlying 
fibers in different regions. Authors also demonstrated this change in fiber alignment can be combined with 
selective mineralization of different regions for fabricating a scaffold that mimics tendon and bone both 
structurally and compositionally232.  
Although these studies demonstrated the potential of heterogeneous scaffolds for augmenting 
rotator cuff tendon-bone repair, there are limitations, the major drawback being the size of the scaffold is 
not biomimetic. In the native insertion, the heterogeneity of mineral and organization are confined within 
several hundred micrometers17. However, most of the heterogenous scaffolds have changes in properties 
across a span of several millimeters or even centimeters.  
 
1.2.6 Development of the Aligned Biphasic Nanofiber-based Scaffold 
Focusing on regeneration of the fibrocartilaginous insertion itself, by incorporating the distinct 
organization and mineral distribution profile in scaffold design, a structurally and compositionally 
biomimetic scaffold was designed and tested both in vitro and in vivo. This scaffold is fabricated via 
electrospinning and consists of two structurally continuous yet compositionally distinct layers: phase A of 
the scaffold consists of aligned PLGA nanofibers, mimicking the non-mineralized fibrocartilage of the 
rotator cuff tendon-bone interface. Phase B of the scaffold consists of aligned PLGA nanofibers loaded 
with hydroxyapatite (HA) nanoparticles, which are found in mineralized tissues, mimicking the mineralized 
fibrocartilage (Figure 1.5)24. To develop this biphasic scaffold, the PLGA layer was first designed, 
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characterized and evaluated in vitro with rotator cuff 
tendon fibroblasts for integrative tendon repair25. Results 
showed that a biomimetic matrix was formed on the 
aligned PLGA scaffold and physiologically-relevant 
scaffold mechanical properties were maintained over 
time, while scar tissue was formed on the unaligned 
PLGA scaffold. Following this study, HA was added into 
the PLGA nanofibers and the influence of scaffold 
mineral content on fibrocartilage formation was 
evaluated in vitro with chondrocytes. Results showed 
that when seeded with chondrocytes, the PLGA phase has the potential to generate non-mineralized 
fibrocartilage and PLGA-HA phase has the potential to generate mineralized fibrocartilage. It was also 
demonstrated that compared to 10% HA incorporation, PLGA-HA scaffolds with 15% HA led to increased 
compressive mechanical properties, positive staining for matrix mineralization and a greater propensity to 
stimulate chondrocyte hypertrophy. Effects of HA concentration in phase B on osteoblast response was 
further investigated and confirmed that 15% HA is optimal for supporting overall osteoblast function, 
differentiation and mineralization potential, which is critical for osteointegration between phase B and the 
humeral head26. Based on these studies, a biomimetic biphasic scaffold was fabricated by spinning a 
PLGA layer on top of a PLGA-HA (15% HA w/w) mesh. This scaffold was characterized in terms of 
mineral distribution, porosity, pore size and mechanical properties of each layer and its effect on 
fibrocartilage formation was evaluated both in vitro and in vivo. The in vitro study showed that when 
seeded with chondrocytes, the biphasic scaffold supported the formation of distinct regions of non-
mineralized and mineralized fibrocartilage-like tissue that mimics the native rotator cuff tendon-bone 
interface. The biphasic scaffold was then evaluated in vivo in a subcutaneous athymic rat model. Results 
from this study demonstrated that the biphasic scaffold was able to support the formation of distinct yet 
continuous non-mineralized and mineralized fibrocartilaginous tissues, as well as promote 
osteointegration between host bone and phase B of the scaffold27. Finally, this biphasic scaffold was used 







Figure 1.5. Aligned nanofiber-based 
biphasic scaffold. Scanning electron 
microscopy image overlaid with energy-
dispersive X-ray spectra across the depth of 
the scaffold. Mineral is confined in Phase B. 
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PLGA or PLGA-HA scaffolds, the biphasic scaffold supported tendon-bone integration through the 
regeneration of an organized fibrocartilage-like tissue24. Collectively, these pioneering studies 
demonstrated the feasibility of enhancing rotator cuff tendon-bone healing with a biomimetic biphasic 
scaffold that consists of aligned PLGA and PLGA-HA nanofibers. 
 
1.3 Summary 
Rotator cuff repair surgeries are associated with high failure rate due to the lack of biological 
fixation between tendon and bone. Current surgical techniques and rotator cuff augmentation grafts do 
not lead to the regeneration of the heterogeneous tendon-bone insertion, which is the key for biological 
fixation. Therefore, there is a significant need for alternative grafting solutions that enables the 
regeneration of the tendon-bone insertion. An aligned nanofiber-based biphasic scaffold was designed for 
this purpose. In order to identify the key parameters that contribute to the in vivo efficacy of this scaffold, 
the studies outlined in this thesis consist of 1) determining the effect of scaffold-dependent properties on 
insertion regeneration and 2) determining the effect of scaffold-independent factors on insertion 
regeneration. The findings of these studies will elucidate the working mechanism of the biphasic scaffold, 
and help to identify strategic biomimicry scaffold design parameters for integrative rotator cuff repair.  
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CHAPTER 2: THE EFFECT OF SCAFFOLD FIBER ALIGNMENT ON 





Previously, it was demonstrated that the aligned, nanofiber-based biphasic scaffold consisting 
poly (lactide-co-glycolide) (PLGA) and PLGA-hydroxyapatite (PLGA-HA) layers led to the formation of 
insertion-like tissue at the tendon-bone junction of the rat rotator cuff, while the same effect was not 
observed in shoulders repaired with single-phased PLGA or PLGA-HA scaffolds233. The biphasic scaffold 
is designed to mimic the structural and compositional properties of the native tendon-bone insertion, and 
scaffold parameters were selected based on in vitro studies. In Aim 1, the effect of these parameters, 
namely scaffold structural properties including fiber alignment and diameter, and scaffold compositional 
properties including mineral distribution and polymer composition will be evaluated in vivo using a rat 
model to determine critical scaffold parameters for strategic biomimicry. In this chapter, the effect of 
scaffold fiber alignment on tendon-bone healing is investigated.  
 
2.1.1 Background and Motivation 
 To regenerate the tendon-bone insertion, the scaffold needs to recapitulate the organizational 
and compositional properties of the native tissue. Because the native insertion fibrocartilage serves to 
minimize the development of stress concentrations at the tendon-bone junction, it has unique features 
that enable effective load transfer between these two types of tissue, which have very different 
mechanical properties. One of these features is the alignment of collagen fibers throughout the insertion 
region. Using a rat model, Thomopoulos et al. quantified collagen fiber orientation at the tendon-bone 
insertion18 by measuring the angular deviation of the collagen fibers at both the non-mineralized and 
mineralized regions. Results showed that although the angular deviation, which ranges from 0º to 40.5º, 
0º indicating perfectly aligned fibers234, exhibits location-dependent variation (edge vs. middle of the 
insertion, non-mineralized vs. mineralized regions). It ranges from 5º to 10º in the insertion region, 
indicating the collagen fibers are aligned. Therefore, fiber alignment can be used as one criterion to 
assess healing, as an insertion-like healing tissue at the tendon-bone junction post-repair should consist 
of aligned collagen fibers.  
Since the native insertion tissue consists of aligned fibers, the scaffold used for the purpose of 
regenerating the tissue should guide the alignment of the newly deposited extracellular matrix (ECM). For 
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fiber-based scaffolds, such as the biphasic scaffold studied in this thesis, the scaffold fiber alignment 
could impact cell alignment, in turn modulating ECM alignment. Several in vitro studies have investigated 
the effect of scaffold fiber alignment on the response of primary cells associated with the soft-hard tissue 
interface. Relevant to rotator cuff repair, Moffat et al cultured human rotator cuff fibroblast on electrospun 
PLGA scaffolds consisting either aligned or unaligned fibers25 and reported the cell morphology followed 
the organization of fibers. Elongated cell morphology was observed for cells seeded on the aligned 
scaffold, while cell spreading to a polygonal shaped was observed for cells seeded on the unaligned 
scaffold. The orientation of the cells further controlled the organization of the ECM, as aligned collagen 
fibers were produced by elongated, aligned cells, and randomly oriented collagen fibers were produced 
by the polygonal cells. In addition to modulating matrix organization, scaffold fiber alignment changed the 
type and quantity of ECM produced by the cells. A biomimetic ECM that maintained its mechanical 
properties at a physiologically-relevant level was formed only the aligned scaffold. On the other hand, the 
random fiber organization of the unaligned scaffold initiated a healing response of the cells, led to the 
deposition of a scar-tissue like ECM. The effect of fiber alignment was not only observed for tendon 
fibroblasts, which are surrounded by aligned ECM in their native environment, but also for mesenchymal 
stem cells (MSCs) which are insertion-relevant but do not are not embedded in an aligned ECM in their 
native environment. An aligned collagen scaffold was shown to promote tenogenic differentiation of 
MSCs235. Furthermore, when MSCs were seeded on aligned polyurethane scaffolds, they became 
elongated and the morphology resembled that of fibroblasts236. Currently, although some rotator cuff 
augmentation scaffolds have aligned fiber as a design criterion132;232;237, the effect of scaffold fiber 
alignment has only been evaluated in vitro. Therefore, there is a need for in vivo evaluation of the effect of 
fiber alignment for integrative rotator cuff repair.  
Rat is selected as the in vivo evaluation model in all chapters from Aim 1. Its shoulder anatomy is 
similar to that of human’s, with the supraspinatus tendon passing underneath the enclosed 
coracoacromial arch238. As a result, it is widely used in rotator cuff related research, from characterization 
of the native17;18;32;156 and healing29;159;166;169 tendon-bone insertion, to assessing the performance of repair 
methods or augmentation grafts for rotator cuff surgery9;28;108;194;237;239. For studies performed in this aim, 
scaffolds with different properties are used to repair an acute full- thickness injury in rat, and tissue 
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healing is assessed predominately through histology. Briefly, at week 5 post-surgery, rats are sacrificed 
and their shoulders harvested. Representative tissue sections of the tendon-bone junction are obtained. 
Collagen and glycosaminoglycan (GAG) distribution is visualized with picrosirius red and alcian blue 
stains, respectively, collagen fiber alignment is assessed with polarized light microscopy; types II and X 
collagen distribution is visualized by immunohistochemistry and mineral distribution across the insertion is 
visualized by micro-computed tomography (micro-CT), as well as von Kossa stain. A scaffold design 
parameter is considered to be critical for insertion regeneration if it leads to the formation of tissue at the 
tendon-bone junction with the following properties: 1) it stains positive for both collagen and GAG for the 
formation of fibrocartilaginous tissue, 2) matrix exhibits organized morphology as assessed through 
polarized light microscopy, 3) it stains positive for both types II and X collagen for the formation of non-
mineralized and mineralized fibrocartilage, and 4) no ectopic bone formation. In each chapter of Aim 1, 
one scaffold property of the aligned, nanofiber-based biphasic scaffold is varied and new tissue by the 
scaffold will be compared to that of the original scaffold, using the listed criteria. A pilot study is performed 
to familiarize with surgical procedure, as well as sample harvesting, processing and analysis methods 
(Chapter 4, study 1). Once finalized, all subsequent rat surgeries for are performed in one setting and 
sample analyses are performed. For these studies, the same control groups (healing tissue of rotator cuff 
repaired without scaffold, and with aligned, nanofiber-based scaffold) are used. Results are presented 
separately in each chapter.  
 
2.1.2 Objective 
It is known that the native insertion consists of aligned collagen fibers, and scaffold with aligned 
fibers leads insertion-related cells, including rotator cuff tendon fibroblasts and MSCs, to deposit an 
aligned collagen matrix in vitro. Therefore, the objective of this study is to evaluate the in vivo effect of 
biphasic scaffold fiber alignment on integrative rotator cuff repair. It is hypothesized that the observed in 
vitro effect of aligned fibers will be translated in vivo by the biphasic scaffold, as the aligned biphasic 
scaffold will lead to the formation of an insertion-like region that is rich in both collagen and 
glycosaminoglycan (GAG), with aligned collagen fibers, and stains positive for types II and X collagen. On 
the other hand, the unaligned biphasic scaffold will lead to the formation of scar-like tissue, which is 
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fibrous and not organized.  
 
2.2 Materials and Methods 
2.2.1 Scaffold Fabrication and Characterization 
Nanofiber-based scaffolds utilized in this study were fabricated via electrospinning24. The PLGA 
solution was prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- 
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA 
(w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-HA solution was prepared with the addition of HA 
nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, MI) to the PLGA solution. Each 
solution was loaded into a syringe with an 18.5-gauge stainless steel blunt tip needle and dispensed via a 
syringe pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The solutions were spun at 8-10 kV (PLGA) 
or 11-13 kV (PLGA-HA). The biphasic scaffold was produced by first collecting a PLGA-HA layer, 
following by electrospinning the PLGA layer directly on top of the PLGA-HA layer. A rotating mandrel was 
used to collect fibers for aligned biphasic scaffold and a stationary plate was used to collect fibers for 
unaligned biphasic scaffold. As fabricated scaffolds were carefully excised from the mandrel and cut into 
3 mm x 6 cm pieces. To ensure that the biphasic scaffold has an even distribution of the non-mineralized 
and mineralized layers, scaffolds with a thickness of 0.2±0.01 mm were selected. These scaffolds were 
carefully peeled, from both ends, into the PLGA and PLGA-HA layers, leaving the middle region, which 
measured to be 3 mm in length intact. The thickness of individual layers was measured and only scaffolds 
with both layers measured to be 0.1±0.01mm were used in the study. The single layers of the scaffold 
were folded back to the corresponding phase of the biphasic region with one fold on each layer to 
accommodate the repair procedure (Figure 2.1). By doing this, it was ensured the scaffold is thick enough 
to fill in the gap created between tendon and bone during the surgery, while retaining the distinct mineral 
distribution profile. Scaffolds were treated with ultraviolet radiation for 15 minutes on both sides and 
stored in sterile condition until used for surgery. 
To quantify the fiber alignment of the scaffolds, as-fabricated scaffold from each group were 
randomly selected and both phases of the scaffolds were imaged with scanning electron microscopy 
(SEM, Hitachi S-4700, Hitachi, Tokyo, Japan). The scaffolds were coated with gold to reduce charging 
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effects and fiber alignment was quantified (n=3 images/group/phase) following published methods25;234 
using customized circular statistics software (Fiber3) in MATLAB (MathWorks, Natick, MA). The circular 
statistics parameters determined included mean vector angle (MA), which represents the average fiber 
alignment of the scaffold (-90º<θ<90º, where 0º indicates horizontal orientation), angular deviation (CSD, 
0º≤s≤40.5º, where 0º indicates perfectly aligned and 40.5º indicates randomly oriented fibers), and mean 
vector length (MVL, 0≤r≤1, where 0 indicates for randomly oriented fibers and 1 indicates perfectly 
aligned fibers). 
 
2.2.2 Surgical Procedure 
All animal procedures were performed at the Microsurgery Training and Research Laboratory in 
the Department of Orthopedic Surgery under a protocol approved by the Institutional Animal Care and 
Use Committee. Adult male Lewis rats (Charles River Laboratories, n=6, 11-12 weeks old, average 
weight=316±10g) were used in this study. For the surgery, each rat was anesthetized in a chamber with 
2-2.5% v/v isoflurane (Isothesia, Henry Schein Animal Health, Melville, NY) in 2 L/min oxygen flow. 
General anesthesia was maintained through a nose cone at an average of 1.5% v/v isoflurane in 2 L/min 
oxygen flow. The shoulder region was shaved, and prepared for aseptic surgery with three rounds of 
alternative ethanol and betadine rubs. Immediately before surgery, systemic antibiotics ampicillin (Henry 
Schein, 50mg/kg body weight), anti-inflammatory drug carprofen (RIMADYLR® Injectable, Pfizer, New 
York, NY, 5 mg/kg body weight) and analgesic buprenorphine (Henry Schein, 1.2 mg/kg, sustained 
release for 72 hours) were injected into rat subcutaneously. Marcain (Henry Schein, 2 mg/kg body weight), 
a local anesthetic was injected subcutaneously to each shoulder right before skin incision was made.  
Bilateral acute rotator cuff repair was performed on each rat with the transosseus bone tunnel 
method, following a published protocol29 (Figure 2.2). In each rat, the shoulders were randomly selected 
to be repaired using the aligned biphasic scaffold, the unaligned biphasic scaffold or without scaffold. The 
selection was also randomized such that no rat received the same treatment in both shoulders. Briefly, a 
longitudinal incision was made on the skin of the shoulder region to expose the deltoid muscle. To locate 
the supraspinatus tendon, the coracoacromioal arch was identified and the deltoid muscle was cut open 
alone the arch. A 5-0 prolene suture (Ethicon, Somerville, NJ) was passed through the cut deltoid muscle 
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to retract it during surgery. Once the deltoid was retracted, the supraspinatus tendon was identified as it 
passes right underneath the arch. To create an acute rotator cuff injury, the supraspinatus tendon was 
sharply detached from its bony insertion with a surgical blade. The fibrocartilaginous footprint of the 
tendon insertion on the greater tuberosity of humerus was removed with a motorized burr. For the 
transosseus tendon-bone repair, a bone tunnel with 0.5 mm diameter was drilled transversely in the 
anterior-posterior direction on the proximal part of the humerus. The tendon stump was grasped by a 5-0 
prolene suture using a technique similar to the Mason-Allen method. For control repair, the suture was 
passed through the bone tunnel to reappose tendon to the anatomic position. For scaffold augmented 
repair, the scaffold was inserted between the distal end of the tendon and the cancellous bone, such that 
its PLGA phase contacting the tendon and PLGA-HA phase contacting the bone. Extra attention was paid 
to ensure the fiber orientation of the aligned scaffold matched with that of the tendon, followed by 
reapposing of the tendon to the anatomic position. Following tendon re-attachment, the deltoid muscle 
was repaired with a 4-0 vinyl suture (Ethicon) and the skin incision was closed by wound clips. Rats were 
not immobilized and allowed for normal cage activity through the duration of this study.  
 
2.2.3 Sample Harvest 
Rats were sacrificed by CO2 overdose at week 5 post-surgery. Shoulders were dissected away 
from the body, rinsed in phosphate buffered saline (PBS, Sigma-Aldrich), and wrapped in PBS-soaked 
gauze for end-point analyses. Shoulders were first scanned with micro-CT, followed by gross dissection 
to leave only the supraspinatus muscle intact on the bone, which were further processed for assessing 
matrix deposition and organization, fibrocartilage, and mineralized tissue formation.  
 
2.2.4 End-point Analyses 
2.2.4.1 Matrix deposition and organization 
Gross dissected shoulders (n=3) were fixed in 80% v/v ethanol with 1% w/v cetylpyridinium 
chloride (Sigma-Aldrich) for 3 days, followed by decalcification in 45 mL of solution consisting formic acid 
(Thermo Fisher Scientific, Waltham, MA), Trizma® HCl (Sigma-Aldrich) and ethylenediaminetetraacetic 
acid (Sigma-Aldrich) on a rocker (Roto-Shake Genie, Scientific Industries, Bohemia, NY) for 21 days. 
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Following complete decalcification, the tissues were dehydrated in an ethanol series (70%– 100%), 
cleared three times in xylenes (Thermo Fisher Scientific), and embedded in paraffin (Thermo Fisher 
Scientific) at 56ºC. Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica, 
Bannockburn, IL) to obtain 7 µm thick sections. To assess collagen and GAG distribution, the sections 
were de-paraffinized and rehydrated, and stained with picrosirius red and alcian blue stains, respectively. 
Collagen fiber alignment at the tendon-bone junction was visualized with circular polarized light 
microscopy of the picrosirius red stained slides. All images were taken with an inverted light microscope 
(Axiovert 25, Carl Zeiss, Thornwood, NY). Images obtained from polarized light microscopy of each 
sample were used to quantify the collagen fiber alignment of repaired shoulders. The images were 
converted to black and white using ImageJ (NIH, Bethesda, MD), followed by fiber organization analysis 
of the interface region using the Fiber3 software to obtain the CSD and MVL of the repaired tissue.  
2.2.4.2 Fibrocartilaginous tissue formation 
Non-mineralized and mineralized fibrocartilage formation was evaluated with 
immunohistochemistry of types II and X collagen across the healing tendon-bone junction, using paraffin-
embedded tissue sections. For type II collagen stain, after paraffin removal and tissue rehydration, 
samples were rinsed with PBS containing 0.1% Tween 20 (Thermo Fisher Scientific), treated with 0.5 
mg/mL hyaluronidase (Sigma-Aldrich) solution for 30 minutes to retrieve antigen, swelled with 0.5 M 
acetic acid (Thermo Fisher Scientific) for 4 hours, treated with serum-free protein block solution (Dako, 
Carpinteria, CA) for 10 minutes and incubated at 4°C overnight with primary anti-collagen II antibodies 
(1:100 dilution, Santa Cruz Biotechnology, Dallas, TX). The slides were rinsed with PBS and incubated 
with FITC-conjugated secondary antibody (1:200 dilution, Invitrogen) for 1 hour at room temperature. 
After rinsing with PBS, sections were incubated in 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI, 
Invitrogen) solution for 30 minutes for cell nuclei staining. Following this step, samples were rinsed in PBS, 
distilled water, and a cover slip applied. The samples were imaged with confocal microscopy (Olympus 
Fluoview FV1000 Confocal Microscope, Central Valley, PA) at 20x magnification using a dual excitation 
wavelength of 488 nm (Collagen II) and 358 nm (DAPI). Immunohistochemical analysis of type X collagen 
was performed following the same protocol, without the 4 hour swelling step. Anti-collagen X antibodies 
(1:100 dilution, Abcam, Cambridge, MA) and Alexa Fluor 488-conjugated secondary antibody (1:200 
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dilution, Invitrogen) were used as primary and secondary antibodies. Images were taken with confocal 
microscopy at dual excitation wavelength of 488 nm (type X collagen) and 358 nm (DAPI).  
2.2.4.3 Mineralized tissue formation 
Formation of mineralized tissue was assess with both micro-CT and von Kossa stain of non-
decalcified shoulders (n=3). Immediately after harvesting, each shoulder was scanned with a micro-CT 
scanner at a voxel size of 21µm (VivaCT 40, Scanco, Swizerland) to obtain 2D images along the axis of 
humerus. Rotator cuff region was selected and contoured on all 2D slices, followed by 3D reconstruction 
using a mineral threshold of 268 mg HA/cm3, a value determined from previous studies24 to visualize the 
bony structures at the healing rotator cuff.  For non-decalcified histology, the gross dissected shoulders 
were fixed with 90% ethanol for 3 days, dehydrated in an ethanol series (70%– 100%), and followed by 
clearing and infiltration. Tissue samples were embedded in poly (methylmethacrylate) (PMMA, MW 
100,000, Polysciences Inc, Warrington, PA) using a modification of the methods of Erben et al240. 
Sections at 7 μm thickness were obtained with a sliding microtome (Leica, Bannockburn, IL). Mineral 
distribution at the tendon-bone junction was visualized by von Kossa stain, with safranin-O counterstain to 
visualize GAG distribution.  
 
2.2.5 Statistical Analysis 
Quantitative results are presented in the form of mean ± standard deviation. The fiber alignment 
parameters of as-fabricated scaffolds were compared between the corresponding phases using student’s 
t-test. Effect of scaffold fiber alignment on tissue morphology was evaluated using one-way analysis of 
variance (ANOVA) between healing tissue and the two phases of the corresponding as-fabricated 
scaffold, with Tukey-Kramer post-hoc test for all pairwise comparison. The alignment parameters of the 
two types of scaffold-repaired tissue were compared with student’s t-test. Significance was attained at p< 
0.05. All statistical analyses were performed using JMP IN 4.0.4. (SAS Institute, Cary, NC) 
 
2.3 Results 
2.3.1 Scaffold Alignment 
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 Prior to use in rat surgery, both phases of the as-fabricated aligned and unaligned biphasic 
scaffolds (n=3) were imaged with SEM (Figure 2.3) to compare fiber organization between scaffolds. 
Fiber alignment was quantified (Table 2.1) for both phases of each scaffold. For the non-mineralized 
PLGA phase, although no difference was found in the MA between aligned and unaligned scaffolds, the 
aligned scaffold had a smaller CSD and a greater MVL, indicating a higher degree of fiber alignment. For 
the mineralized PLGA phase, all three parameters indicated a significantly higher degree of fiber 
alignment in the as-fabricated aligned scaffold compared to the unaligned scaffold.  
 
2.3.2 Matrix Deposition and Organization 
 Formation and distribution of fibrocartilaginous tissue across the tendon-bone junction was 
visualized with picrosirius red (collagen) and alcian blue (GAG) stains of de-calcified shoulders (Figure 
2.4). It can be seen that although the interface region was stained positive for collagen in all groups, it 
was only the aligned scaffold repair group that stained positive for GAG. Furthermore, polarized light 
images showed that the fibers of the healing tissue at the tendon-bone junction of both control (repaired 
without any scaffold) and unaligned scaffold repaired shoulders were disorganized, but a high degree of 
alignment was observed in the aligned scaffold repaired group. To determine the effect of scaffold fiber 
alignment on matrix organization, fiber alignment analysis was performed on the healing tissue at the 
tendon-bone junction of scaffold repaired shoulders to determine matrix fiber CSD and MVL (Figure 2.5). 
No difference was observed between the healing tissue and scaffold for the aligned scaffold repaired 
shoulders. Compared to the as-fabricated scaffold, the tissue repaired by the unaligned scaffold had a 
smaller CSD and a greater MVL, indicating improved organization of the tissue. When the alignment 
parameters were compared between the two types of healing tissue, the aligned scaffold repaired tissue 
had a smaller CSD and MVL trended higher (p<0.1), indicating the formation of a more organized tissue.  
 
2.3.3 Fibrocartilaginous Tissue Formation 
 Immunohistochemistry was performed on the de-calcified shoulders to determine types II and X 
collagen distribution at the tendon-bone junction of repaired shoulders (Figure 2.6). The aligned scaffold 
repaired shoulder stained positive for both types of collagen, across a span over 200 µm at the tendon-
36
bone junction. On the other hand, types II and X collagen was only seen over a very small region in the 
unaligned scaffold repaired tissue. Minimal deposition of both types was found in the control repair.  
 
2.3.4 Mineralized Tissue Formation 
 Micro-CT scan of the harvested shoulders and von Kossa stain of the non-decalcified tendon-
bone junction tissue section were performed to determine the formation of mineralized tissue around the 
healing region (Figure 2.7). No ectopic bone formation was observed in any samples. 
 
2.4 Discussion  
 In this chapter, the in vivo effect of biphasic scaffold fiber alignment on tendon-bone healing was 
evaluated. Specifically, biphasic scaffold consisting aligned or unaligned nanofibers were fabricated, 
characterized in terms of fiber alignment, and used to repair an acute full-thickness rotator cuff injury in 
the rat model. Shoulders were harvested at week 5 post-surgery. The fiber alignment at the repaired 
insertion region was both visualized and quantified with polarized light microscopy and fiber alignment 
analysis. Matrix type and distribution, as well as mineral distribution across the tendon-bone junction were 
evaluated with histology and micro-CT. 
 By collecting electrospun fibers with a stationary plate instead of a rotator mandrel, a biphasic 
scaffold consists of unaligned fibers in both phases were fabricated. SEM images and quantitative fiber 
alignment analysis confirmed that the fibers in this scaffold were randomly aligned. This unaligned 
scaffold was used to repair an acute rat rotator cuff tear in the rat model, and the healing tissue were 
characterized and compared to that from aligned scaffold repaired shoulder. Analysis of healing tissue 
organization showed that aligned biphasic scaffold modulated tissue fiber alignment, as the as-fabricated 
scaffold and healing tissue had comparable CSD and MVL. It demonstrated that the in vitro guidance of 
scaffold alignment on cellular level25 was reflected at tissue level in vivo. It is worth noting that in the 
unaligned group, the healing tissue had a smaller CSD and a greater MVL when compared to the as-
fabricated scaffold, indicating a better fiber organization in the tissue. This could be explained by the 
intrinsic matrix remodeling process of collagen based tissues during healing. Using skin healing model, 
Wolman et al. showed that collagen fibers become more aligned as they mature241 over time. 
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Furthermore, Perry et al. used small intestine submucosa, an unaligned graft with a CSD of 39º, similar to 
that of the unaligned biphasic scaffold to repair rotator cuff injury in the rat model, and reported a 
decrease in CSD of the healing tissue from week 2 to week 16108. Despite this process, the biphasic 
scaffold still led to the formation of a more aligned tissue compared to that formed by the unaligned 
scaffold, with a smaller CSD and a trend of a greater MVL. 
Scaffold fiber alignment also affected the composition of the healing tissue. The aligned scaffold 
led to the formation of a tissue that was rich in collagen and GAG, consists of aligned ECM, and 
contained both types II and X collagen, which are ECM markers of non-mineralized and mineralized 
fibrocartilage. The unaligned scaffold led to the formation of a fibrous tissue that stained negative for GAG, 
which is similar to the control healing, which was repaired without scaffold.  It was reported in vitro that 
both MSCs and fibrochondrocytes produced an ECM that was rich in both collagen and GAG when they 
were cultured on electrospun poly (ε-caprolactone)242. Since both cells are relevant to the tendon-bone 
insertion, results from this chapter demonstrated the effect was translated in vivo.  
Regardless of the scaffold alignment, no ectopic bone formation was observed in any samples 
repaired by the biphasic scaffold, indicating active incorporation of the HA by bone.  
 
2.5 Conclusion 
 This chapter investigated the effect of scaffold fiber alignment on tendon-bone healing, using a rat 
rotator cuff repair model. This parameter was selected since multiple studies showed it modulated in vitro 
response of cells that relevant to the insertion. Scaffold fiber alignment was modulated by changing the 
fiber collection method. Aligned and unaligned biphasic scaffolds were used to augment rat rotator cuff 
repair. Results showed that the in vitro effect was translated in vivo, as the biphasic scaffold led to the 
formation of an insertion-like aligned tissue that was rich in both collagen and GAG, stained positive for 
types II and X collagen at the tendon-bone junction. Collectively, these results showed that fiber 
alignment is a critical design criterion and a scaffold for rotator cuff tendon-bone repair should consists of 
aligned fibers.  
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Figure 2.1.  Biphasic scaffold preparation for in vivo studies. From left to right: three views of the 
3 mm x 6 cm x 0.2 mm biphasic scaffold strips, with PLGA  layer on top of PLGA-HA  layer, biphasic 
scaffold with single layers selectively removed but with a 3 mm over lapping biphasic region, and the 
final configuration of biphasic scaffold used in surgery, with one PLGA and one PLGA-HA layer folded 



























Figure 2.2.  Schematic of the rat rotator cuff repair procedure. a. intact tendon on humerus (SST: 
supraspinatus tendon), b. detached tendon with the removal of native fibrocartilage (F: footprint) and 
drilled bone tunnel (arrow), c. tendon reapposed to bone with suture through bone tunnel in the 
control group, d. placement of biphasic scaffold (arrow) on the footprint, e. tendon reapposed to bone 
with suture through bone tunnel in the repairs where a scaffold was used. 
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Figure 2.3. Fiber organization of as-fabricated aligned and 
unaligned biphasic scaffolds. SEM micrographs (1500x, scale bar = 
10 µm) showed distinct fiber organization of the as-fabricated aligned 





Type Phase MA CSD MVL 
Aligned PLGA 4.28±1.28 16.35±1.21 0.84±0.024 
PLGA-HA 3.57±1.30 17.45±1.39 0.81±0.029 
Unaligned PLGA 27.15±22.51 38.99±0.85# 0.073±0.04# 
PLGA-HA 67.47±15.25# 35.61±0.98# 0.23±0.042# 
Table 2.1. Fiber alignment parameters of as-fabricated aligned and unaligned 
biphasic scaffolds  
 
MA: mean vector angle (-90º<θ<90º, where 0º indicates horizontal orientation), 
CSD: angular deviation (0º≤s≤40.5º, where 0º indicates perfectly aligned and 
40.5º indicates randomly oriented fibers), MVL: mean vector length (0≤r≤1, where 
0 indicates for randomly oriented fibers and 1 indicates perfectly aligned fibers). 
(#: significant difference compared to the corresponding phase of the aligned 
biphasic scaffold,  n=3, p<0.05) 
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Figure 2.4. Effect of fiber alignment on extracellular matrix distribution and organization. From 
left to right: collagen distribution (picrosirius red, 10x, bar=200μm), GAG distribution (alcian blue, 10x, 
bar=200μm), and collagen fiber alignment (polarized light microscopy, 10x, bar=200μm) of the healing 
tissue. All three types of tissue were stained positive for collage, but only aligned scaffold repaired 
tissue stained positive for GAG. The fibers at the insertion region were organized in the aligned scaffold 





























































MVL of Scaffold and Repaired Tissue
*
Figure 2.5. Quantitative fiber alignment analysis of the scaffold and healing tissue. No difference 
was observed between scaffold and healing tissue for the aligned scaffold repaired shoulders. The 
unaligned scaffold repaired tissue had a better alignment compared to the scaffold with a lower CSD 
and a greater MVL. The aligned scaffold repaired tissue has a better alignment compared to the 
unaligned scaffold repair tissue with a smaller CSD and a trend (p<0.1) of a greater MVL.   







































Figure 2.6. Effect of scaffold fiber alignment on fibrocartilage 
and mineralized fibrocartilage formation. Types II and X 
collagen immunohistochemical stains (green) at the healing 
tendon-bone junction (with blue DAPI counter stain, 20x, 
bar=200μm). No type II or X collagen deposition was observed in 
the control group, aligned scaffold repaired shoulder stained 
strongly for both types, unaligned scaffold repaired shoulder only 
had a very small region stained positive for types II and X collagen. 











Figure 2.7. Effect of scaffold fiber alignment on mineralized tissue 
formation. No ectopic bone was formed in the tendon region of rotator cuff 
repaired without scaffold, with aligned scaffold or unaligned scaffold, as 
indicated by the micro-CT 3D reconstructed image and von Kossa stain (4x, 


















CHAPTER 3: THE EFFECT OF SCAFFOLD FIBER DIAMETER ON 




One of the goals of Aim 1 is to examine the effects of scaffold structural properties on the 
regeneration of rotator cuff tendon-bone interface. In Chapter 2, the effect of fiber alignment is explored 
and results demonstrated that aligned fibers are needed for the biphasic scaffold to promote the formation 
of a fibrocartilaginous tissue consisting aligned fibers that mimics the native insertion. In this chapter, the 
effect of another scaffold structural property, fiber diameter, on in vivo rotator cuff tendon-bone healing is 
investigated. 
 
3.1.1 Background and Motivation 
 As mentioned in previously, an ideal tissue engineering scaffold should be biomimetic in 
organization and composition. In addition to fiber alignment, which effect is investigated in Chapter 3, 
another property that is worth to investigate is the scaffold fiber diameter. In connective tissues such as 
the tendon and ligament, the aligned collagen matrix is formed by collagen molecules through a hierarchy 
structure243. The smallest structural unit is the collagen molecule. It consists of a triple helix and has a 
diameter of approximately 1 nm244. These molecules assemble to form fibril, the second level of collagen 
structure, with a diameter up to 360 nm243. The fibrils assemble into collagen fibers, the third level of 
collagen structure, with a diameter of 1-300 µm245. Eventually, collagen fibers organize together to form 
fascicle bundles with a diameter of 15-1000 µm246. These bundles are the basic unit of the collagenous 
matrix of the tendon. The collagen fiber diameter also changes with the state of the soft tissue. When the 
tissue is injured, collagen fibrils in the scar tissue generally have a smaller fiber diameter. For example, 
Wang et al. reported the average fibril diameter of the supraspinatus tendon at the tendon-bone end is 
57±3 mm in healthy individuals, and 51±3 mm in individuals with a torn tendon126. Similarly, Svensson et 
al. reported a higher percentage of small fibrils were found in human patellar tendon which was previously 
injured compared to that of healthy ones247. Fibrils with small diameter are also associated with tendon 
abnormality, as Ameye et al. showed that mice with biglycan/fibromodulin-deficiency had lower collagen 
fibril diameter in the quadriceps tendon248. 
 Because of the hierarchical structure of collagen in the connective tissues and the observed 
change in fibril diameter between healthy and injured tissue, the ability of fiber diameter to control cell 
47
response has been investigated in vitro on a variety of fibrous scaffolds with different types of 
cells30;236;249-252. Related to rotator cuff repair, Erisken et al. reported that aligned electrospun poly (lactic-
co-glycolic) (PLGA) scaffold with nano-sized fibers led to higher cell number, total collagen and 
proteoglycan production of human rotator cuff fibroblast, while the microfibers promoted the expression of 
fibroblast phenotypical markers30. The aligned, nanofiber-based scaffold investigated in this thesis has an 
average fiber diameter similar to the nano-sized fibers used in Erisken et al.’s study. Therefore, it is of 
interest to investigate the effect of fiber diameter on the rotator cuff tendon-bone healing when its fiber 
diameter is changed to micrometer scale. 
 
3.1.2 Objective 
 The biphasic scaffold has nanometer-sized fibers on both phases24. Since the in vitro effect of 
fiber diameter was observed for rotator cuff tendon fibroblasts, the objective of this chapter is to 
investigate the in vivo effect of biphasic scaffold fiber diameter on rotator cuff tendon-bone insertion 
formation. It is hypothesized that the observed in vitro effect of fiber diameter will be translated in vivo, as 
the aligned biphasic scaffold with nanofibers will lead to the formation of a fibrocartilaginous tissue rich in 
collagen fibers, glycosaminoglycan (GAG) and the scaffold with microfibers will not lead to minimal 
amount of healing tissue formation.  
 
3.2 Material and Methods 
3.2.1 Scaffold Fabrication and Characterization 
Nanofiber-based scaffolds utilized in this study were fabricated via electrospinning24. The PLGA 
solution was prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- 
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA 
(w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-hydroxyapatite (HA) solution was prepared with 
the addition of HA nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, MI) to the 
PLGA solution. To increase fiber diameter, PLGA content in polymer solution was increased to achieve a 
ratio of 50/40/10 for PLGA (w/v), DMF (v/v), and ethanol (v/v). Each solution was loaded into a syringe 
with an 18.5-gauge stainless steel blunt tip needle and dispensed via a syringe pump (Harvard Apparatus, 
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Holliston, MA) at 1 mL/h. The solutions were spun at 8-10 kV (PLGA) or 11-13 kV (PLGA-HA). Fibers 
were collected on a rotating mandrel, resulting aligned fiber layers. The biphasic scaffold was produced 
by electrospinning the PLGA layer directly on top of the PLGA-HA layer. As-fabricated scaffolds were 
carefully excised from the mandrel and cut into 3 mm x 6 cm pieces. To ensure that the biphasic scaffold 
has an even distribution of the non-mineralized and mineralized layers, scaffolds with a thickness of 
0.2±0.01 mm were selected. These scaffolds were carefully peeled, from both ends, into the PLGA and 
PLGA-HA layers, leaving the middle region, which measured to be 3 mm in length intact. The thickness of 
individual layers was measured and only scaffolds with both layers measured to be 0.1±0.01mm were 
used in the study. The single layers of the scaffold were folded back to the corresponding phase of the 
biphasic region with one fold on each layer to accommodate the repair procedure. By doing this, it was 
ensured the scaffold is thick enough to fill in the gap created between tendon and bone during the surgery, 
while retaining the distinct mineral distribution profile. Scaffolds were sterilized with ultraviolet radiation for 
15 minutes on both sides and stored under sterile conditions until used for surgery. 
To measure the fiber diameter of the scaffolds, as-fabricated nanofiber-based or microfiber-based 
biphasic scaffolds from each group were randomly selected and both phases of the scaffolds (n=3) were 
imaged with scanning electron microscopy (SEM, Hitachi S-4700, Hitachi, Tokyo, Japan). The scaffolds 
were coated with gold to reduce charging effects and fiber diameter of both phases of the two types of 
scaffolds was measured following a previous used method30. Briefly, five vertical lines with even spacing 
in between were drawn on the image; the intersections of these lines with fibers were identified and used 
to measure fiber diameter with Image J (NIH, Bethesda, MD). 
 
3.2.2 Surgical Procedure 
All animal procedures were performed at the Microsurgery Training and Research Laboratory in 
the Department of Orthopedic Surgery under a protocol approved by the Institutional Animal Care and 
Use Committee. Adult male Lewis rats (Charles River Laboratories, n=6, 11-12 weeks old, average 
weight=316±10g) were used in this study. For the surgery, each rat was anesthetized in a chamber with 
2-2.5% v/v isoflurane (Isothesia, Henry Schein Animal Health, Melville, NY) in 2 L/min oxygen flow. 
General anesthesia was maintained through a nose cone at an average of 1.5% v/v isoflurane in 2 L/min 
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oxygen flow. The shoulder region was shaved, and prepared for aseptic surgery with three rounds of 
alternative ethanol and betadine rubs. Immediately before surgery, systemic antibiotics ampicillin (Henry 
Schein, 50mg/kg body weight), anti-inflammatory drug carprofen (RIMADYLR® Injectable, Pfizer, New 
York, NY, 5 mg/kg body weight) and analgesic buprenorphine (Henry Schein, 1.2 mg/kg, sustained 
release for 72 hours) were injected into rat subcutaneously. Marcain (Henry Schein, 2 mg/kg body weight), 
a local anesthetic was injected subcutaneously to each shoulder right before skin incision was made.  
Bilateral acute rotator cuff repair was performed on each rat with the transosseus bone tunnel 
method, following a published protocol29. In each rat, the shoulders were randomly selected to be 
repaired using the nanofiber-based biphasic scaffold, the microfiber-based biphasic scaffold, or without 
scaffold. The selection was also randomized such that no rat received the same treatment in both 
shoulders. Briefly, a longitudinal incision was made on the skin of the shoulder region to expose the 
deltoid muscle. To locate the supraspinatus tendon, the coracoacromioal arch was identified and the 
deltoid muscle was cut open alone the arch. A 5-0 prolene suture (Ethicon, Somerville, NJ) was passed 
through the cut deltoid muscle to retract it during surgery. Once the deltoid was exposed, the 
supraspinatus tendon was identified as it passes right underneath the arch. To create an acute rotator 
cuff injury, the supraspinatus tendon was sharply detached from its bony insertion with a surgical blade. 
The fibrocartilaginous footprint of the tendon insertion on the greater tuberosity of humerus was removed 
with a motorized burr. For the transosseus tendon-bone repair, a bone tunnel with 0.5 mm diameter was 
drilled transversely in the anterior-posterior direction on the proximal part of the humerus. The tendon 
stump was grasped by a 5-0 prolene suture (Ethicon) using a technique similar to the Mason-Allen 
method. For control repair, the suture was passed through the bone tunnel to reappose tendon to the 
anatomic position. For scaffold augmented repair, the scaffold was inserted between the distal end of the 
tendon and the cancellous bone, such that its PLGA phase contacting the tendon and PLGA-HA phase 
contacting the bone. Extra attention was paid to ensure the fiber orientation of both the nanofiber-based 
and microfiber-based scaffolds matched with that of the tendon, followed by reapposing of the tendon to 
the anatomic position. Following tendon re-attachment, the deltoid muscle was repaired with a 4-0 vinyl 
suture (Ethicon) and the skin incision was closed by wound clips. Rats were not immobilized and allowed 
for normal cage activity through the duration of this study.  
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3.2.3 Sample Harvest 
Rats were sacrificed by CO2 overdose at week 5 post-surgery. Shoulders were dissected away 
from the body, rinsed in phosphate buffered saline (PBS, Sigma-Aldrich), and wrapped in PBS-soaked 
gauze for end-point analyses. Shoulders were first scanned with micro-CT, followed by gross dissection 
to leave only the supraspinatus muscle intact on the bone, which were further processed for assessing 
matrix deposition and organization, fibrocartilage, and mineralized tissue formation.  
 
3.2.4 End-point Analyses 
3.2.4.1 Matrix deposition and organization 
Gross dissected shoulders (n=3) were fixed in 80% v/v ethanol with 1% w/v cetylpyridinium 
chloride (Sigma-Aldrich) for 3 days, followed by decalcification in 45 mL of solution consisting formic acid 
(Thermo Fisher Scientific, Waltham, MA), Trizma® HCl (Sigma-Aldrich) and ethylenediaminetetraacetic 
acid (Sigma-Aldrich) on a rocker (Roto-Shake Genie, Scientific Industries, Bohemia, NY) for 21 days. 
Following complete decalcification, the tissues were dehydrated in an ethanol series (70%– 100%), 
cleared three times in xylenes (Thermo Fisher Scientific), and embedded in paraffin (Thermo Fisher 
Scientific) at 56ºC. Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica, 
Bannockburn, IL) to obtain 7 µm thick sections. To assess collagen and GAG distribution, the sections 
were de-paraffinized and rehydrated, and stained with picrosirius red and alcian blue stains, respectively. 
Collagen fiber alignment at the tendon-bone junction was visualized with circular polarized light 
microscopy of the picrosirius red stained slides. All images were taken with an inverted light microscope 
(Axiovert 25, Carl Zeiss, Thornwood, NY).  
3.2.4.2 Fibrocartilaginous tissue formation 
Non-mineralized and mineralized fibrocartilage formation was evaluated with 
immunohistochemistry of types II and X collagen across the healing tendon-bone junction, using paraffin-
embedded tissue sections. For type II collagen staining, after paraffin removal and tissue rehydration, 
samples were rinsed with PBS containing 0.1% Tween 20 (Thermo Fisher Scientific), treated with 0.5 
mg/mL hyaluronidase (Sigma-Aldrich) for 30 minutes to retrieve antigens, swelled with 0.5 M acetic acid 
(Thermo Fisher Scientific) for 4 hours, treated with serum-free protein blocking solution (Dako, Carpinteria, 
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CA) for 10 minutes and incubated at 4°C overnight with primary anti-collagen II antibodies (1:100 dilution, 
Santa Cruz Biotechnology, Dallas, TX). The slides were rinsed with PBS and incubated with FITC-
conjugated secondary antibody (1:200 dilution, Invitrogen) for 1 hour at room temperature. After rinsing 
with PBS, sections were incubated in 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI, Invitrogen) 
solution for 30 minutes for cell nuclei staining. Following this step, samples were rinsed in PBS, distilled 
water, and a cover slip applied. The samples were imaged with confocal microscopy (Olympus Fluoview 
FV1000 Confocal Microscope, Central Valley, PA) at 20x magnification using a dual excitation 
wavelength of 488 nm (Collagen II) and 358 nm (DAPI). Immunohistochemical analysis of type X collagen 
was performed following the same protocol, without the 4 hour swelling step. Anti-type X collagen 
antibodies (1:100 dilution, Abcam, Cambridge, MA) and Alexa Fluor 488-conjugated secondary antibody 
(1:200 dilution, Invitrogen) were used as primary and secondary antibodies, respectively. Images were 
taken with confocal microscopy at dual excitation wavelength of 488 nm (type X collagen) and 358 nm 
(DAPI).  
3.2.4.3 Mineralized tissue formation 
Formation of mineralized tissue was assess with both micro-CT and von Kossa stain of non-
decalcified shoulders (n=3). Immediately after harvesting, each shoulder was scanned with a micro-CT 
scanner at a voxel size of 21µm (VivaCT 40, Scanco, Swizerland) to obtain 2D images along the axis of 
humerus. Rotator cuff region was selected and contoured on all 2D slices, followed by 3D reconstruction 
using a mineral threshold of 268 mg HA/cm3, a value determined from previous studies to visualize the 
bony structures at the healing rotator cuff.  For non-decalcified histology, the gross dissected shoulders 
were fixed with 90% ethanol for 3 days, dehydrated in an ethanol series (70%– 100%), and followed by 
clearing and infiltration. Tissue samples were embedded in poly (methylmethacrylate) (PMMA, MW 
100,000, Polysciences Inc, Warrington, PA) using a modification of the methods of Erben et al240. 
Sections at 7 μm thickness were obtained with a sliding microtome (Leica, Bannockburn, IL). Mineral 
distribution at the tendon-bone junction was visualized by von Kossa staining, with safranin-O 
counterstaining to visualize GAG distribution.  
 
3.2.5 Statistical Analysis 
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Quantitative results are presented in the form of mean ± standard deviation. The fiber diameter 
between the corresponding phases of the as-fabricated nanofiber- and microfiber-based scaffolds was 
compared using student’s t-test. Significance was attained at p< 0.05. All statistical analyses were 
performed using JMP IN 4.0.4. (SAS Institute, Cary, NC) 
 
3.3 Results 
3.3.1 Scaffold Fiber Diameter 
 Representative SEM images and scaffold fiber diameters of the scaffolds are shown in figure 3.1, 
demonstrating significant differences in fiber diameter between nanofiber- and microfiber-based scaffolds 
(Table 3.1).  
 
3.3.2 Matrix Deposition and Organization 
 Formation and distribution of fibrocartilaginous tissue across the tendon-bone junction was 
visualized with picrosirius red (collagen) and alcian blue (GAG) stains of de-calcified shoulders (Figure 
3.2). The healing tissue of nanofiber-based biphasic scaffold repaired shoulder stained positive for both 
collagen and GAG, and the collagen fibers at the insertion were aligned. For the microfiber-based scaffold 
repaired shoulders, however, it was consistently observed that the tendon was not healed to the humeral 
head, as a gap was seen between tendon and the bone, at the location where in the nanofiber-based 
scaffold regenerated tissue was formed. In one of the shoulders, a piece of scaffold debris was still visible 
at the tendon-bone junction, with minimal amount of matrix deposition. Due to this lack of tissue formation, 
other end-point analyses were not performed on the microfiber-based scaffold repaired samples.  
 
3.4 Discussion 
 This chapter investigates the effect of scaffold fiber diameter on integrative rotator cuff tendon-
bone healing. In this chapter, aligned biphasic scaffold with nanofibers or microfibers were fabricated, 
characterized in terms of fiber diameter, and used to repair acute full-thickness rotator cuff tear in rat. 
Shoulders were harvested at week 5 post-surgery; matrix type and distribution, as well as mineral 
distribution across the tendon-bone junction were evaluated with histology and micro-CT. 
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 By increasing the PLGA to solvent ratio from 35/65 to 50/50 in the electrospinning solution, the 
fiber diameter of resulting scaffold was successfully increased in both phases. Fiber diameter 
measurement confirmed that the microfiber-based scaffolds had significantly larger fibers than the 
nanofiber-based scaffolds. As expected, the nanofiber-based biphasic scaffold led to the formation of 
biomimetic tissue, which contains both collagen and GAG, as well as aligned collagen fibers, furthermore, 
the tissue was stained positive for both type II and X collagen. On the other hand, discontinuity of tissue 
between the detached tendon and humeral head was consistently observed in the microfiber-based 
scaffold repaired shoulders.  
This difference could be explained by the change in matrix deposition rate caused by different 
fiber diameters. When the biphasic scaffold was implanted for rotator cuff repair, the PLGA phase 
contacted the tendon, and the PLGA-HA phase contacted the bone. Since aceullar scaffolds were used, 
the biphasic scaffold recruited the host cells resided at the native tissue and guided their proliferation, 
differentiation and matrix production. For the PLGA phase, tendon fibroblasts were recruited to the 
biphasic scaffold. For this phase, the average fiber diameter of scaffolds was 690±113 nm for the 
nanofiber-based scaffolds and 1708±284 nm for the microfiber-based scaffolds. These diameters are 
comparable to these of the nanofiber-based and microfiber-based PLGA scaffolds used in the in vitro 
study conducted by Erisken et al., in which human rotator cuff tendon fibroblasts response on these 
scaffolds were compared30. In the in vitro study, it was reported that when fibroblasts were seeded on the 
nanofiber-based scaffold, they proliferated more and deposited more collagen and GAG at day 28. On the 
other hand, cells seeded on microfiber-based scaffolds increased gene expression of tendon 
phenotypical markers, but only deposited limited amount of ECM. In this study, the observed in vitro effect 
of fiber diameter was translated in vivo. The nanofibers mimic injured tendon tissue, thus stimulating the 
healing response of host fibroblasts, leading to cell proliferation and matrix deposition30. On the other 
hand, the microfibers are mimetic of the fibers of healthy tissue, promoting host cells to maintain their 
phenotype. Since fibroblasts in the uninjured tendon do not actively produce ECM but rather maintain the 
ECM253, the host cells deposited minimal amount of ECM during the period of healing time, resulting in 
the observed gap between tendon and bone in the microfiber-based biphasic scaffold repaired shoulders. 
For the PLGA-HA phase, cells that are relevant for insertion regeneration are MSCs from bone marrow 
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and an ideal fiber diameter will lead to fibroblastic/chondrogenic differentiation of the MSCs, since cells 
from these lineages deposit fibrocartilaginous ECM. Currently, no studies have been performed to 
investigate the effect of fiber diameter of mineral containing fibers on MSC differentiation. However, 
studies using aligned polymer fibers with diameters close to that of the nanofibers of PLGA-HA phase 
demonstrated their ability to enhance fibrogensis236 and chondrogensis252 of MSCs. Therefore, it is 
possible that these effects were translated in this study, resulting in fibrochondrogenic matrix deposition in 
the nanofiber-based scaffold repaired shoulders. Overall, for the biphasic scaffold, since microfibers lead 
to lower fibroblast matrix deposition on PLGA phase and do not promote differentiation of MSCs on the 
PLGA-HA phase towards fibroblastic or chondrogenic linages, the combined effects of them led to 
minimal deposition of fibrocartilaginous tissue at the tendon-bone junction of the microfiber-based scaffold 
repaired shoulder.  
 
3.5 Conclusion 
In this chapter, the in vivo effect of scaffold fiber diameter on the regeneration of rotator cuff 
tendon-bone interface was investigated in a rat model. This property was selected since it was 
demonstrated in vitro affect matrix deposition of interface-relevant cells. The fiber diameter of aligned 
nanofiber-based biphasic scaffold was increased by increasing polymer ratio in the electrospinning 
solution. Results showed that compared to the nanofiber-based scaffold, microfiber-based scaffold led to 
minimal deposition of matrix. This chapter demonstrated that nanosized-fibers are critical for the 
regeneration of an insertion-like matrix at the tendon-bone junction and a scaffold designed for this 
purpose should consist of nanofibers.  
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Type Phase Fiber diameter (nm) 
Nanofiber PLGA 690 ± 113 
PLGA-HA 328 ± 66 
Microfiber PLGA 1708 ± 284# 
PLGA-HA 1681 ± 242# 
Figure 3.1. Characterization of nanofiber- and microfiber-based biphasic 
scaffolds. SEM micrographs (1500x, scale bar = 10 µm) of the as fabricated 






Table 3.1. Fiber diameter of nanofiber- and 
microfiber-based biphasic scaffolds 
 
(#: significant difference compared to the 
corresponding phase of the nanofiber-based 
biphasic scaffold,  n=3, p<0.05) 
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Figure 3.2. Effect of fiber diameter on extracellular matrix distribution and organization. For 
nanofiber-based scaffold, from left to right: collagen distribution (picrosirius red, 10x, bar=200μm), 
GAG distribution (alcian blue, 10x, bar=200μm), and collagen fiber alignment (polarized light 
microscopy, 10x, bar=200μm). For microfiber-based scaffold, collagen distribution is shown at 4x (top 
row, picrosirius red, bar =500µm) to show the overall position of tendon and bone, and shown at 10 x 


































CHAPTER 4: THE EFFECT OF SCAFFOLD MINERAL DISTRIBUTION 





The aligned nanofiber-based biphasic scaffold mimics the native tendon-bone insertion in terms 
of its structure and composition. In Chapters 2 and 3, the in vivo effect of scaffold structural properties: 
fiber alignment and diameter on rotator cuff tendon-bone healing are evaluated. In this and the next 
chapter, effect of scaffold compositional properties on insertion regeneration will be explored.  
Compared to other rotator cuff repair patches and tissue engineered scaffolds, one unique 
feature of the biphasic scaffold is the structurally continuous, yet compositionally distinct poly (lactide-co-
glycolide) (PLGA) and PLGA-hydroxyapatite (HA) layers to mimic the non-mineralized and mineralized 
fibrocartilage of the native tendon-bone insertion, over a span of several hundred micrometers. Since it 
was demonstrated that only scaffold with this biphasic mineral distribution led to positive healing response 
for rotator cuff repair24, the effect of mineral distribution within the scaffold on in vivo rotator cuff tendon-
bone healing will be evaluated in this chapter.  
 
4.1.1 Background and Motivation 
In tissue engineering, the scaffolds is designed to mimic the native extracellular matrix (ECM) to 
provide compositional, structural or mechanical cues that modulate response of cells, either pre-seeded 
on or recruited by the scaffold, such that they produce ECM resembles the native tissue and lead to 
eventual tissue regeneration254. It is known that the native rotator cuff tendon-bone interface consists of 
tendon, non-mineralized fibrocartilage, mineralized fibrocartilage and bone13;17;19;255. The two fibrocartilage 
layers are compositionally distinct from either tendon or bone as they contain type II collagen and 
proteoglycans, which are not found in tendon or bone. When comparing the two fibrocartilage layers, the 
mineralized layer also contains type X collagen and mineral. The biphasic scaffold mimics this feature by 
have the PLGA and PLGA-HA layers. When used for augmenting rotator cuff repair, the biphasic scaffold 
is expected to be placed at the tendon-bone junction with its PLGA phase contacting tendon and PLGA-
HA phase contacting bone to mimic the native insertion order. Since each phase provides specific cues 
for regenerating the corresponding fibrocartilage layer, it is expected biphasic scaffold order is critical for 
a positive tendon-bone healing response. Thus, in the first part of this chapter, the effect of mineral 
distribution is investigated by in vivo evaluation of healing efficacy of a biphasic scaffold placed at the 
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tendon-bone junction with reserved order (PLGA phase contacting bone and PLGA-HA phase contacting 
tendon).  
For a long time, the transition from non-mineralized to mineralized fibrocartilage was considered 
to be across a clear line of division (tidemark) and mineral content increases sharply across this line13;255. 
However, recent characterization studies using rat shoulder demonstrated the increase in mineral content 
is in a gradual, almost linear fashion from the non-mineralized fibrocartilage to mineralized 
fibrocartilage17;32. In the aligned, nanofiber-based biphasic scaffold, the mineral content increases directly 
from 0% to 15% between the two phases. Theoretically, this biphasic design can be made to be more 
biomimetic by incorporating a more gradual mineral change from one side of the scaffold to another, or a 
mineral gradient across its thickness. Therefore, in the second part of this chapter, the effect of mineral 
distribution is investigated by determining the healing efficacy of a gradient scaffold in the rat model.  
The study that evaluated effect of phase order was the first in vivo study performed in this thesis, 
therefore, it also served as a pilot study to familiarize with surgical procedure, as well as sample 
harvesting, processing and analyze methods. As a result, surgeries were only performed on two 
shoulders for each group and they were both processed for decalcified histology. End-point analyses for 
this study only included collagen and glycosaminoglycan (GAG) distribution, collagen fiber alignment 
analysis, and type II collagen distribution.  
 
4.1.2 Objective 
 The objective of this chapter is to investigate the in vivo healing effect of scaffold composition 
from the perspective of mineral distribution within the scaffold. This chapter contains two studies. In the 
first study, the importance of phase order will be evaluated by placing the biphasic scaffold with PLGA 
phase contacting bone and PLGA-HA phase contacting tendon. It is expected that when the reversed 
phase order is used for repairing rat shoulder, the healing tissue will consist of mainly disorganized 
fibrous tissue. In the second study, the effect of mineral distribution across the thickness of the biphasic 
scaffold, from its PLGA phase (0% HA) to PLGA-HA phase (15% HA) will be evaluated. It is expected that 
a gradient scaffold with a more gradual change in mineral content from 0% to 15% HA through its 
thickness will lead to the formation of an insertion-like tissue, which is rich in both collagen and GAG, 
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consists of organized collagen fibers and stains positive for types II and X collagen. Furthermore, as the 
biphasic scaffold, the gradient scaffold will not lead to the formation of ectopic bone at the tendon-bone 
junction.  
 
4.2 Effect of Phase Order on Insertion Healing 
4.2.1 Materials and Methods 
4.2.1.1 Scaffold fabrication 
Nanofiber-based scaffolds utilized in this study were fabricated via electrospinning24. The PLGA 
solution was prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- 
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA 
(w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-HA solution was prepared with the addition of HA 
nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, MI) to the PLGA solution. Each 
solution was loaded into a syringe with an 18.5-gauge stainless steel blunt tip needle and dispensed via a 
syringe pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The solutions were spun at 8-10 kV (PLGA) 
or 11-13 kV (PLGA-HA). The biphasic scaffold was produced by electrospinning the PLGA layer directly 
on top of the PLGA-HA layer. A rotating mandrel was used to collect fibers to create aligned fibers on 
both phases. As fabricated scaffolds were carefully excised from the mandrel and cut into 3 mm x 6 cm 
pieces. To ensure that the biphasic scaffold has an even distribution of the non-mineralized and 
mineralized layers, scaffolds with a thickness of 0.2±0.01 mm were selected. These scaffolds were 
carefully peeled, from both ends, into the PLGA and PLGA-HA layers, leaving the middle region, which 
measured to be 3 mm in length intact. The thickness of individual layers was measured and only scaffolds 
with both layers measured to be 0.1±0.01mm were used in the study. The single layers of the scaffold 
were folded back to the corresponding phase of the biphasic region with one fold on each layer to 
accommodate the repair procedure (Figure 2.1). By doing this, it was ensured the scaffold is thick enough 
to fill in the gap created between tendon and bone during the surgery, while retaining the distinct mineral 
distribution profile. Scaffolds were treated with ultraviolet radiation for 15 minutes on both sides and 
stored in sterile condition until used for surgery. 
4.2.1.2 Surgical procedure 
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All animal procedures were performed at the Microsurgery Training and Research Laboratory in 
the Department of Orthopedic Surgery under a protocol approved by the Institutional Animal Care and 
Use Committee. Adult male Lewis rats (Charles River Laboratories, n=3, 11-12 weeks old, average 
weight=316±10g) were used in this study. For the surgery, each rat was anesthetized in a chamber with 
2-2.5% v/v isoflurane (Isothesia, Henry Schein Animal Health, Melville, NY) in 2 L/min oxygen flow. 
General anesthesia was maintained through a nose cone at an average of 1.5% v/v isoflurane in 2 L/min 
oxygen flow. The shoulder region was shaved, and prepared for aseptic surgery with three rounds of 
alternative ethanol and betadine rubs. Immediately before surgery, systemic antibiotics ampicillin (Henry 
Schein, 50mg/kg body weight), anti-inflammatory drug carprofen (RIMADYLR® Injectable, Pfizer, New 
York, NY, 5 mg/kg body weight) and analgesic buprenorphine (Henry Schein, 1.2 mg/kg, sustained 
release for 72 hours) were injected into rat subcutaneously. Marcain (Henry Schein, 2 mg/kg body weight), 
a local anesthetic was injected subcutaneously to each shoulder right before skin incision was made.  
Bilateral acute rotator cuff repair was performed on each rat with the transosseus bone tunnel 
method, following a published protocol29 (Figure 2.2). In each rat, the shoulders were randomly selected 
to be repaired using the biphasic scaffold, the biphasic scaffold with reversed order or without scaffold. 
The selection was also randomized such that no rat received the same treatment in both shoulders. 
Briefly, a longitudinal incision was made on the skin of the shoulder region to expose the deltoid muscle. 
To locate the supraspinatus tendon, the coracoacromioal arch was identified and the deltoid muscle was 
cut open alone the arch. A 5-0 prolene suture (Ethicon, Somerville, NJ) was passed through the cut 
deltoid muscle to retract it during surgery. Once the deltoid was retracted, the supraspinatus tendon was 
identified as it passes right underneath the arch. To create an acute rotator cuff injury, the supraspinatus 
tendon was sharply detached from its bony insertion with a surgical blade. The fibrocartilaginous footprint 
of the tendon insertion on the greater tuberosity of humerus was removed with a motorized burr. For the 
transosseus tendon-bone repair, a bone tunnel with 0.5 mm diameter was drilled transversely in the 
anterior-posterior direction on the proximal part of the humerus. The tendon stump was grasped by a 5-0 
prolene suture using a technique similar to the Mason-Allen method. For control repair, the suture was 
passed through the bone tunnel to reappose tendon to the anatomic position. For scaffold augmented 
repair, the scaffold was inserted between the distal end of the tendon and the cancellous bone, with the 
62
PLGA phase contacting the tendon and PLGA-HA phase contacting the bone in the normal phase order 
group, and with the PLGA phase contacting the bone and PLGA-HA phase contacting the tendon in the 
reversed phase order group. Extra attention was paid to ensure the fiber orientation of both scaffolds 
matched with that of the tendon, followed by reapposing of the tendon to the anatomic position. Following 
tendon re-attachment, the deltoid muscle was repaired with a 4-0 vinyl suture (Ethicon) and the skin 
incision was closed by wound clips. Rats were not immobilized and allowed for normal cage activity 
through the duration of this study. 
4.2.1.3 Sample harvest 
Rats were sacrificed by CO2 overdose at week 5 post-surgery. Shoulders were dissected away 
from the body, rinsed in phosphate buffered saline (PBS, Sigma-Aldrich), and wrapped in PBS-soaked 
gauze for end-point analyses. Shoulders were dissected to leave only the supraspinatus muscle intact on 
the bone, which were further processed for assessing matrix deposition and organization, and 
fibrocartilage formation. 
4.2.1.4 End-point analyses 
Because of the nature of the pilot study, all samples were processed for decalcified histology. 
Gross dissected shoulders (n=2) were fixed in 80% v/v ethanol with 1% w/v cetylpyridinium chloride 
(Sigma-Aldrich) for 3 days, followed by decalcification in 45 mL of solution consisting formic acid (Thermo 
Fisher Scientific, Waltham, MA), Trizma® HCl (Sigma-Aldrich) and ethylenediaminetetraacetic acid 
(Sigma-Aldrich) on a rocker (Roto-Shake Genie, Scientific Industries, Bohemia, NY) for 21 days. 
Following complete decalcification, the tissues were dehydrated in an ethanol series (70%– 100%), 
cleared three times in xylenes (Thermo Fisher Scientific), and embedded in paraffin (Thermo Fisher 
Scientific) at 56ºC. Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica, 
Bannockburn, IL) to obtain 7 µm thick sections. To assess collagen and GAG distribution, the sections 
were de-paraffinized and rehydrated, and stained with picrosirius red and alcian blue stains, respectively. 
Collagen fiber alignment at the tendon-bone junction was visualized with circular polarized light 
microscopy of the picrosirius red stained slides. All images were taken with an inverted light microscope 
(Axiovert 25, Carl Zeiss, Thornwood, NY). Fibrocartilage formation was evaluated with 
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immunohistochemistry of types II collagen across the healing tendon-bone junction. After paraffin removal 
and tissue rehydration, samples were rinsed with PBS containing 0.1% Tween 20 (Thermo Fisher 
Scientific), treated with 0.5 mg/mL hyaluronidase (Sigma-Aldrich) solution for 30 minutes to retrieve 
antigen, swelled with 0.5 M acetic acid (Thermo Fisher Scientific) for 4 hours, treated with serum-free 
protein blocking solution (Dako, Carpinteria, CA) for 10 minutes and incubated at 4°C overnight with 
primary anti-type II collagen antibodies (1:100 dilution, Santa Cruz Biotechnology, Dallas, TX). The slides 
were rinsed with PBS and incubated with FITC-conjugated secondary antibody (1:200 dilution, Invitrogen) 
for 1 hour at room temperature. After rinsing with PBS, sections were incubated in 4',6-Diamidino-2-
Phenylindole, Dihydrochloride (DAPI, Invitrogen) solution for 30 minutes for cell nuclei staining. Following 
this step, samples were rinsed in PBS, distilled water, and a cover slip was applied. The samples were 
imaged with confocal microscopy (Olympus Fluoview FV1000 Confocal Microscope, Central Valley, PA) 
at 20x magnification using a dual excitation wavelength of 488 nm (type II collagen) and 358 nm (DAPI).  
 
4.2.2 Results 
All rats survived the surgery and returned to normal cage activity within one week post-surgery. 
The shoulders were decalcified and stained for collagen matrix deposition and organization (Figure 4.1). 
Fibrous tissue formed in all groups. However, in the reversed scaffold repaired shoulder, less tissue was 
deposited at the tendon-bone junction and a hole was seen between tendon and bone. Organized tissue 
was only formed in the shoulder where the correct phase order was used. Fibrocartilage formation and 
distribution was visualized with alcian blue stain and immunohistochemistry of type II collagen (Figure 
4.2). No fibrocartilage was formed in the control repair. When correct phase order was used, the healing 
tissue stained positive for GAG and type II collagen across the tendon-bone junction. When reversed 
phase order was used, only some region of the peripheral of the gap stained positive for GAG and type II 
collagen.  
 
4.3 Effect of Mineral Gradient on Insertion Healing 
4.3.1 Materials and Methods 
4.3.1.1 Gradient scaffold fabrication and characterization 
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In this study, the biphasic scaffold was fabricated following the same method described in section 
4.2.1.1. To fabricate a gradient scaffold with a gradual change in mineral content across the thickness of 
the scaffold, PLGA solution, PLGA-HA solutions with 5%, 10% and 15% HA were made. Each solution 
was loaded into a syringe with an 18.5-gauge stainless steel blunt tip needle and dispensed via a syringe 
pump (Harvard Apparatus) at 1 mL/h. The solutions were spun at 8-10 kV (PLGA) or 11-13 kV (PLGA-
HA), fibers were collected on a rotating mandrel, resulting aligned nanofiber layers. The gradient scaffold 
was produced by electrospinning the solutions with the following order: PLGA-HA (15%), PLGA-HA (10%), 
PLGA-HA (5%) and PLGA (0% HA). Each solution was spun for the same amount of time for the purpose 
of achieving the same thickness in each layer, which approximates the linear mineral change in native 
insertion. As-fabricated scaffolds were carefully excised from the mandrel and cut into 3 mm x 6 cm 
pieces. Scaffolds were treated with ultraviolet radiation for 15 minutes on both sides and stored in sterile 
condition until used for surgery. 
To confirm the mineral distribution across the thickness of the gradient scaffold, it was carefully 
peeled into four layers and the actual mineral content of each layer was measured by thermogravimetric 
analysis (TGA, Q500, TA Instruments, New Castle, DE, n=3). The sample was loaded onto a tared 
platinum pan, heated to 100ºC, and temperature increased to 900ºC at a rate of 20ºC/minute, in O2 
atmosphere. The weight of the sample was monitored throughout the process. Since PLGA burns off 
between 300ºC and 400ºC256, the weight percent of HA was obtained as the (residual weight/initial weight) 
x 100%. 
4.3.1.2 Surgical procedure 
The surgery was performed following the same procedure as described in section 4.2.1.2 with 
n=6 shoulders/group. In each rat, the shoulders were randomly selected to be repaired using the biphasic 
scaffold, the gradient scaffold, or without scaffold. The selection was also randomized such that no rat 
received the same treatment in both shoulders. 
4.3.1.3 Sample harvest 
Rats were sacrificed by CO2 overdose at week 5 post-surgery. Shoulders were dissected away 
from the body, rinsed in phosphate buffered saline (PBS, Sigma-Aldrich), and wrapped in PBS-soaked 
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gauze for end-point analyses. Shoulders were first scanned with micro-CT, followed by gross dissection 
to leave only the supraspinatus muscle intact on the bone, which were further processed for assessing 
matrix deposition and organization, fibrocartilage, and mineralized tissue formation.  
4.3.1.4 End-point analyses 
Gross dissected shoulders (n=3) were fixed in 80% v/v ethanol with 1% w/v cetylpyridinium 
chloride (Sigma-Aldrich) for 3 days, followed by decalcification in 45 mL of solution consisting formic acid 
(Thermo Fisher Scientific, Waltham, MA), Trizma® HCl (Sigma-Aldrich) and ethylenediaminetetraacetic 
acid (Sigma-Aldrich) on a rocker (Roto-Shake Genie, Scientific Industries, Bohemia, NY) for 21 days. 
Following complete decalcification, the tissues were dehydrated in an ethanol series (70%– 100%), 
cleared three times in xylenes (Thermo Fisher Scientific), and embedded in paraffin (Thermo Fisher 
Scientific) at 56ºC. Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica, 
Bannockburn, IL) to obtain 7 µm thick sections. To assess collagen and GAG distribution, the sections 
were de-paraffinized and rehydrated, and stained with picrosirius red and alcian blue stains, respectively. 
Collagen fiber alignment at the tendon-bone junction was visualized with circular polarized light 
microscopy of the picrosirius red stained slides. All images were taken with an inverted light microscope 
(Axiovert 25, Carl Zeiss, Thornwood, NY).  
Non-mineralized and mineralized fibrocartilage formation was evaluated with 
immunohistochemistry of types II and X collagen across the healing tendon-bone junction, using paraffin-
embedded tissue sections. For type II collagen staining, after paraffin removal and tissue rehydration, 
samples were rinsed with PBS containing 0.1% Tween 20 (Thermo Fisher Scientific), treated with 0.5 
mg/mL hyaluronidase (Sigma-Aldrich) for 30 minutes to retrieve antigens, swelled with 0.5 M acetic acid 
(Thermo Fisher Scientific) for 4 hours, treated with serum-free protein blocking solution (Dako, Carpinteria, 
CA) for 10 minutes and incubated at 4°C overnight with primary anti-type II collagen antibodies (1:100 
dilution, Santa Cruz Biotechnology, Dallas, TX). The slides were rinsed with PBS and incubated with 
FITC-conjugated secondary antibody (1:200 dilution, Invitrogen) for 1 hour at room temperature. After 
rinsing with PBS, sections were incubated in 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI, 
Invitrogen) solution for 30 minutes for cell nuclei staining. Following this step, samples were rinsed in PBS, 
distilled water, and a cover slip was applied. The samples were imaged with confocal microscopy 
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(Olympus Fluoview FV1000 Confocal Microscope, Central Valley, PA) at 20x magnification using a dual 
excitation wavelength of 488 nm (type II collagen) and 358 nm (DAPI). Immunohistochemical analysis of 
type X collagen was performed following the same protocol, without the 4 hour swelling step. Anti-type X 
antibodies (1:100 dilution, Abcam, Cambridge, MA) and Alexa Fluor 488-conjugated secondary antibody 
(1:200 dilution, Invitrogen) were used as primary and secondary antibodies. Images were taken with 
confocal microscopy at dual excitation wavelength of 488 nm (type X collagen) and 358 nm (DAPI).  
Formation of mineralized tissue was assess with both micro-CT and von Kossa staining of non-
decalcified shoulders (n=3). Immediately after harvesting, each shoulder was scanned with a micro-CT 
scanner at a voxel size of 21µm (VivaCT 40, Scanco, Swizerland) to obtain 2D images along the axis of 
humerus. Rotator cuff region was selected and contoured on all 2D slices, followed by 3D reconstruction 
using a mineral threshold of 268 mg HA/cm3, a value determined from previous studies to visualize the 
bony structures at the healing rotator cuff24.  For non-decalcified histology, the gross dissected shoulders 
were fixed with 90% ethanol for 3 days, dehydrated in an ethanol series (70%– 100%), and followed by 
clearing and infiltration. Tissue samples were embedded in poly (methylmethacrylate) (PMMA, MW 
100,000, Polysciences Inc, Warrington, PA) using a modification of the methods of Erben et al240. 7 μm 
thick sections were obtained with a sliding microtome (Leica, Bannockburn, IL). Mineral distribution at the 
tendon-bone junction was visualized by von Kossa staining, with safranin-O counterstaining to visualize 
GAG distribution.  
4.3.1.5 Statistical Analysis 
Quantitative results are presented in the form of mean ± standard deviation. The average mineral 
content of the individual layers was compared with one-way ANOVA, with Tukey-Kramer post-hoc test for 
all pairwise comparison. Significance was attained at p< 0.05 and statistical analyses were performed 
using JMP IN 4.0.4. (SAS Institute, Cary, NC) 
 
4.3.2 Results 
4.3.2.1 Gradient scaffold characterization 
 Mineral gradient through the scaffold thickness was created via layer-by-layer electrospinning. 
Comparing to the biphasic scaffold, this gradient scaffold consists of four layers: PLGA, PLGA-HA (5%), 
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PLGA-HA (10%) and PLGA-HA (15%) (Figure 4.3.a). The mineral content of each layer was confirmed 
with TGA (Figure 4.3.b) and results showed that each layer had an actual HA content close to the 
expected value (Table 4.1), and significantly different from the other layers, confirming the step-wise 
change in mineral content. 
4.3.2.2 Matrix deposition and organization 
 Formation and distribution of fibrocartilaginous tissue across the tendon-bone junction was 
visualized with picrosirius red (collagen) and alcian blue (GAG) stains of decalcified shoulders (Figure 
4.4). The healing tissue of biphasic scaffold repaired shoulder was stained positive for both collagen and 
GAG, and the collagen fibers at the insertion were aligned. A much smaller aligned fibrocartilaginous 
region was seen at the tendon-bone junction of the gradient scaffold repaired shoulders.   
4.3.2.3 Fibrocartilaginous tissue formation 
 Immunohistochemistry was performed on the decalcified shoulders to determine types II and X 
collagen distribution at the tendon-bone junction of repaired shoulders (Figure 4.5).  The biphasic scaffold 
repaired shoulder stained positive for both types of collagen, across a span over 200 µm at the tendon-
bone junction. On the other hand, types II and X collagen was only seen sparsely in the gradient scaffold 
repaired tissue.   
4.3.2.4 Mineralized tissue formation 
 Micro-CT scan of the harvested shoulders and von Kossa stain of the non-decalcified tendon-
bone junction tissue section were performed to determine the formation of mineralized tissue around the 
healing region (Figure 4.6). No ectopic bone formation was observed in any of the biphasic scaffold 
repaired shoulders. Micro-CT showed that one shoulder, which was used for decalcified histology, had 
mineralized tissue at the tendon-bone junction. When the picrosirius red stained section of this sample 
was examined, some bone-like tissue was seen at the tendon-bone junction (Figure 4.7). 
 
4.4 Discussion 
In this chapter, the in vivo effect of scaffold mineral distribution on tendon-bone healing was 
evaluated. Specifically, biphasic scaffolds with reversed phase order or scaffolds with a mineral gradient 
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through its thickness were used to repair an acute full-thickness rotator cuff injury in the rat model. Matrix 
type and organization, as well as mineral distribution across the tendon-bone junction were evaluated 
with histology and micro-CT. 
The results demonstrated that the location of mineral in the scaffold is critical for the formation of 
an insertion-like tissue, as the reversed-order biphasic scaffold caused less matrix deposition and the 
formation of disorganized collagen fibers. This is expected since the biphasic scaffold was designed to 
provide phase-specific cues that guide formation of fibrocartilage at the tendon side and mineralized 
fibrocartilage at the bone side. Therefore, for the ultimate goal of this biphasic scaffold, which is the 
application in clinics, it is important that a design feature is incorporated to ensure that the scaffold will be 
placed at the tendon-bone junction only with its intended order.  
To mimic the linear change in mineral in the native insertion, a four-layered scaffold with a more 
gradual mineral change across its thickness compared to the biphasic scaffold was used to repair rat 
rotator cuff. Unexpectedly, this scaffold did not show better performance compared to the biphasic 
scaffold, as the fibrocartilaginous region formed was much less prominent that that of the biphasic 
scaffold. Furthermore, in one of the shoulders repaired with gradient scaffold, ectopic bone formation was 
seen at the tendon-bone junction. This might provide an explanation to the sub-optimal performance of 
the gradient scaffold. Compared to the biphasic scaffold, the PLGA region of the gradient scaffold was 
thinner. When the scaffold was used in rat shoulder repair, in addition to enable tendon fibroblasts 
attachment and proliferation, the PLGA layer also acts as a barrier to prevent mineralized tissue formation 
from the bone side to the tendon size. The thinner PLGA layer was not as effective as a barrier compared 
to the PLGA layer in the biphasic scaffold, leading to the formation of ectopic mineralized tissue at the 
tendon end. Similarly, during healing, as the thinner PLGA layer degrades, the underlying PLGA-HA layer 




 In this chapter, the effect of mineral distribution on tendon-bone interface regeneration was 
evaluated. In the first study, effect of phase order was investigated by repairing the rat shoulder with the 
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PLGA phase of the biphasic scaffold contacting bone and the PLGA-HA phase contacting tendon. 
Results demonstrated that the biphasic scaffold is only effective when the correct phase order was used. 
In the second study, the effect of mineral gradient was investigated by fabricating a four layer scaffold 
with a more gradual change in mineral content though it thickness. Results demonstrated that although 
theoretically the gradient scaffold is more biomimetic than the biphasic scaffold, it did not lead to 
integrative rotator cuff repair. Results from this chapter collectively demonstrated that the biphasic 
distribution of mineral in the scaffold is a key scaffold parameter that leads to the formation of an 



























Figure 4.1. Effect of biphasic scaffold phase order on collagen matrix 
formation and organization. All groups were stained positive for collagen 
(picrosirius red stain, 4x, bar=400 µm) at the tendon-bone junction. Less tissue 
was deposited when scaffold with reversed order was used to repair the 
rotator cuff. Biphasic scaffold with correct phase order led to the formation of 
an organized tissue at the rotator cuff tendon-bone junction (polarized light 
microscopy, 4x). 
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Figure 4.2. Effect of biphasic scaffold phase order on fibrocartilage 
formation. Control repair stained negative for GAG (alcian blue stain, 4x, bar 
=400 µm) and type II collagen (10x, bar=200 µm). Shoulders repaired with 
biphasic scaffold with intended order stained positive for GAG and type II 
collagen over a span of ~200 µm. Shoulders repaired with reserved scaffold 





















Layer HA% from TGA 
PLGA 0.35±0.11* 
PLGA-HA (5%) 5.80±0.08* 
PLGA-HA (10%) 10.80±0.10* 
PLGA-HA (15%) 15.56±0.21* 
Figure 4.3. Gradient scaffold design and characterization. a) schematic 
demonstrating the difference in mineral distribution through the thickness of 
biphasic and gradient scaffold, b) the TGA profile of individual layers in the 
gradient scaffold. 




































(*: significant difference from other groups, 
n=3, p<0.05) 
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Figure 4.4. Effect of scaffold mineral gradient on extracellular matrix distribution and 
organization. Extracellular matrix formation at the healing rotator cuff repaired by biphasic and 
gradient scaffolds. From left to right: collagen distribution (Picrosirius red, 10x, bar=200μm), 
GAG distribution (Alcian blue, 10x, bar=200μm), and collagen fiber alignment (polarized light 
microscopy, 10x, bar=200μm). The biphasic scaffold repaired shoulder is rich in collagen and 
GAG, and aligned fibers are observed at the tendon-bone insertion. Gradient scaffold repaired 





















Figure 4.5. Effect of scaffold mineral gradient on fibrocartilage and 
mineralized fibrocartilage formation. Types II (green) and X (green) 
immunohistochemistry stainings of rotator cuff repaired by biphasic and 
gradient scaffolds with cell nucleus stained with DAPI (blue) (20x, bar = 
200μm). The biphasic scaffold repaired shoulder stained positive for both 
types of collagen. Types II and X collagen distributed sparsely in the gradient 



















Figure 4.6. Effect of scaffold mineral gradient on mineralized tissue formation. No 
ectopic bone was formed in the tendon region of rotator cuff repaired with biphasic scaffold 
and most of shoulders repaired by the gradient, as indicated by the micro-CT 3D 






Figure 4.7. Ectopic bone formation at the tendon-bone junction of gradient 
scaffold repaired shoulder. Micro-CT 3D reconstructed image shows the 
formation of bone-like tissue in one shoulder repaired by the gradient scaffold 
(arrow). Corresponding picrosirius red stained slides also indicated formation of 
tissue with bone-like morphology at the tendon-bone junction. 
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CHAPTER 5: THE EFFECT OF SCAFFOLD POLYMER COMPOSTION 





In Chapters 2-4, the in vivo effects of biphasic scaffold properties on rotator cuff repair are 
examined by varying fiber alignment, diameter and mineral distribution. Results show that an effective 
scaffold for integrative rotator cuff repair should contain evenly distributed non-mineralized and 
mineralized layers consisting aligned nanofibers. In the tissue engineering approach, an ideal scaffold 
facilitates host cell attachment and proliferation, as well as degrades at a rate that allows cells to 
penetrate into the scaffold while providing space for new tissue deposition. In this chapter, the effect of 
scaffold polymer composition on rotator cuff tendon-bone healing will be explored from the perspective of 
degradation rate.  
 
5.1.1 Background and Motivation  
Currently, the biphasic scaffold contains only poly (lactide-co-glycolide) (PLGA). PLGA is selected 
since it is biocompatible257-259, biodegradable257, and approved by the FDA for tissue engineering 
applications260. In vitro studies in which chondrocytes were seeded on this biphasic scaffold showed that 
by week 6, significant degradation occurred with fibrocartilaginous tissue penetrating towards the center 
of the scaffold. It was also observed in vivo that by week 5 post-surgery, the biphasic scaffold was no 
longer visible on micro-CT scan of rat shoulder, indicating significant degradation. Since scaffold 
degradation is required for new tissue deposition, the relatively fast degradation rate of the PLGA based 
biphasic scaffold is selected as a critical design parameter for integrative tendon-bone healing. To test 
this hypothesis, the degradation rate of the aligned, nanofiber-based scaffold will be changed, and a 
scaffold with a slower degradation rate will be used for rotator cuff repair. 
By changing polymer composition, the degradation rate of polymeric scaffold can be modulated. 
Specifically in this chapter, an aligned, nanofiber-based biphasic scaffold with a slower degradation rate 
will be fabricated by mixing poly (ε-caprolactone) (PCL) with PLGA. Both PCL and PLGA are polyesters, 
which degrade through hydrolysis. The rate of hydrolysis depends on both the polymer hydrophilicity261 
and crystallinity262. Generally, either an increase in hydrophilicity or a decrease in polymer crystallinity 
increases the ability of the polymer to absorb water, leading to a faster degradation rate. PLGA consists 
of lactide and glycolide, with the glycolide being the mord hydrophilic molecule. PCL consists of ε-
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caprolactone, which has five hydrophobic –CH2 groups. Since PLGA has two types of monomers and 
PCL has one type, the monomers of PCL are arranged in longer hydrocarbon chains and is more readily 
packed into crystalline structures due to the relatively uniform structure compared to PLGA263;264. As PCL 
is comprised of a more hydrophobic monomer and contains a higher degree of crystallinity, it has a 
slower degradation rate compared to PLGA265. It was investigated in our lab the optimal PCL:PLGA ratio 
in terms of cell response is 5:1, which significantly slowed down the scaffold degradation rate without 
alternating human ligament fibroblast proliferation and matrix deposition compared to pure PLGA266. 
Therefore, in this chapter, a biphasic scaffold that uses PCL/PLGA (5:1 ratio) as its polymer material is 
fabricated and used for rat shoulder repair.  
 
5.1.2 Objective 
 By changing the scaffold polymer composition from PLGA to PCL/PLGA blend, the degradation 
rate of the resulting scaffold becomes significantly slower. The objective of this chapter is to investigate 
the in vivo effect of polymer composition on rat rotator cuff repair. It is hypothesized that PCL/PLGA 
scaffold with a slower degradation rate will prevent the deposition and remodeling of the extracellular 
matrix at the tendon-bone junction of injured rate rotator cuff. Specifically, less matrix deposition and a 
fibrous matrix will be observed at the tendon-bone junction repaired by PCL/PLGA scaffold compared to 
the pure PLGA scaffold.  
 
5.2 Materials and Methods 
5.2.1 Scaffold Fabrication and Characterization 
Nanofiber-based scaffolds were fabricated via electrospinning24. The PLGA solution was 
prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- 
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA 
(w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-HA solution was prepared with the addition of 
hydroxyapatite (HA) nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, MI) to the 
PLGA solution. For the PCL/PLGA scaffold, a 5:1 ratio of PCL (Sigma-Aldrich, Mw=70,000-90,000 Da) to 
PLGA was used. The polymers were dissolved in a mixture of 40/60 (v/v) DMF and dichloromethane 
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(Sigma-Aldrich), followed by addition of ethanol. 15% w/w HA nanoparticles were added to the 
PCL/PLGA blend for fabricating the PCL/PLGA-HA phase. Each solution was loaded into a syringe with 
an 18.5-gauge  (PLGA based solutions) or 23-gauge (PLGA/HA based solutions) stainless steel blunt tip 
needle and dispensed via a syringe pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The solutions 
were spun at 8-10 kV (non-mineralized phase) or 11-13 kV (mineralized phase). Fibers were collected on 
a rotating mandrel, resulting aligned fiber layers. The biphasic scaffold was produced by electrospinning 
the non-mineralized layer directly on top of the mineralized layer. As-fabricated scaffolds were carefully 
excised from the mandrel and cut into 3 mm x 6 cm pieces. To ensure that the biphasic scaffold has an 
even distribution of the non-mineralized and mineralized layers, scaffolds with a thickness of 0.2±0.01 mm 
were selected. These scaffolds were carefully peeled, from both ends, into non-mineralized and 
mineralized layers, leaving the middle region, which measured to be 3 mm in length intact. The thickness 
of individual layers was measured and only scaffolds with both layers measured to be 0.1±0.01mm were 
used in the study. The single layers of the scaffold were folded back to the corresponding phase of the 
biphasic region with one fold on each layer to accommodate the repair procedure (Figure 2.1). By doing 
this, it was ensured the scaffold is thick enough to fill in the gap created between tendon and bone during 
the surgery, while retaining the distinct mineral distribution profile. Scaffolds were sterilized with ultraviolet 
radiation for 15 minutes on both sides and stored under sterile conditions until surgery. 
To confirm the incorporation of both PLGA and PCL in the resulting PCL/PLGA scaffold, Fourier 
Transform Infrared Spectroscopy (Spectrum 100, PerkinElmer, Waltham, Massachusetts) was performed 
on both phases of the as-fabricated PLGA and PCL/PLGA biphasic scaffolds. Briefly, FTIR spectra were 
collected in Attenuated Total Reflectance (ATR) mode (200 scans, resolution at 4 cm−1) and analyzed for 
characteristic peaks to confirm the presence of PLGA (C=O, 1780 cm-1) and PCL (C=O, 1724 cm-1). 
Since Chapters 2 and 3 show that aligned nanofibers are required for the integrative tendon-bone healing, 
scanning electron microscopy (SEM) images of both phases of the as-fabricated PCL/PLGA biphasic 
scaffold were obtained (Hitachi S-4700, Hitachi, Tokyo, Japan), and used for fiber alignment and diameter 
(n=3/type/phase) characterization following the methods described in sections 2.2.1 and 3.2.1. 
 
5.2.2 Surgical Procedure 
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All animal procedures were performed at the Microsurgery Training and Research Laboratory of 
the Department of Orthopedic Surgery under a protocol approved by the Institutional Animal Care and 
Use Committee. Adult male Lewis rats (Charles River Laboratories, n=6, 11-12 weeks old, average 
weight=316±10g) were used in this study. For the surgery, each rat was anesthetized in a chamber with 
2-2.5% v/v isoflurane (Isothesia, Henry Schein Animal Health, Melville, NY) in 2 L/min oxygen flow. 
General anesthesia was maintained through a nose cone at an average of 1.5% v/v isoflurane in 2 L/min 
oxygen flow. The shoulder region was shaved and prepared for aseptic surgery with three rounds of 
alternative ethanol and betadine rubs. Immediately before surgery, systemic antibiotics ampicillin (Henry 
Schein, 50mg/kg body weight), anti-inflammatory drug carprofen (RIMADYLR® Injectable, Pfizer, New 
York, NY, 5 mg/kg body weight) and analgesic buprenorphine (Henry Schein, 1.2 mg/kg, sustained 
release for 72 hours) were injected into rat subcutaneously. Marcain (Henry Schein, 2 mg/kg body weight), 
a local anesthetic was injected subcutaneously to each shoulder right before skin incision was made.  
Bilateral acute rotator cuff repair was performed on each rat with the transosseus bone tunnel 
method, following a published protocol29. In each rat, the shoulders were randomly selected to be 
repaired using the PLGA-based biphasic scaffold, the PCL/PLGA-based biphasic scaffold, or without 
scaffold. The selection was also randomized such that no rat received the same treatment in both 
shoulders. Briefly, a longitudinal incision was made on the skin of the shoulder region to expose the 
deltoid muscle. To locate the supraspinatus tendon, the coracoacromioal arch was identified and the 
deltoid muscle was cut open alone the arch. A 5-0 prolene suture (Ethicon, Somerville, NJ) was passed 
through the cut deltoid muscle to retract it during surgery. Once the deltoid was exposed, the 
supraspinatus tendon was identified as it passes right underneath the arch. To create an acute rotator 
cuff injury, the supraspinatus tendon was sharply detached from its bony insertion with a surgical blade. 
The fibrocartilaginous footprint of the tendon insertion on the greater tuberosity of humerus was removed 
with a motorized burr. For the transosseus tendon-bone repair, a bone tunnel with 0.5 mm diameter was 
drilled transversely in the anterior-posterior direction on the proximal part of the humerus. The tendon 
stump was grasped by a 5-0 prolene suture (Ethicon) using a technique similar to the Mason-Allen 
method. For control repair, the suture was passed through the bone tunnel to reappose tendon to the 
anatomic position. For scaffold augmented repair, the scaffold was inserted between the distal end of the 
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tendon and the cancellous bone, such that its non-mineralized phase contacting the tendon and 
mineralized phase contacting the bone. Extra attention was paid to ensure the fiber orientation of both 
scaffolds matched with that of the tendon, followed by reapposing of the tendon to the anatomic position. 
Following tendon re-attachment, the deltoid muscle was repaired with a 4-0 vinyl suture (Ethicon) and the 
skin incision was closed by wound clips. Rats were not immobilized and allowed for normal cage activity 
through the duration of this study.  
 
5.2.3 Sample Harvest 
Rats were sacrificed by CO2 overdose at week 5 post-surgery. Shoulders were dissected away 
from the body, rinsed in phosphate buffered saline (PBS, Sigma-Aldrich), and wrapped in PBS-soaked 
gauze for end-point analyses. Shoulders were first scanned with micro-CT, followed by gross dissection 
to leave only the supraspinatus muscle intact on the bone, which were further processed for assessing 
matrix deposition and organization, fibrocartilage, and mineralized tissue formation.  
 
5.2.4 End-point Analyses 
5.2.4.1 Matrix deposition and organization 
Gross dissected shoulders (n=3) were fixed in 80% v/v ethanol with 1% w/v cetylpyridinium 
chloride (Sigma-Aldrich) for 3 days, followed by decalcification in 45 mL of solution consisting formic acid 
(Thermo Fisher Scientific, Waltham, MA), Trizma® HCl (Sigma-Aldrich) and ethylenediaminetetraacetic 
acid (Sigma-Aldrich) on a rocker (Roto-Shake Genie, Scientific Industries, Bohemia, NY) for 21 days. 
Following complete decalcification, the tissues were dehydrated in an ethanol series (70%– 100%), 
cleared three times in xylenes (Thermo Fisher Scientific), and embedded in paraffin (Thermo Fisher 
Scientific) at 56ºC. Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica, 
Bannockburn, IL) to obtain 7 µm thick sections. To assess collagen and GAG distribution, the sections 
were de-paraffinized and rehydrated, and stained with picrosirius red and alcian blue stains, respectively. 
Collagen fiber alignment at the tendon-bone junction was visualized with circular polarized light 
microscopy of the picrosirius red stained slides. All images were taken with an inverted light microscope 
(Axiovert 25, Carl Zeiss, Thornwood, NY).  
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5.2.4.2 Fibrocartilaginous tissue formation 
Non-mineralized and mineralized fibrocartilage formation was evaluated with 
immunohistochemistry of types II and X collagen across the healing tendon-bone junction, using paraffin-
embedded tissue sections. For type II collagen stain, after paraffin removal and tissue rehydration, 
samples were rinsed with PBS containing 0.1% Tween 20 (Thermo Fisher Scientific), treated with 0.5 
mg/mL hyaluronidase (Sigma-Aldrich) solution for 30 minutes to retrieve antigen, swelled with 0.5 M 
acetic acid (Thermo Fisher Scientific) for 4 hours, treated with serum-free protein block solution (Dako, 
Carpinteria, CA) for 10 minutes and incubated at 4°C overnight with primary anti-type II collagen 
antibodies (1:100 dilution, Santa Cruz Biotechnology, Dallas, TX). The slides were rinsed with PBS and 
incubated with FITC-conjugated secondary antibody (1:200 dilution, Invitrogen) for 1 hour at room 
temperature. After rinsing with PBS, sections were incubated in 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (DAPI, Invitrogen) solution for 30 minutes for cell nuclei staining. Following this step, 
samples were rinsed in PBS, distilled water, and a cover slip applied. The samples were imaged with 
confocal microscopy (Olympus Fluoview FV1000 Confocal Microscope, Central Valley, PA) at 20x 
magnification using a dual excitation wavelength of 488 nm (type II collagen) and 358 nm (DAPI). 
Immunohistochemical analysis of type X collagen was performed following the same protocol, without the 
4 hour swelling step. Anti-collagen X antibodies (1:100 dilution, Abcam, Cambridge, MA) and Alexa Fluor 
488-conjugated secondary antibody (1:200 dilution, Invitrogen) were used as primary and secondary 
antibodies. Images were taken with confocal microscopy at dual excitation wavelength of 488 nm (type X 
collagen) and 358 nm (DAPI).  
5.2.4.3 Mineralized tissue formation 
Formation of mineralized tissue was assess with both micro-CT and von Kossa stain of non-
decalcified shoulders (n=3). Immediately after harvesting, each shoulder was scanned with a micro-CT 
scanner at a voxel size of 21µm (VivaCT 40, Scanco, Swizerland) to obtain 2D images along the axis of 
humerus. Rotator cuff region was selected and contoured on all 2D slices, followed by 3D reconstruction 
using a mineral threshold of 268 mg HA/cm3, a value determined from previous studies24 to visualize the 
bony structures at the healing rotator cuff.  For non-decalcified histology, the gross dissected shoulders 
were fixed with 90% ethanol for 3 days, dehydrated in an ethanol series (70%– 100%), and followed by 
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clearing and infiltration. Tissue samples were embedded in poly (methylmethacrylate) (PMMA, MW 
100,000, Polysciences Inc, Warrington, PA) using a modification of the methods of Erben et al240. 7 μm 
thick sections were obtained with a sliding microtome (Leica, Bannockburn, IL). Mineral distribution at the 
tendon-bone junction was visualized by von Kossa stain, with safranin-O counterstain to visualize GAG 
distribution. 
 
5.2.5 Statistical Analysis 
Quantitative results are presented in the form of mean ± standard deviation. Differences in fiber 
diameter and alignment between the corresponding phases of the as fabricated PLGA-based and 
PCL/PLGA-based biphasic scaffolds were tested using student’s t-test and significance was attained at 
p< 0.05. All statistical analyses were performed using JMP IN 4.0.4 (SAS Institute, Cary, NC). 
 
5.3 Results 
5.3.1 Scaffold Characterization 
 PCL/PLGA-based biphasic scaffolds were fabricated by mixing the PCL and PLGA polymers at 
5:1 ratio. FTIR-ATR was performed to determine the composition of resulting scaffold (Figure 5.1), 
confirming the presence of both PLGA and PCL in the PCL/PLGA scaffold. SEM was used to assessed 
the surface morphology of the PCL/PLGA scaffold (Figure 5.2). Scaffold diameter and alignment 
parameters are listed in Table 5.1. Results confirmed the PCL/PLGA scaffold consists of aligned 
nanofibers in both phases.  
 
5.3.2 Matrix Deposition and Organization 
Formation and distribution of fibrocartilaginous tissue across the tendon-bone junction was 
visualized with picrosirius red (collagen) and alcian blue (GAG) stains of de-calcified shoulders (Figure 
5.3). Healing tissue formed on the PLGA-based biphasic scaffold repaired shoulder stained strongly for 
both collagen and GAG, furthermore the collagen fibers at the insertion followed the alignment of the 
tendon region, as shown in the polarized light microscopy image. For the PCL/PLGA-based scaffold 
repaired shoulder, although the tendon-bone junction was rich in collagen, the fibers were not as densely 
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packed as in the PLGA repaired shoulder and randomly oriented. Additionally, minimal GAG deposition 
was observed at the tendon-bone junction.  
 
5.3.3 Fibrocartilaginous Tissue Formation 
Immunohistochemistry showed that the ECM was rich in both types II and X collagen at the 
tendon-bone junction of the PLGA-based scaffold repaired shoulder. However, the PCL/PLGA scaffold 
repaired tissue stained positive for type II collagen only in an isolated region and stained negative for 
collagen type X (Figure 5.4).  
 
5.3.4 Mineral Distribution 
 Micro-CT scan of the harvested shoulders and von Kossa stain of the non-decalcified tendon-
bone junction tissue section were performed to determine the formation of mineralized tissue around the 
healing region (Figure 5.5). No ectopic mineralized tissue formed at the tendon end in the PLGA-based 
scaffold repaired shoulder. On the other hand, in the PCL/PLGA repaired shoulder, the von Kossa stain 
showed a non-tissue region on the tendon that was not stained positive for collagen with regions stained 
positive for mineral. The corresponding micro-CT 3D reconstructed image showed a mineralized region 
which was morphologically different from bone at the tendon-bone junction.  
 
5.4 Discussion  
 This chapter investigates the effect of scaffold polymer composition on the in vivo repair efficacy 
of the biphasic scaffold from the perspective of degradation rate. PCL, which is less hydrophilic and a 
semicrystalline polymer, has a slower degradation rate compared to PLGA. Therefore, in this chapter, 
PCL was mixed with PLGA at 5:1 ratio to fabricate a biphasic scaffold with a slower degradation rate. The 
composition of the PCL/PLGA scaffold was confirmed with FTIR, SEM characterization confirmed the 
PCL/PLGA scaffold consists of aligned nanofibers. This scaffold was subsequently used to repair a full-
thickness rotator cuff tear in a rat model. 
The slower in vivo degradation of PCL/PLGA scaffold was evident in both the von Kossa stained 
tissue sections and micro-CT 3D reconstructed images of the shoulder. In the von Kossa stain, the 
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PCL/PLGA scaffold was seen as a region in the tendon that was partially mineralized and had distinct 
morphology compared to the tendon. In the micro-CT image, a mineralized region between clavicle and 
humeral head with morphology resembled that of a porous structure rather than cortical bone was 
observed, both its location and morphology indicated the presence of un-degraded PCL/PLGA scaffold. 
Histological stainings showed that this PCL/PLGA-based scaffold resulted in inferior healing compared to 
that of PLGA-based scaffold, as the tendon-bone junction contained minimal amount of GAG, type II 
collagen and no type X collagen was observed, indicating the formation of fibrous tissue. This result was 
expected, and could be explained by the slower degradation rate. Degradation is important for tissue 
healing, as it increases porosity of the scaffold, which provides additional spaces for cells to infiltrate and 
deposit matrix267-272 in the long term. The slow degradation rate of the PCL/PLGA scaffold slowed down 
ECM deposition at the tendon-bone junction. Since collagen remodeling is a temporal event, this delay in 
ECM deposition led to a delayed collagen fiber re-organization, which resulted a less aligned collagen 
matrix in the PCL/PLGA scaffold repaired shoulder. 
In addition to degradation rate, the hydrophilicity of the PCL/PLGA-scaffold was decreased 
compared to the PLGA-based scaffold, as PCL is a more hydrophobic polymer273-275. It has been 
observed in several studies that increased biomaterial hydrophobicity leads to unfavorable cell response, 
such as decreased cell adhesion276-280 and proliferation279;281;282. Relevant to rotator cuff repair, it has 
been reported that due to increase hydrophobicity, a pure PCL spin-casted film led to lower initial 
attachment and a slower proliferation rate of human mesenchymal stem cells (MSCs) compared to that of 
PLGA283. Therefore, it is possible that when used in rat rotator cuff repair in this study, the higher 
hydrophobicity of the PCL/PLGA scaffold lowered the ability of MSCs from the bone marrow to initially 
attach, and subsequently proliferate and differentiate on the scaffold. Since MSCs have the ability to 
differentiate into the chondrogenic lineage on fibrous scaffold284 to produce GAG, types II and X collagen, 
the effect of increasing hydrophobicity also contributed to the inferior healing observed in the PCL/PLGA 
scaffold repaired shoulder 
 To eliminate the bias caused by increased hydrophobicity and to isolate the effect of degradation, 
this study can be improved by plasma treating the PCL/PLGA scaffold prior to implantation. Plasma 
treatment leads to the preferential exposure of oxygen containing groups such as –OH and –C=O to the 
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surface of the polymer, thereby increasing its hydrophilicity285-287. It has been shown to enhance 
fibroblasts, chondrocytes and osteoblast-like cell attachment and proliferation on electrospun PCL 
scaffold286 and similar performance is expected for plasma treated PCL/PLGA scaffolds.  
 
5.5 Conclusion 
 This chapter investigates the effect of scaffold polymer composition from the aspect of 
degradation rate of the biphasic scaffold. PCL/PLGA-based biphasic scaffold was used in a rat rotator 
cuff repair model, and showed a slower in vivo degradation rate as indicated by micro-CT and von Kossa 
staining. This scaffold lead to the formation of an inferior ECM compared to the PLGA-based biphasic 
scaffold. Therefore, it can be concluded that the PLGA provides a suitable degradation rate in the short 
term, which allowed deposition and remodeling of the extracellular matrix for integrative rotator cuff repair.   
 In chapters 2-5, a systematic investigation on the biphasic parameters is carried out to determine 
critical scaffold design parameters that contribute to integrative rotator cuff tendon-bone healing. 
Specifically, scaffold fiber alignment and diameter, mineral distribution across the scaffold thickness and 
the scaffold polymer composition were selected and their effects were evaluated in a rat model. Results 
showed that in terms of scaffold structure, observed in vitro effects of fiber alignment and diameter were 
translated in vivo, and aligned nanofibers are required for the formation of an insertion-like tissue that 
contained both collagen and GAG, consisting aligned collagen fibers and stained positive for both types II 
and X collagen at the tendon-bone junction of healing rat rotator cuff. In terms of scaffold mineral 
distribution, not only a biphasic structure with a mineralized and a non-mineralized layer is need, it is 
critical to place it at the correct orientation when used in vivo. Although a scaffold with mineral gradient 
across its thickness is more biomimetic, it does not further improve the formation of insertion-like tissue. It 
could even be detrimental, as ectopic bone formation was observed in some rat shoulders when the 
gradient scaffold was used. When the scaffold degradation rate is slowed by changing the polymer 
composition, an inferior tissue is formed at the tendon-bone junction due to limited ability of newly formed 
tissue to deposit and remodel on the scaffold. Collectively, the results from the chapters of Aim 1 show 
that a biphasic scaffold that has distinct non-mineralized and mineralized layers consisting of aligned 
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nanofibers, constructed from PLGA or polymers with similar degradation rate is needed for integrative 
rotator cuff repair in the rat model at week 5 post-surgery.  
 When the biphasic scaffold is used in vivo, scaffold-independent properties are also presented 
and which could impact the scaffold performance. Therefore, in Aim 2, in vivo studies will be carried out to 





























FTIR Spectrum of Mineralized Phase
PLGA-HA
PCL/PLGA-HA
Figure 5.1. Incorporation of PLGA and PCL in the PCL/PLGA-based biphasic scaffold. 
FTIR spectra of both phases of PLGA- and PCL/PLGA-based scaffolds. The PLGA-based 
scaffold showed the characteristic C=O peak around 1780 cm-1 (red arrow) and the PCL/PLGA-
based scaffold showed both the characteristic C=O peak of PCL around1724 cm-1 (green 
arrow) and a stretch around 1780 cm-1 (blue arrow) due to the presence of PLGA in the blend. 
Furthermore, the presence of HA in the mineralized phases of both scaffolds is confirmed by 
the PO4





MA MVL CSD 
PLGA 
Non-mineralized 690 ± 113 4.28 ± 1.28 0.84 ± 0.02 16.4 ± 1.21 
Mineralized 328 ± 66 3.57 ± 1.30 0.81 ± 0.03 17.5 ± 1.39 
PCL/PLGA 
Non-mineralized 693 ± 137 1.34 ± 0.19 
 
0.93 ± 0.01# 
 
10.9 ± 0.79# 
 
  
Mineralized 417 ± 101 4.75 ± 1.10 
 
0.95 ± 0.01 
 






Figure 5.2. Fiber organization of as-fabricated PLGA- and PCL/PLGA- 
based biphasic scaffold. SEM micrographs (1500x, scale bar = 10 µm) 
showed similar fiber morphology between scaffolds. 
Table 5.1. Fiber  diameter and alignment parameters of as-fabricated PLGA- and 
PCL/PLGA-based biphasic scaffolds  
(#: significant difference compared to the corresponding phase of the PLGA-based biphasic 


























Figure 5.3. Effect of scaffold polymer composition on extracellular matrix distribution 
and organization. Extracellular matrix formation at the healing rotator cuff repaired by PLGA- 
or PCL/PLGA-based biphasic scaffold. From left to right: collagen distribution (Picrosirius red, 
10x, bar=200μm), GAG distribution (Alcian blue, 10x, bar=200μm), and collagen fiber 
alignment (polarized light microscopy, 10x, bar=200μm). The PLGA biphasic scaffold repaired 
shoulder is rich in collagen and GAG, and aligned fibers are observed at the tendon-bone 
insertion. The PCL/PLGA biphasic scaffold repaired shoulder is rich in collagen, but has 
minimal GAG deposition with random fiber alignment at the tendon-bone junction. 
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Figure 5.4. Effect of scaffold polymer composition on fibrocartilage and 
mineralized fibrocartilage formation. Types II and X immunohistochemistry 
staining for PLGA- and PCL/PLGA-based biphasic scaffold repaired shoulders 
(20x, bar = 200μm). Compared to PLGA-based scaffold repaired shoulder, the 
PCL/PLGA repaired shoulder had minimum amount of type II collagen 
production and no type X collagen produced. 








Figure 5.5. Effect of scaffold polymer composition on mineralized tissue 
formation. Micro-CT 3D reconstructed shoulders (bar = 1 cm) and von Kossa 
staining (4x, bar = 500μm) for mineral distribution of the PLGA and PCL/PLGA 
biphasic scaffold repaired shoulders. No ectopic bone formation was observed 
in the PLGA scaffold repaired shoulder. In the PCL/PLGA scaffold repaired 
shoulder, micro-CT image showed ectopic mineralization at the tendon-bone 
junction(arrow). The von Kossa stain showed non-tissue material (arrows) at 


















 In Aim 1, the effect of individual scaffold-dependent parameters on the regeneration of tendon-
bone insertion is evaluated by changing these parameters one at a time and comparing the healing 
response to that of the biphasic scaffold with the original design. Through assessment of the composition 
and morphology of the healing tissue, it is concluded that the selected parameters, including fiber 
alignment and diameter, mineral distribution across the thickness of the scaffold, and scaffold polymer 
composition all modulate the in vivo healing. It is concluded that a biphasic scaffold which contains a non-
mineralized layer and a mineralized layer, consisting of aligned nanofibers and placed at the tendon-bone 
junction with non-mineralized phase contacting tendon and mineralized phase contacting bone is 
necessary for integrative rotator cuff tendon-bone healing.  
 When an in vivo model is used to evaluate scaffold performance, compared to an in vitro model, it 
provides unique opportunities to evaluate the effect of scaffold-independent parameters on rotator cuff 
healing. In Aim 2, two of such parameters, tissue healing time and selection of animal model are chosen, 
and their effects on rotator cuff healing are investigated to provide a more thorough understanding of the 
biphasic scaffold performance. Specifically in this chapter, the effect of time on integrative rotator cuff 
healing is investigated. 
 
6.1.1 Background and Motivation 
In previous chapters, rat shoulders were harvested and analyzed at 5 weeks post-surgery. This 
time point was selected since it provides a long enough healing period such that the morphological 
differences in the healing tissue caused by using different scaffolds are evident, as observed in previous 
studies24;288. Furthermore, it is supported by other studies that use rat rotator cuff repair models, as the 
differences in healing were observed as early as 2 weeks post-surgery194;289 and often by 4 weeks post-
surgery9;108;194;197;237;289 when comparing the effects of different treatment methods. Although the 5-week 
long studies provide important information for short term healing response, the healing tissue continues to 
remodel and mature over time290-293 to maintain its functionality and to achieve the eventual regeneration 
in the long term. Since the biphasic scaffold is biodegradable, it is critical that the rate of scaffold 
degradation is matched, or exceeded by the rate of extracellular matrix (ECM) deposition of the healing 
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tissue92;294-296 such that the scaffold is replaced by the regenerated tissue, without compromising its 
integrity or mechanical properties of it. Therefore, it is necessary to evaluate the long term performance of 
the biphasic scaffold by investigating the long term rotator cuff healing response.  
In the 5-week studies, when comparing the healing response between different groups, 
qualitative analyses, such as histology and immunohistochemistry were used. Although they provide 
visual evidence of the composition and organization of the healing tissue, these methods also have 
limitations. For example, it is expected the integration between tendon and bone becomes stronger at the 
later stage of healing, which cannot be measured using these methods. In addition, they cannot provide 
accurate information on the functionality of the repaired shoulder, which is frequently used in clinical 
settings to assess the healing. Therefore, a more quantitative method is needed in this study to assess 
the long term healing response. In the clinic, functionality of the repaired shoulder is assessed at post-op 
follow-up, during which the patient’s pain, satisfaction with the operation, and shoulder performance are 
evaluated through questionnaires and a series of standardized functionality tests, such as active shoulder 
motion, range of flexion and abduction297. The results are often quantified and reported in the form of 
standardized scales or scores, such as the visual analogue scale63;298, American Shoulder and Elbow 
Surgeons shoulder score63;96;215;298, UCLA score197;215;298 or the Constant score63;231. For animal studies, it 
is impossible to obtain such information, therefore, mechanical properties of the repaired rotator cuff 
tendon, such as its stiffness168;169;194;197;198;237, Young’s modulus28;108;197;237, maximum load194;197;198;237;289, 
and maximum stress194;197;198;237;299 are reported to represent the functionality of healing. Therefore, in this 
chapter, the mechanical properties of repaired shoulders are obtained and used as the criteria to 
compare healing response.  
 
6.1.2 Objective 
The objective of this study is to investigate the effect of time on integrative rotator cuff healing 
with the biphasic scaffold by comparing the mechanical properties of rat rotator cuff repaired with or 
without the biphasic scaffold at the short (week 5) and long (week 20) term time points. It is expected that 
at week 5, the mechanical properties of biphasic scaffold augmented shoulders will be higher than those 
from the control group, and this trend will be maintained over time, as higher mechanical properties will 
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also be found in the biphasic augmented group at week 20.   
 
6.2 Materials and Methods 
6.2.1 Scaffold Fabrication 
 Nanofiber-based scaffolds utilized in this study were fabricated via electrospinning24. The poly 
(lactide-co-glycolide) (PLGA) solution was prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, 
Birmingham, AL) in N, N- dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a 
ratio of 35/55/10 for PLGA (w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-HA solution was 
prepared with the addition of HA nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, 
MI) to the PLGA solution. Each solution was loaded into a syringe with an 18.5-gauge stainless steel 
blunt tip needle and dispensed via a syringe pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The 
solutions were spun at 8-10 kV (PLGA) or 11-13 kV (PLGA-HA), fibers were collected on a rotating 
mandrel, resulting in aligned nanofiber layers. The biphasic scaffold was produced by electrospinning the 
PLGA layer directly on top of the PLGA-HA layer. As fabricated scaffolds were carefully excised from the 
mandrel and cut into 3 mm x 6 cm pieces. To ensure that the biphasic scaffold has an even distribution of 
the non-mineralized and mineralized layers, scaffolds with a thickness of 0.2±0.01 mm were selected. 
These scaffolds were carefully peeled, from both ends, into the PLGA and PLGA-HA layers, leaving the 
middle region, which measured to be 3 mm in length intact. The thickness of individual layers was 
measured and only scaffolds with both layers measured to be 0.1±0.01mm were used in the study. The 
single layers of the scaffold were folded back to the corresponding phase of the biphasic region with one 
fold on each layer to accommodate the repair procedure. By doing this, it was ensured the scaffold is 
thick enough to fill in the gap created between tendon and bone during the surgery, while retaining the 
distinct mineral distribution profile. Scaffolds were treated with ultraviolet radiation for 15 minutes on both 
sides and stored in sterile condition until used for surgery. 
 
6.2.2 Surgical Procedure 
 All animal procedures were performed at the Microsurgery Training and Research Laboratory of 
the Department of Orthopedic Surgery under a protocol approved by the Institutional Animal Care and 
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Use Committee. Adult male Lewis rats (Charles River Laboratories, n=20, 11-12 weeks old, average 
weight=310±8g) were used in this study. For the surgery, each rat was anesthetized in a chamber with 2-
2.5% v/v isoflurane (Isothesia, Henry Schein Animal Health, Melville, NY) in 2 L/min oxygen flow. General 
anesthesia was maintained through a nose cone with 1.5% v/v isoflurane in 2 L/min oxygen flow. The 
shoulder region was shaved, and sterilized with three rounds of alternative ethanol and betadine rubs. 
Immediately before surgery, systemic antibiotics ampicillin (Henry Schein, 50mg/kg body weight), anti-
inflammatory drug carprofen (RIMADYLR® Injectable, Pfizer, New York, NY, 5 mg/kg body weight) and 
analgesic buprenorphine (Henry Schein, 1.2 mg/kg, sustained release for 72 hours) were injected 
subcutaneously. Marcain (Henry Schein, 2 mg/kg body weight), a local anesthetic was injected 
subcutaneously to each shoulder right before skin incision was made.  
Bilateral acute rotator cuff repair was performed on each rat with the transosseus bone tunnel 
method, following a published protocol29. In each rat, one shoulder was randomly selected to be repaired 
using the biphasic scaffold and the contralateral shoulder was repaired without scaffold. Briefly, a 
longitudinal incision was made on the skin of the shoulder region to expose the deltoid muscle. To locate 
the supraspinatus tendon, the coracoacromioal arch was identified and the deltoid muscle was cut open 
alone the arch. A 5-0 prolene suture (Ethicon, Somerville, NJ) was passed through the cut deltoid muscle 
to retract it during surgery. Once the deltoid was exposed, the supraspinatus tendon was identified as it 
passes right underneath the arch. To create an acute rotator cuff injury, the supraspinatus tendon was 
sharply detached from its bony insertion with a surgical blade. The fibrocartilaginous footprint of the 
tendon insertion on the greater tuberosity of humerus was removed with a motorized burr. For the 
transosseus tendon-bone repair, a bone tunnel with 0.5 mm diameter was drilled transversely in the 
anterior-posterior direction on the proximal part of the humerus. The tendon stump was grasped by a 5-0 
prolene suture using a technique similar to the Mason-Allen method. For control repair, the suture was 
passed through the bone tunnel to reappose tendon to the anatomic position. For biphasic scaffold 
augmented repair, the scaffold was inserted between the distal end of the tendon and the cancellous 
bone, such that its PLGA phase contacting the tendon and PLGA-HA phase contacting the bone. The 
biphasic scaffold was carefully oriented such that its fiber alignment matched with that of the tendon, 
followed by reapposing of the tendon to the anatomic position (Figure 2.2). Following tendon re-
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attachment, the deltoid muscle was repaired with a 4-0 vinyl suture (Ethicon) and the skin incision was 
closed by wound clips. Rats were not immobilized and allowed for normal cage activity through the 
duration of this study.  
 
6.2.3 Sample Harvest 
Rats were randomly selected at weeks 5 or 20 post-surgery, and were sacrificed by CO2 
overdose. Shoulders were dissected away from the body, rinsed in phosphate buffered saline (PBS), and 
wrapped in PBS-soaked gauze for end-point analyses.   
 
6.2.4 End-point Analyses 
6.2.4.1 X-ray micro computed tomography analysis 
Immediately after harvesting, each shoulder was scanned with a micro-CT scanner at a voxel 
size of 21µm (VivaCT 40, Scanco, Swizerland) to obtain 2D images along the long axis of humerus. The 
rotator cuff region was selected and contoured on all 2D slices, followed by 3D reconstruction using a 
mineral threshold of 268 mg HA/cm3, a value determined from previous studies24 to visualize the bony 
structures at the healing rotator cuff.  
6.2.4.2 Mechanical testing 
After micro-CT scan, rat shoulders were stored at -80ºC until mechanical testing. For mechanical 
testing, samples were thawed at 4ºC overnight. Gross dissection was performed to remove the scapula, 
infraspinatus, subscapular and teres minor muscles, leaving only the supraspinatus muscle and its 
tendon attached to the humeral head. The muscle was scrapped off and a fine dissection was performed 
to carefully remove the remaining muscle tissue, tendon sheath, and non-load bearing scar tissue at the 
tendon-bone insertion (Figure 6.1, panels A and B). After fine dissection, to measure the optical strain, 
Verhoeff’s stain lines were placed on the tendon at the insertion, and at 2, 4, and 8 mm away from the 
insertion, in the direction perpendicular to the long axis of the supraspinatus tendon. Tendon cross-
sectional areas were obtained with a custom device that uses two orthogonal linear variable transformers 
to measure location and a laser to measure tendon thickness by passing through specific locations of the 
tendon237, using the stain lines as references. Following this, the distal portion of the tendon that is above 
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the 8 mm staining line was embedded between two pieces of sandpaper with a cyanoacrylate adhesive 
and the distal portion of the humerus was potted in poly (methylmethacrylate) PMMA (Figure 6.1, panel 
C). The sample was placed in a customized clamp and submerged in a 34ºC PBS bath; its uniaxial 
tendon properties were obtained using an Instron 5543 mechanical tester (Instron Corp, Norwood, MA) 
(Figure 6.1, panel D). Briefly, a preload of 0.08 N was applied to the tendon to eliminate slack; the tendon 
was preconditioned for 10 cycles from 0.1 to 0.5 N at a rate of 1%/s. The tendon was held for 5 minutes 
to return to equilibrium, and then loaded to 5% strain at a rate of 5%/s, followed by a 10-minute relaxation. 
The tendon was then returned to its initial gauge length and loaded with 0.3% strain/s until failure. Video 
images of the tendon during ramp to failure were captured by a camera and the location of failure was 
recorded. Mechanical properties were obtained as following: the maximum load was read directly as the 
highest point on the force-displacement curve; maximum stress was calculated by dividing the maximum 
force by the initial tendon area. Stiffness was obtained as the slope of the linear region of the force-
displacement curve. Strain was obtained from stain line displacement images using custom tracking 
software300 and the Young’s modulus was obtained from the stress-strain curve. The tendon 
midsubstance and insertion areas were used to calculate the Young’s modulus of the corresponding 
regions. The viscoelastic properties of the tendon were represented by tendon percent relaxation, which 
was calculated as the ratio of equilibrium load to peak load during the stress-relaxation test.  
Outliners, in which shoulders failure pre-maturely due to sample preparation error such as over-
dissection and inappropriate dissection were excluded, resulting a final sample n=9 for each group. For 
the purpose of comparison, same number of un-operated rats at the same age as rats at weeks 5 and 20 
post-surgery in this study were sacrificed. Their shoulders were harvested and processed following the 
same method for operated shoulders to obtain the native supraspinatus tendon midsubstance and 
insertion mechanical properties. 
 
6.2.6 Statistical Analysis 
Results are presented in the form of mean ± standard deviation. For each mechanical property, a 
one-tailed t-test was performed between the operated shoulders at the same time point to determine the 
effect of the biphasic scaffold. A one-tailed t-test was also performed for the same group at different time 
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points to determine the effect of healing time. Properties of each operated group were compared with the 
corresponding ones of the native shoulder at the same time point, using a one-tailed t-test. All statistical 




 All rats survived the surgery. Two rats died from reasons unrelated to the surgery at week 1 and 2 
post-surgery, and their shoulders were excluded for end-point analyses. Therefore, n=9 
shoulders/group/time point were included in data analyses.  
 
6.3.1 Mineral Distribution 
Mineral distribution and bone healing of the operated shoulders was assessed with micro-CT 
scan (Figure 6.2). Bone tunnels were visible in week 5 samples and measured to be approximately 0.5 
mm in diameter. By week 20, size of the bone tunnel was visibly reduced in both groups.  
 
6.3.2 Mechanical Properties 
 Tensile mechanical properties of the repaired shoulder were obtained by uniaxial tensile 
mechanical testing (Figure 6.3). These properties are summarized in Table 6.1, together with native 
tendon-bone properties. When comparing the properties between operated groups at the same time point, 
it can be seen that at week 5, the scaffold repaired group had a higher maximum load and a lower % 
relaxation of the supraspinatus tendon compared to the control group. However, at week 20, no 
significant difference in these two properties was observed between the two groups. In addition, the 
maximum stress of the biphasic scaffold repaired group was even lower than that of the control.  
When comparing the properties of the same group over time, although a trend of improvement 
(p<0.01) was observed in some mechanical properties (stiffness of scaffold repaired shoulders, and 
percent relaxation of control shoulders, stats not shown), only the change in maximum load of the control 
group was statistically significant.  
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When compared to the native tissue, it is worth noting that at week 5, the percent relaxation of the 
control repair was significantly greater than that of the native. At week 20, this property of the control 
repair became comparable to that of the native. At both time points, the percent relaxation of scaffold 
repaired shoulders remained comparable to that of the native. In addition, regardless time and group, the 
maximum stress, tendon midsubstance modulus, insertion modulus and stiffness of the operated 
shoulders were significantly lower than those of the native shoulders. 
 
6.4 Discussion 
 In this study, the effect of healing time on biphasic scaffold-mediated rotator cuff healing is 
explored by evaluating the efficacy of the biphasic scaffold in the long term. Using the well-established rat 
model, bilateral rotator cuff repair of an acute, full-thickness injury was performed with and without the 
augmentation of the biphasic scaffold at the tendon-bone insertion. Rat shoulders were harvested at 
weeks 5 and 20 post-surgery. Micro-CT analysis was utilized to visualize the distribution of mineralized 
tissue at the healing rotator cuff. Mechanical properties, such as maximum load and stress, tendon and 
insertion modulus, stiffness, and % relaxation of these shoulders were obtained and compared between 
groups at the same time and in the same group over time. Corresponding mechanical properties of native 
shoulders from rats with matching ages were also obtained and compared to those of the operated 
shoulders. 
 Micro-CT images reveal that the mineralized region of the rotator cuff had similar morphology 
between the control and biphasic scaffold augmented shoulders. From week 5 to 20 post-surgery, the 
size of bone tunnel was reduced in both groups, indicating the good intrinsic healing ability of rat. No 
ectopic mineralized tissue was observed in the biphasic repaired group, indicating the incorporation of HA 
from the scaffold by the native tissue.  
 Results from the previous chapters show that at week 5, organized ECM consisting of both 
collagen and glycosaminoglycan formed in the biphasic scaffold repaired shoulder, while unorganized 
fibrous scar tissue formed in the control shoulder. Using the same animal model and surgical approach, 
Perry et al. reported that when comparing shoulders repaired with a small intestinal submucosa scaffold 
at different time points, the shoulders with a significantly better fiber organization also exhibited a 
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decreasing trend in percent relaxation of the supraspinatus tendon108. This structure-function relationship 
is also observed in this study, as the percent relaxation value of the biphasic scaffold repaired shoulders 
was significantly lower than that of the control samples at week 5, and similar to that of the native 
insertion, which has organized collagen fibers15;18. Furthermore, this change in matrix morphology was 
reflected in certain mechanical properties, as the maximum load the tendon can sustain before it breaks 
was significantly higher in the biphasic scaffold group compared to the control at week 5.  
For the effect of healing time, it was hypothesized that when comparing between groups, the 
efficacy of the biphasic scaffold in the short term would be maintained in the long term. Therefore it was 
expected that at week 20, the mechanical properties of the biphasic scaffold would be greater than those 
of the control. However, results from this study do not provide supporting evidence for this hypothesis, as 
the percent relaxation and maximum load became similar between groups at week 20. Furthermore, in 
the biphasic scaffold group, although some trends were seen, no significant improvement was observed 
in any of the properties over time. In the control group, only the maximum load increased over time.  
This unexpected result may have resulted from several potential factors. Since similar trends over 
time were observed regardless if the scaffold was used or not, the cause could be the rat model itself. 
Lewis rats used in this study had an average weight of 310g, 384g and 475 g at the time of surgery, 5 and 
20 weeks post-surgery. Since the body weight changed significantly from one time point to another, the 
intrinsic rotator cuff structure could also have change significantly. Using the Sprague-Dowley rat, 
Malcolm et al. reported that when rat body weight increased from 400 g to 600 g, the size of rotator cuff 
muscles changed continuously. For example, a 27% increase in supraspinatus muscle physiology cross-
sectional area (PCSA) was observed as a result301, which could lead to increase in tendon PCSA302;303. In 
this study, trends of increasing tendon midsubstance and insertion cross-sectional areas over time were 
observed in operated shoulders (Table 6.2). Since these areas were used to calculate modulus and 
maximum stress, they could confound the effects of healing and lead to no change in modulus/stress over 
time, even though the load and stiffness showed an increasing trend over time. In addition to body weight, 
the age of the rats also changed from approximately 3 months old at the beginning of study, to 4.5 and 8 
months old at weeks 5 and 20 post-surgery, respectively. Since the average life span of Lewis rat is about 
20 months304, the change in age could impact its intrinsic rotator cuff healing ability. Using Sprague-
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Dawley rats, Lavagino et al. showed that cell number in the rat tail tendon decreased in animals from 1 to 
3 to 12 months old305. Not only does cell proliferation rate decrease with aging, but the ability of cells to 
produce ECM is also impacted. Using Wistar rats, Kenji et al. reported that collagen I and III were down-
regulated in 6 and 24 month old rats compared to 10 week old rats, indicating reduced capacity of 
collagen synthesis306. Therefore, it is also possible that in this study, at the later healing stage, cellular 
activity and the ability of cells to synthesize collagen decreased in the rotator cuff tissue. As a result, 
tissue remodeling and maturation was delayed, leading to no significant change in mechanical properties 
over time.  
Specifically for the biphasic scaffold-repaired group, there are several possible causes for the fact 
that the good healing capacity compared to the control group observed at week 5 was not observed at 
week 20. The first reason is that healing in rats occurs relatively quickly, and it is possible that the effect 
of any treatment is only observed within a short period of time. Although to date no study has specifically 
evaluated the rate of rotator cuff healing in rat, several studies have shown that the differences in rotator 
cuff histology and mechanical properties caused by different treatment methods are observed as early as 
2109;194;289, 3307, and 4 weeks post-surgery193;197. This early healing response is not necessarily maintained 
at a later time point. Ide et al. performed a study to evaluate the effect of fibroblast growth factor-2 on rat 
tendon-bone healing. It was reported that enhanced healing from growth factor was only observed initially 
at week 2 post-surgery. By weeks 4 and 6, the healing response of the control shoulder became 
comparable to that repaired with growth factor199. Perry et al. used the same animal model to evaluate the 
effect of small intestine submucosa on rotator cuff healing and observed no difference in supraspinatus 
tendon modulus and stiffness from week 8 to week 16 post-surgery108. Therefore, it might be more 
relevant in this study to investigate the effect of healing time in a relatively short time frame, such as from 
week 2 to week 5 post-surgery.  
 
6.5 Conclusion 
In summary, this chapter investigated the effect of time on scaffold augmented rotator cuff healing 
by measuring mechanical properties of repaired shoulder at weeks 5 and 20 post-surgery. Results 
showed that at week 5, certain mechanical properties of the biphasic scaffold repaired shoulder were 
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significantly higher than these of the control, indicating a better healing response from the scaffold and 
agreed with histology results from Chapters 2-5. However, unexpectedly, at week 20 post-surgery, the 
mechanical properties of biphasic scaffold repaired shoulder became similar to these of the control. This 
could be caused by the selection of the rat model, as healing occurs relatively quickly in this model and its 
intrinsic rotator cuff structure and healing ability changes over time.  
Collectively, Chapters 2-6 demonstrate that the biphasic scaffold shows a great potential for 
achieving integrative rotator cuff repair, as its promising performance at week 5 post-surgery is shown 
both histologically and mechanically. The next step is to confirm that this promising result can be 





Figure 6.1. Sample preparation for mechanical testing. A) shoulder thawed in 
4ºC fridge overnight. B) shoulder after  fine dissection, leaving only the repaired 
supraspinatus tendon attaching on the humerus. C) shoulder sample with stain 
lines, potted in PMMA and embedded in sandpaper. D) sample loaded for 
mechanical testing. 
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Figure 6.2. Mineral distribution in the repaired shoulder at weeks 5 and 20 
post-surery. 3D reconstruction of the rotator cuff region of operated rat 
shoulders at different time points. From week 5 to week 20, the size of bone 
tunnel reduced (arrows). 







































































































Figure 6.3. Effect of healing time on rat shoulder mechanical properties. Tensile 
mechanical properties of rat shoulders repaired with or without the biphasic scaffold at weeks 5 
and 20 post-surgery.   































































































Control 6.25 ± 1.35# 1.84 ± 0.83# 11.1 ± 7.4# 7.86 ± 5.96# 5.26 ± 2.27# 51.9 ± 10.2# 
Scaffold 8.64 ± 3.49*,# 2.60 ± 1.30# 9.80 ± 9.20# 6.48 ± 5.65# 4.67 ± 1.46# 43.9 ± 4.47* 
Native 16.6 ± 3.17 13.3 ± 3.1 247.1 ± 104.8 162.3 ± 60.9 24.5 ± 6.78 42.0 ± 1.62 
Week 20 
Control 10.4 ± 4.16^,# 2.75 ± 1.16# 10.4 ± 5.87# 7.47 ± 6.0#  7.42 ± 4.15# 45.7 ± 9.53 
Scaffold 10.5 ±6.53# 1.81 ± 0.97*,# 9.41 ± 5.67# 5.86 ± 2.75# 6.80 ± 3.92# 40.3 ± 8.83 
  Native 18.8 ± 4.44 11.7 ± 3.65 252.9 ± 99.2 213.7 ± 59.8 26.8 ± 7.15 40.8 ± 3.91 
(*: significant difference compared to control, ^:significant difference compared to week 5 value, #: significant difference 
compared to native, n=9, p<0.05) 








Week 5 3.87 ± 0.97 3.85 ± 0.93 
Week 20 4.05 ± 1.76 4.65 ± 2.18 
Scaffold 
Week 5 3.78 ± 1.85 4.58 ± 2.41 
  Week 20 4.15 ± 0.64 5.28 ± 1.43 
Table 6.2. Tendon and Insertion Cross-Sectional 
Area over Time 
(n=9, p<0.05) 
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CHAPTER 7: THE EFFECT OF ANIMAL MODEL ON ROTATOR CUFF 




In Chapters 2-6, a rat model was used to evaluate the effect of scaffold-dependent properties, 
including fiber alignment and diameter, mineral distribution and polymer composition, and a scaffold-
independent property, healing time, on the integrative rotator cuff tendon-bone healing. The results 
collectively demonstrated that an aligned, nanofiber-based biphasic scaffold has great potential for 
integrative rotator cuff repair.  
The ultimate goal is the application of this biphasic scaffold in the clinical setting. Therefore, in 
this chapter, the clinical feasibility of utilizing this biphasic scaffold, as well as its repairing efficacy, will be 
evaluated in a large animal model.  
 
7.1.1 Background and Motivation 
The purpose of using a large animal model is twofold. First of all, the feasibility of utilizing this 
biphasic scaffold in clinically-relevant settings can be evaluated. Although rat is a good model for rotator 
cuff research because of the similarity in shoulder structure between rat and human238, its small size limits 
the application of certain common surgical approaches. For example, cuff repair using suture anchors 
cannot be practiced in rat, because the size of anchors is often greater than that of the rat humerus. 
Currently, in rotator cuff repair surgeries in which large full-thickness tears are repaired, the torn tendon is 
reapposed to the bone with the double-row suture-bridge technique, in which two rows of suture anchors 
are used76;82. Therefore, a large animal model is needed to test the feasibility of incorporating the biphasic 
scaffold in cuff repair utilizing the double-row suture-bridge technique. Specifically, the biphasic scaffold 
will be placed between the torn tendon and humeral head in an “inlay” position, and fixed to the bone with 
the tendon stump (Figure 7.1). Secondly, only rat model is used in Chapters 2-6 and rat has good intrinsic 
healing capacity. It is important to confirm that the safety and observed repair efficacy of the biphasic 
scaffold can be replicated in other animals before any further movement towards clinical application can 
be made. Therefore, in addition to the methods used in the rat studies, blood tests, and imaging-based 
approaches will be performed in the large animal model to provide a thorough assessment of healing.  
Sheep is selected as the animal model for this chapter, since the dimension of its infraspinatus 
tendon is similar to that of human supraspinatus tendon34;74. Sheep has been widely used and is a readily 
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accepted animal model for shoulder-related research, including testing rotator cuff augmentation 
techniques and grafts74;89;110;138;227. 
 
7.1.2 Objectives 
 The objectives of this study are to test the feasibility of augmenting the rotator cuff tendon-bone 
healing with the biphasic scaffold in the “inlay” position, utilizing the double-row suture-bridge technique, 
and to examine the efficacy of this aligned nanofiber-based biphasic scaffold for integrative rotator cuff 
repair in the sheep model. It is hypothesized that the scaffold can be successfully used in conjunction with 
the double-row suture-bridge technique and will lead to the formation of a fibrocartilaginous tissue with 
organized collagen fibers, which resembles the composition and organization of the native tendon-bone 
insertion. 
 
7.2 Materials and Methods 
7.2.1 Scaffold Fabrication  
Nanofiber-based scaffolds were fabricated via electrospinning24. The PLGA solution was 
prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- 
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA 
(w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-HA solution was prepared with the addition of 
hydroxyapatite (HA) nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, MI) to the 
PLGA solution. Each solution was loaded into a syringe with an 18.5-gauge and dispensed via a syringe 
pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The solutions were spun at 8-10 kV (non-mineralized 
phase) or 11-13 kV (mineralized phase). Fibers were collected on a rotating mandrel, resulting in aligned 
fiber layers. The biphasic scaffold was produced by electrospinning the non-mineralized layer directly on 
top of the mineralized layer. As-fabricated scaffolds were carefully excised from the mandrel and cut into 
2 cm x 5 cm pieces. To ensure that the biphasic scaffold has an even distribution of the non-mineralized 
and mineralized layers, scaffolds with a thickness of 0.2±0.01 mm were selected. These scaffolds were 
then carefully peeled, from both ends, into the PLGA and PLGA-HA layers, leaving the middle region, 
which measured to be 1.5 cm in length intact. The thickness of individual layers was measured and only 
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scaffolds with both layers measuring 0.1±0.01mm were used in the study. To ensure that the scaffold is 
thick enough to fill in the gap formed between tendon and bone after removal of the native fibrocartilage 
footprint, the single layer of the scaffold was folded back to the corresponding phase of the biphasic 
region with one fold on each layer. The excessive material was removed, leaving a scaffold measured to 
be 20 x 15 x 0.4 mm, which is large enough to cover the sheep infraspinatus footprint (size measured 
with cadaver sheep shoulder). Scaffolds were sterilized with ultraviolet radiation for 15 minutes on both 
sides and stored under sterile conditions until surgery. 
 
7.2.2 Surgical Procedure 
 All animal procedures were performed at the Preclinical Surgical Research Laboratory in 
Colorado State University under a protocol approved by the Institutional Animal Care and Use Committee. 
Skeletally mature female sheep (Rambouillet X Columbia, total=18, 200±19 lb, >4 yrs) were used in this 
study. Following induction with Valium (7.5 mg total) and ketamine (3.3 mg/kg) through intravenous 
injection, sheep were intubated and maintained under anesthesia through inhalation of isoflurane (1.5-3% 
v/v in 2 L/min oxygen flow). Sheep were positioned in a lateral recumbence on the surgical table with 
wool sheared at the surgical area, and prepared for aseptic surgery with multiple alternative scrubs of 
povidine iodine and isopropyl alcohol, and draped with a sterile surgical drape. Morphine (1 mg/kg, 
subcutaneous) was administrated after induction, and lidocaine (25μg/kg/min, intravenous) and ketamine 
hydrochloride (10μg/kg/min, intravenous) were administrated continuously during the surgery for pain 
management. Unilateral surgery to repair an acute full-thickness cuff tear was performed on the right 
shoulder of each sheep (Figure 7.2). Briefly, after making an incision on the skin, the infraspinatus muscle 
and its associated tendon was identified. The tendon was sharply detached from its footprint on humeral 
head with a blade, followed by removal of native fibrocartilaginous insertion with a motorized burr. The 
medial row of two anchors (PEEK Corkscrew FT, 4.5 mm x 14 mm, Arthrex, Naples, FL), each preloaded 
with two sutures (#2 FiberWire) was placed into the humeral head. These four sutures passed through 
the tendon stump from its articular to the bursal side to reappose the tendon to bone. Sutures were then 
passed through the eyelet of the two lateral anchors (BioComposite SwiveLock C Vented, 4.75 mm x 19.1 
mm, Arthrex), following a cross pattern to minimize stress concentration. The lateral anchors were placed 
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to the greater tuberosity of the humeral head, with the sutures tightened to secure the reapposed tendon 
in place. For the shoulder repaired with biphasic scaffold, after tendon detachment, the biphasic scaffold 
was placed underneath the tendon stump towards its distal end, with the PLGA phase contacting tendon 
and was fixed to the bone with the same methods used in control repair, thus achieving the “inlay” 
placement of the biphasic scaffold with the PLGA-HA phase contacting the bone. Attention was paid to 
position the biphasic scaffold such that the fiber alignment matched with that of the tendon. Following this, 
the muscle and skin were sutured backed and the animals were returned to indoor pens with no 
immobilization once they recovered from anesthesia. Sheep were randomly selected and sacrificed at 
week 4 (n=2) and 16 (n=7) post-surgery through overdoes of pentobarbital sodium (88 mg/kg).  
 
7.2.3 Biocompatibility Test 
 To test the biocompatibility of the scaffold, sheep blood samples were collected immediately 
before surgery (week 0) and sacrifice at weeks 4 (n=2) and 16 (n=7) post-surgery through the juguar vein. 
A blood panel was run on the samples to obtain blood serum parameters. Neutrophil count and total 
protein content were selected as indicators for biocompatibility of the biphasic scaffold, as they have been 
used in literature for this purpose308-312. In addition, the blood Ca and P concentration were measured as 
an indicator of scaffold degradation and the toxicity of the HA particles to sheep.  
 
7.2.4 Healing Assessment  
7.2.4.1 Image-based analyses 
 Image-based methods were used to assess the healing. Specifically, for soft-tissue healing, 
ultrasound imaging was performed on the operated and contralateral shoulders at weeks 4 and 16 post-
surgery for all sheep using a 12-MHz linear transducer-equipped ultrasound machine (GE LOGIQ® 9, 
General Electronic, Little Chalfont, United Kingdom). The infraspinatus tendon was imaged in both 
transverse (short-axis) and longitudinal (long-axis) planes. Furthermore, magnetic resonance imaging 
(MRI, 1.5-T superconducting magnet, Signa Horizon LX, General Electric) was performed on two 
operated shoulders from each group at both time points following euthanasia. In addition, two non-
operated shoulders were scanned for comparison purpose.  
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7.2.4.2 Tissue harvest 
Immediately following sacrifice, the right shoulder of each sheep was harvested. The shoulders 
were grossly dissected (n=2 and 7 for week 4 and 16 samples, respectively) to leave only the 
infraspinatus muscle and its tendon attached to the humeral head. This tissue was fixed in 10% neutral 
buffered formalin (NBF) for three weeks and stored in 35% ethanol in the long term. For easy access to 
the repaired tendon-bone region, each harvested shoulder was further processed as following: the middle 
point between the anchors in the same row was identified, and a line connecting the two middle points 
was drawn on the sample. Following this line, each sample was carefully spilt into two halves through the 
sagittal plane using a slow speed saw. From this central line, a 3 mm thick piece was cut from each half 
of the shoulder(Figure 7.3). These two pieces were then fixed in 10% NBF for three days before further 
analyses. One piece was used for scanning electron microscopy (SEM) imaging, followed by decalcified 
histology to determine tissue morphology and fibrocartilaginous tissue formation. The other was used for 
micro-computed tomography (micro-CT) analyses, X-ray imaging and non-decalcified histology to 
determine mineral distribution. This method is advantageous compared to processing the whole tendon-
bone complex for three reasons. First of all, it ensured that the same region was selected for all samples 
to eliminate potential deviation caused by location. Secondly, it ensured that only the healing region 
where the biphasic scaffold was implanted was selected. Finally, this method ensured that for each 
sample, the corresponding decalcified and non-decalcified histology can be obtained, thus the location of 
mineral in respect to the soft tissue. For each shoulder, only one piece from each half was selected since 
the smallest distance measured between the two anchors in the same row was 9 mm, and selecting two 
pieces from each half could lead to inclusion of a region that was not repaired with the biphasic scaffold, 
thus leading to inaccurate report of healing response. Additional benefits of using 3 mm pieces instead of 
the whole sample includes enabling X-ray imaging, as the machine (Faxitron X-ray Corporation, 
Specimen Radiography System, Model MX20, Wheeling, IL) used for scanning had limited penetration 
depth and saving time and storage space for  micro-CT scan.  
7.2.4.3 Tissue morphology  
 Two shoulders were randomly selected from each group at each time point for SEM imaging. The 
samples were dehydrated using a series of ethanol with increasing concentration from 70-100% and 
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placed in a fume hood overnight to completely evaporate the ethanol. The tissue pieces were imaged at 
20 KV using SEM (FEI Quanta 600, Hillsboro, OR).  
7.2.4.4 Fibrocartilaginous matrix formation and organization 
After SEM, samples were processed for de-calcified histology. Briefly, the samples were placed in 
60 mL of solution consisting formic acid (Thermo Fisher Scientific, Waltham, MA), Trizma® HCl (Sigma-
Aldrich) and ethylenediaminetetraacetic acid (Sigma-Aldrich) on a rocker (Scientific Industries Inc., 
Bohemia, NY) for 35 days with 3-4 changes of solution to achieve maximum decalcification. Following 
complete decalcification, the tissues were dehydrated in an ethanol series (70– 100%), cleared three 
times in xylenes (Thermo Fisher Scientific) and embedded in paraffin (Thermo Fisher Scientific) at 56ºC. 
Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica Microsystems, Bannockburn, 
IL) to obtain 7 µm thick sections, which were de-paraffinized and rehydrated before histological analyses. 
Collagen and glycosaminoglycan (GAG) distribution were assessed with picrosirius red and safranin O 
stainings, respectively. Collagen fiber alignment at the tendon-bone junction was visualized with polarized 
light microscopy of the picrosirius red stained slides. All images were taken with an inverted light 
microscope (Axiovert 25, Carl Zeiss, Thornwood, NY).  
Distribution of types I and II collagen was evaluated with immunohistochemistry using paraffin 
embedded sections. For type I collagen staining, after paraffin removal and rehydration, samples were 
rinsed with phosphate buffered saline (PBS, Sigma-Aldrich) containing 0.1% Tween 20 (Thermo Fisher 
Scientific), treated with serum-free protein blocking solution (Dako, Carpinteria, CA) for 30 minutes and 
incubated at 4°C overnight with primary anti-type I collagen antibodies (1:100 dilution, Novus Biologicals, 
Litteton, CO). The slides were rinsed with PBS and incubated with Alexa Fluor-488 conjugated secondary 
antibody (1:200 dilution, Invitrogen, Life Technologies, Carlsbad, CA) for 1 hour at room temperature. 
After rinsing with PBS, sections were incubated in 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI, 
Invitrogen) solution for 30 minutes for cell nuclei staining. Samples were then rinsed with PBS, distilled 
water, and a cover slip was applied. The samples were imaged using confocal microscopy (Olympus 
Fluoview FV1000 Confocal Microscope, Central Valley, PA) at 20x magnification using a dual excitation 
wavelength of 488 (type I collagen) and 358 nm (DAPI). Immunohistochemical analysis of type II collagen 
was performed following the same protocol, with an additional step in which samples were treated with 
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0.5 mg/mL hyaluronidase (Sigma-Aldrich) for 30 min, and swelled with acetic acid (Thermo Fisher 
Scientific) for 4 hours to expose the collagen epitopes immediately following the first 1X PBS wash, with 
anti-type II collagen antibodies (1:100 dilution, Abcam, Cambridge, MA) and FITC-conjugated conjugated 
secondary antibody (1:200 dilution, Invitrogen). Images were taken with confocal microscopy at dual 
excitation wavelength of 488 (type II collagen) and 358 nm (DAPI). 
7.2.4.5 Mineralized tissue formation  
For designated samples, sagittal plane view X-ray images were obtained to visualized the mineral 
distribution (Faxitron, exposure time = 6000 ms, voltage = 26 kV). The sample was also scanned in micro-
CT (VivaCT 40, Scanco, Switzerland) with a voxel size of 34 µm to acquire the 2D sagittal views through 
the thickness of the sample. A threshold of 317 mg HA/cm3 was selected for 3D reconstruction of the 
scanned piece for visualization of mineral distribution. Furthermore, HA density at the healing region was 
quantified by selecting a series of five (5 x 2.5 mm) consecutive regions from the surface of the sample 
towards the inside of the humeral head (Figure 7.4, n=2 and 7 for week 4 and 16 samples, respectively). 
Mineral density of each region was evaluated with micro-CT and used for calculating average mineral 
density of each group at different time points. 
After images were obtained from X-ray and micro-CT analyses, samples were processed for non-
decalcified histology. The tissue pieces were dehydrated in serial alcohol concentrations (70%– 100%), 
followed by clearing and infiltration. They were embedded in poly (methylmethacrylate) (PMMA, MW 
100,000, Polysciences Inc, Warrington, PA) using a modification of the methods of Erben et al240. 7 μm 
thick sections were obtained with a sliding microtome (Leica, Bannockburn, IL). Mineral distribution at the 
tendon-bone junction was obtained by von Kossa staining with neutral red counter staining.  
 
7.2.5 Statistical Analysis 
Quantitative results are presented in the form of mean ± standard deviation. At each time point, 
student’s t-test was used to compared blood parameters and mineral density between the scaffold and 




A biphasic scaffold measuring 20 x 15 x 0.4 mm was prepared following the same procedure as 
in the rat surgery. The biphasic scaffold was successfully used to augment rotator cuff repair in the sheep, 
incorporating the double-row suture-bridge technique. All sheep survived the surgery and began to move 
freely within one hour after waking up from anesthesia. Two sheep, one with scaffold repaired shoulder 
and one with control repair shoulder, died from non-surgery related causes at weeks 12 and 15. These 
shoulders were harvested but not analyzed, therefore, for the week 16 group, n=6 sheep/group was 
included for all analyses.  
 
7.3.1 Biocompatibility 
Blood panel was not run for one animal sacrificed at week 4 due to blood clotting. As a result, 
comparison of blood parameters between control and scaffold repaired groups was only performed for 
sheep sacrificed at week 16. At both week 0 (base line) and week 16, no difference between groups were 
observed for any of the parameters examined (Figure 7.5). 
 
7.3.2 Tissue Healing 
 Tissue healing over time was assessed by ultrasound imaging and MRI of the whole sheep 
shoulder. Representative longitudinal view ultrasound images of the native and operated shoulders of 
both groups at week 4 and 16 post-surgery are shown in Figure 7.6. The tendon-bone interface was 
identified as a clearly defined band between the infraspinatus tendon and the humeral head in the native 
shoulders. At week 4, formation of a gap between tendon and bone due to tendon detachment is 
observed in both groups. By week 16, this gap can no longer be identified on ultrasound images in both 
groups, indicating the formation of tissue at the tendon-bone junction over time. Similar observations were 
made in MRI images (Figure 7.7). In the native shoulder, the infraspinatus tendon completely covered the 
humeral head. The distance between the tendon stump and humeral head decreased from week 4 to 
week 16 post-surgery in both groups, indicating tissue formation in both groups over time. Moreover, 
ectopic bone formation was observed in the tendon region in one of the control shoulders, which was also 
confirmed in histology, but was not observed in any of the scaffold-repaired shoulders. 
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7.3.3 Tissue Morphology and Extracelluar Matrix Distribution 
Since tissue formation was limited at week 4, tissue morphology and ECM distribution analyses 
was focused on week 16 samples. General tissue morphology was assessed using SEM (Figure 7.8). 
The SEM micrographs showed the normal morphology of the insertion region with a smooth transition 
from tendon to bone and a clear division between the non-mineralized and mineralized tissue. In the 
control repair, a transitional region that is not well-defined was seen between the tendon and the bone, 
and the morphology was different from the native insertion. On the other hand, the morphology of the 
scaffold-repaired shoulder was similar to that of the native shoulder, as the non-mineralized and 
mineralized tissues were separated by a well-defined boundary. Picrosirius red staining and polarized 
light microscopy was used to determine the distribution and organization of collagen formed at the 
tendon-bone junction (Figure 7.9). Both the control and scaffold repaired shoulders had abundant 
collagen matrix formed. The fibers in the scaffold group showed a more organized morphology that 
followed tendon fiber alignment, while the collagen fibers in the control group were randomly organized. 
Formation of fibrocartilaginous tissue was assessed with safranin-O staining and immunohistochemistry 
of types I and II collagen distribution (Figure 7.10). The tendon-bone junction of biphasic scaffold repaired 
shoulder stained more strongly for proteoglycans compared to the control repair. Furthermore, although 
type I collagen was abundant in the healing tissue formed in both groups, minimal type II collagen was 
found in the control repair, while the tendon-bone junction of the scaffold repaired shoulder stained 
positive for type II collagen, confirming the formation of fibrocartilaginous tissue.  
 
7.3.4 Mineral Distribution 
 Accumulation of mineral at tendon-bone junction was visualized in both X-ray and reconstructed 
micro-CT 3D images (Figure 7.11). At week 4, mineral was only seen at bone surface of scaffold repaired 
samples. By week 16, deposition of mineral was observed on the bone surface of control and scaffold-
repaired samples. This was reflected in mineral density, which was significantly higher in the scaffold 
group compared to the control group at week 4. By week 16, similar mineral density was observed 
between groups. von Kossa staining of week 16 samples showed differences in the morphology of 
mineralized tissue. In the control sample, a clearly defined line was observed between the mineralized 
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 In this chapter, the effect of animal model on insertion regeneration was evaluated by implanting 
the biphasic scaffold in sheep shoulder and observing healing response at weeks 4 and 16 post-surgery. 
The aligned, nanofiber-based biphasic scaffold was successfully used to repair an acute full-thickness 
rotator cuff tear in the sheep model. This is the first in vivo study that evaluates the feasibility and efficacy 
of utilizing a scaffold designed specifically for regenerating the tendon-bone interface with the double-row 
suture-bridge technique.  
 The biphasic scaffold did not lead to any adverse reaction in the sheep as no post-operative 
complications were observed in any of the animals. Results showed that the biphasic scaffold did not lead 
to changes in neutrophil and total protein concentration in the serum, at either time point, indicating it is 
non-toxic and biocompatible. This result was expected since the biocompatibility of both PLGA and HA 
have been reported in vivo313;314. No difference in Ca and P concentration between the control and 
scaffold group was observed at either time point, indicating the amount of HA incorporated in the 
mineralized phase of the biphasic scaffold did not result in a systematic change in blood ion concentration,  
 Tissue healing was observed in both groups at short and long terms, both at a slower rate 
compared to the rat model, as a tissue gap was still visible at week 4 post-surgery. This gap, however, 
was filled by newly formed tissue by week 16 post-surgery. This result is consistent with what has been 
reported for sheep rotator cuff tendon-bone healing, as new connective tissue formation was observed 
over time in repair with89;110;138;227 and without the use of augmentation scaffold95;138;227;315. Therefore, the 
intrinsic tissue healing ability of the sheep used in this chapter was confirmed. 
At week 16, the tissue formed in the control repair consisted mainly of disorganized type I 
collagen fibers with minimal amount of type II collagen and limited proteoglycan deposition, indicating the 
formation of a fibrous scar tissue. On the other hand, when the aligned, nanofiber-based biphasic scaffold 
was used to augment the tendon-bone repair, a fibrocartilaginous tissue was formed. This tissue was 
similar to the native tendon-bone insertion, as compositionally it was rich in types I and II collagen I, and 
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glycosaminoglycans, and organizationally the collagen fibers at the insertion were aligned. This result 
was similar to what was observed in the rat model, indicating the efficacy of the biphasic scaffold is 
independent of animal model.   
 Several studies have used the sheep model to demonstrate efficacy of rotator cuff repair grafts 
for acute full-thickness repair. Comparing results from these studies to what was observed in this chapter, 
it can be seen that the biphasic scaffold is advantageous in several ways. First, within a similar healing 
time frame, the biphasic scaffold led to a similar healing response as when growth factors were added to 
other augmentation grafts. For example, Rodeo et al. reported extensive cartilage formation with 
insertion-like organization at the tendon-bone interface of shoulders repaired using a collagen carrier 
loaded with a mixture of bone protein extract at week 12 post-surgery, but not when plain carriers were 
used315. Similarly Hee et al. reported formation of insertion-like tissue in shoulders repaired by collagen 
scaffolds loaded with platelet-derived growth factor-BB at week 12 post-surgery205. Second, the biphasic 
scaffold accelerated healing response compared to other plain repair grafts. For example, Nicholson et al. 
observed reformation of the tendon-bone junction in shoulders repaired with cross-linked porcine dermal 
patch89, and Van Kampen et al. reported that the use of a reconstituted collagen scaffold led to the 
formation of well-integrated fibrocartilage between tendon and bone110, only after 2489 and 26 weeks110 
post-surgery, while similar repair response was observed at week 16 post-surgery when the biphasic 
scaffold was used. The great repair efficacy of the biphasic scaffold could be partially contributed to the 
distinct non-mineralized to mineralized layer design. Dickerson et al. fabricated a partially mineralized 
graft through selective mineralization of completely de-mineralized bovine cancellous bone and used it to 
repaired a partial-thickness rotator cuff tear227. It was reported that at week 16, a non-mineralized to 
mineralized fibrocartilage region was observed at the sheep tendon-bone junction when this graft was 
used. However, compared to the biphasic scaffold, the mineralized and non-mineralized regions of the 
bone matrix-based grafts were much wider and not physiologically relevant, resulting in a thicker 
fibrocartilaginous region compared to that of the native one. In addition, compared to this allogenic graft, 
the biphasic scaffold is easy to fabricate, with well controlled mineral distribution and scaffold fiber 
alignment.  
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In addition to the formation of fibrocartilage tissue, results from this chapter also demonstrated 
the ability of the biphasic scaffold to modulate formation of mineralized tissue at the sheep tendon-bone 
junction. At week 4, the higher mineral concentration at the biphasic scaffold-repaired bone surface 
indicates that the scaffold remained at the tendon-bone junction, thus providing cues to the host cells to 
differentiate. By week 16, the mineral density of both repair groups became similar, indicating the 
incorporation of the HA of the biphasic scaffold by the host cells. The incorporated HA modulated tissue 
formation at the tendon-bone junction. Von Kossa staining showed that in the control repair, the scar 
tissue transit directly into bone, which was also reported in previous study227. On the other hand, an active 
mineralization front was observed in the biphasic scaffold repaired group, demonstrating controlled 
mineralization guided by the HA in the PLGA-HA phase of the biphasic scaffold, as the ability of HA to 
guide mineralization has been reported in vitro316;317 and in vivo258;317. Furthermore, although the biphasic 
scaffold contained a mineralized layer, ectopic bone formation at the tendon region was only observed in 
the control group. It is possible that bone marrow stem cells leached from the humerus marrow during 
surgery led to the formation of ectopic bone in the tendon of the control repair, as it was reported in other 
study that MSC–collagen gel led to ectopic bone formation in repaired tendons318. On the other hand, the 
biphasic scaffold acted as a barrier to prevent any mineralized tissue formation at the tendon region. 
Therefore, the layered design of the biphasic scaffold led to controlled mineralization at the tendon-bone 
junction.  
Collectively, these results demonstrated that the aligned, nanofiber-based biphasic scaffold led to 
insertion-like tissue formation at the tendon-bone junction in sheep.  
 
7.5 Conclusion 
 In this chapter, the effect of animal model on insertion regeneration efficacy of the aligned, 
nanofiber-based biphasic scaffold was evaluated in a sheep model, which mimics clinical settings. 
Results showed that the biphasic scaffold was successfully implanted in sheep shoulders in an “inlay” 
position between tendon and bone with the double-row suture-bridge technique, and the repair efficacy of 
the biphasic scaffold observed in rat was independent of the animal model. At week 16, the biphasic 
scaffold led to the formation of an insertion-like fibrocartilage tissue at the sheep rotator cuff tendon-bone 
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junction. The formed tissue was rich in types I, II collagen and proteoglycans, with aligned collagen fibers. 
The biphasic scaffold also guided selective mineralization at the tendon-bone junction, as it prevented 
ectopic bone formation at the tendon side, while promoting active mineralization at the bone side. Results 
from this chapter also demonstrated the advantage of the biphasic scaffold compared to other grafts, as it 




Figure 7.1. Intended use of the biphasic scaffold in clinical setting. Rotator cuff repair with 
double-row suture-bridge technique and biphasic scaffold as an inlay at the tendon-bone junction. 


















Figure 7.2. Sheep rotator cuff repair using the double-row suture-bridge 
technique and the biphasic scaffold. 
a. The intact infraspinatus tendon-bone junction. T: tendon, I: insertion, B: bone  
b. Acute full-thickness injury created by detaching tendon from bone at the 
insertion. Native insertion footprint is outlined by the dashed rectangular. Circles 
represent locations of suture anchor placement (blue: medial row, red: lateral 
row)  
c. Biphasic scaffold (arrow) sutured to tendon stump through sutures from the 
medial row anchors  
d. Tendon re-opposed to the humeral head with biphasic scaffold placed in between 
e. Tendon stump fixed to bone through sutures running between the four anchors  
f. Finish look of the repaired shoulder, blue and red arrows point to the location of 
corresponding anchors. Notice the X pattern of sutures that secure the biphasic 


















Figure 7.3. Sheep shoulder preparation for end-point analyses. From left to right: a photo of freshly 
harvested repaired shoulder demonstrating the location of the cutting plane (blue dash line) and the two 
pieces of 3-mm thick tissues (A&B) ; a schematic showing the cutting plane and tissues relative to 
suture anchors (blue: medial row, red: lateral row); tissue pieces used for SEM, decalcified histology( A), 









Figure 7.4. Region selection for quantifying mineral density. 
On a representative 2D micro-CT slice, the green rectangles show 
the areas contoured for mineral density calculation. Each box 
measures 2.5 x 5 mm. The medial anchor is shown on the image 
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Figure 7.5. Selected sheep blood parameter measurement. Week 0 data indicates the baseline 
between control and scaffold group is comparable.The biphasic scaffold did not lead to long term 
biocompatibility issue as neutrophil and total protein in control and scaffold group were comparable at 
week 16. No significant difference  in serum  Ca and P concentration was observed, indicating the 
biphasic scaffold is not toxic (n=7, p<0.05).   
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Figure 7.6. Ultrasound image (longitudinal view) of sheep shoulder. From left to right: native 
shoulder, repaired shoulders at week 4 and 16 post-surgery. The native insertion is clearly visible on 
ultrasound image as a bright line between tendon and bone (arrows). The gap formed between 
tendon and bone that is visible on  the week 4 images (arrow) disappeared on the week 16 images, 
















Figure 7.7. MRI image (sagittal view) of sheep shoulder. From left to right: native shoulder, 
repaired shoulders at week 4 and 16 post-surgery. Sagittal view of the native  sample shows the 
tendon  laying on top and inserting into the bone underneath. At week 4, discontinuity between 
tendon and bone was observed (arrow). This gap was filled by newly formed tissue in both groups 
by week 16. In addition, formation of ectopic bone was observed in the control shoulder (dashed 
yellow circle). 
Control












Figure 7.8. SEM image of sheep shoulder at week 16 post-surgery. From left to right: native, 
control and scaffold repaired shoulder. Overview (32x for native, scale bar = 1 mm,  50x for repaired 
shoulders, scale bar = 1mm) shows the location of tendon and bone. In the higher magnification 
images (200 x, scale bar = 200 µm), the native shoulder shows a well defined boundary (tidemark) 
between no-mineralized and mineralized tissue and a smooth transition between them,  Control repair 
has a larger area of transition tissue, while the  morphology of scaffold repaired sample closely 
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Figure 7.9. Collagen distribution and organization across sheep tendon-bone junction 
at week 16 post-surgery. Control (top) and scaffold (bottom) repaired  sheep shoulder, from 
left to right: collagen distribution (Picrosirus Red, 4x, scale bar = 200 µm) and alignment 
(polarized microscopy, 4x, scale bar = 200 µm) from tendon to bone. Collagen was found to 
be abundant in both control and scaffold group and collagen fibers in the scaffold group is 





























Figure 7.10. Fibrocartilage formation at sheep tendon-bone junction at week 16 post-surgery. 
Control (top) and scaffold (bottom) repaired  sheep shoulder, from left to right: proteoglycans (Safranin O, 
10x, scale bar = 200 µm), types I and II collagen (Immunohistochemistry, 10x, scale bar = 200 µm) 
distribution at the insertion. Much more proteoglycans were found at the insertion region of the scaffold-
repaired shoulder compared to the control. Type I collagen was found in both groups, while type II 
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Figure 7.11. Mineral distribution in the repaired sheep shoulders. X-ray and corresponding 
reconstructed 3D micro-CT image of shoulder samples (top). At week 4, mineral deposition was 
observed on bone surface of scaffold repaired  shoulder (arrows). By week 16, mineral deposition was 
observed on bone surface of both groups. The biphasic scaffold increased mineral density at week 4 
and actively modulates mineralization at the tendon-bone junction. 











































CHAPTER 8: MESENCYMAL STEM CELL LOADED ALIGNED 
NANOFIBER-BASED BIPHASIC SCAFFOLD FOR INTEGRATIVE 




 In previous chapters, effects of scaffold intrinsic and extrinsic parameters that could modulate the 
rotator cuff repair response are investigated using as-fabricated scaffolds in rat and sheep models. 
Through a series of well-planned experiments, a robust scaffold system that leads to integrative rotator 
cuff repair is established. Together, studies from the first half of the thesis (Chapters 2-7) lead to the 
foundation of work that could result in the eventual development of a clinically available rotator cuff repair 
scaffold that could benefit hundreds of thousands of patients. In the following chapters of this thesis, 
exploratory studies will be carried out on different aspects of the scaffold system. The potential of external 
factors, such as pre-seeding with cells (Chapters 8), biomechanical loading (Chapter 9), growth factor 
(Chapter 10) on integrative rotator cuff repair and how to incorporate them into the scaffold system will be 
investigated. The working mechanism of the biphasic scaffold will be explored in Chapter 11 via in vitro 
experiments.  
 
8.1.1 Background and Motivation 
  In the previous chapters, as-fabricated scaffolds were used in the surgery, which means all 
healing response observed on the scaffold is from the host cells that migrated to the scaffold during 
healing. However, the host cells have limited capacity to migrate to scaffolds, as the scaffolds are not pre-
loaded with chemotaxis agents that attract cells to migrate towards them. This lack of host cell migration 
leads to limited in vivo extracellular matrix (ECM) deposition on the scaffold, which might explain the 
observed fact that although biphasic scaffold led to the formation of insertion-like tissue at the tendon-
bone junctions, the mechanical properties of the repaired shoulders were still significantly lower than that 
of the native ones-there was simply not enough ECM to strongly hold the tendon stump and the bone.  
 To overcome this limitation, one approach is to pre-seed the scaffold with cells before 
implantation. Ideally, these cells should have the ability to proliferate and produce fibrocartilaginous tissue. 
To this end, mesenchymal stem cells (MSCs) are selected, since compared to the primary 
fibrochondrocytes that are native to the insertion, they are easier to obtain, maintain the ability to 
proliferate in 2D culture, and able to differentiate into fibrochondrogenic lineage with appropriate stimulus. 
Therefore, in this chapter, the aligned, nanofiber-based scaffold will be pre-seeded with allogenic MSCs, 
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and used to repair acute rat rotator cuff tear. 
 
8.1.2 Objective  
 The objective of this study is to evaluate the performance of MSCs pre-seeded aligned, 
nanofiber-based biphasic on integrative rotator cuff repair, in terms of both morphology and mechanical 
properties of repaired shoulders. It is observed in Chapter 6 that when as-fabricated biphasic scaffolds 
were used, mechanical properties of the repaired shoulder remained similar from short to term. Therefore, 
it is expected that with the pre-seeded MSCs, the biphasic scaffold will lead to an increase in shoulder 
mechanical properties from short term (week 5 post-surgery) to long term (week 10 post-surgery), which 
will not be observed in the control, where the shoulders are repaired without the scaffold. 
 
8.2 Materials and Methods 
8.2.1 Scaffold Fabrication 
 Aligned, nanofiber-based biphasic scaffolds were fabricated via electrospinning24. The PLGA 
solution was prepared by dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- 
dimethylformamide (DMF, Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA 
(w/v), DMF(v/v), and ethanol (v/v). Similarly, the PLGA-HA solution was prepared with the addition of 
hydroxyapatite (HA) nanoparticles (15% w/w, diameter: 100-150nm, Nanocerox, Ann Arbor, MI) to the 
PLGA solution. Each solution was loaded into a syringe with an 18.5-gauge and dispensed via a syringe 
pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The solutions were spun at 8-10 kV (non-mineralized 
phase) or 11-13 kV (mineralized phase). Fibers were collected on a rotating mandrel for aligned scaffold 
fibers. The biphasic scaffold was produced by electrospinning the non-mineralized layer directly on top of 
the mineralized layer. As-fabricated scaffolds were carefully excised from the mandrel and cut into 3 mm 
x 6 cm pieces. To ensure that the biphasic scaffold has an even distribution of the non-mineralized and 
mineralized layers, scaffolds with a thickness of 0.2±0.01 mm were selected. These scaffolds were 
carefully peeled, from both ends, into the PLGA and PLGA-HA layers, leaving the middle region, which 
measured to be 3 mm in length intact. The thickness of individual layers was measured and only scaffolds 
with both layers measured to be 0.1±0.01mm were used in the study. The single layers of the scaffold 
139
were folded back to the corresponding phase of the biphasic region with one fold on each layer to 
accommodate the repair procedure. By doing this, it was ensured the scaffold is thick enough to fill in the 
gap created between tendon and bone during the surgery, while retaining the distinct mineral distribution 
profile. The excessive single PLGA layer was completed removed, and most of the excessive PLGA-HA 
layer was trimmed, leaving only a 5 mm long region extending from the folded scaffold, for the purpose of 
scaffold handling and phase identification during surgery. Scaffolds were sterilized with ultraviolet 
radiation for 15 minutes on both sides and stored under sterile conditions until seeding.  
 
8.2.2 Mesenchymal Stem Cell Isolation, Culture, and Seeding 
 Allogenic MSCs were used in this study and Lewis rats were selected since they are considered 
syngeneic194 such that the use of allogenic cells will not lead to immune response. Adult male Lewis rats 
(Charles River Laboratories, n=3, 11-12 weeks old, average weight=316±10g) were sacrificed with CO2 
overdose, their legs were harvested; skin and muscles were removed until bones are exposed. Femur 
and tibia were cracked open and 10mL of fully-supplemented (FS) medium consisting Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, 
GA), 1% antibiotics (10,000 U/ml penicillin, 10 mg/ml streptomycin), 0.1% antibacterial (gentamicin sulfate) 
and 0.1% antifungal (amphotericin B) was used to flush bone marrow out of the bone cavity. The resulting 
mixture was collected and plated on a 150mm2 plate. 72 hours after plating, non-attaching cells and bone 
marrow were removed with phosphate buffered saline (PBS) washes. Cells remained in plate were 
cultured and expanded. In this study, MSCs up to passage 3 were used. 
 Prior to cell seeding, the aforementioned scaffold strips with single layer on each side and 3 mm 
overlap region in the middle were soaked in FS medium containing 10 μg/mL of fibronectin (Invitrogen, 
Carlsbad, CA) for 4 hours. The purpose of this pre-soaking is to make the scaffold less hydrophobic and 
let fibronectin to deposit on the scaffold, both of which enhance cell adhesion to the scaffold. To seed 
MSCs, cells were dissociated from the plate and collected by centrifuge. Three scaffolds were placed in 
each of 15 mL conical tube with 15 mL of FS medium. The concentrated MSC suspension was diluted in 
the tube to achieve a final concentration of 8.75 x 105 cells/scaffold. The tubes with scaffold and cells 
were placed on a rotating shaker for 20 minutes for dynamic seeding that allows cell attachment and 
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distribution on the scaffold. After seeding, scaffolds were kept in the tube at 37ºC until use in the surgery. 
 
8.2.3 Surgical Procedure 
All animal procedures were performed at the Microsurgery Training and Research Laboratory in 
the Department of Orthopedic Surgery under a protocol approved by the Institutional Animal Care and 
Use Committee. Adult male Lewis rats (Charles River Laboratories, n=11, 11-12 weeks old, average 
weight=316±10g) were used in this study. For the surgery, each rat was anesthetized in a chamber with 
2-2.5% v/v isoflurane (Isothesia, Henry Schein Animal Health, Melville, NY) in 2 L/min oxygen flow. 
General anesthesia was maintained through a nose cone at an average of 1.5% v/v isoflurane in 2 L/min 
oxygen flow. The shoulder region was shaved, and prepared for aseptic surgery with three rounds of 
alternative ethanol and betadine rubs. Immediately before surgery, systemic antibiotics ampicillin (Henry 
Schein, 50mg/kg body weight), anti-inflammatory drug carprofen (RIMADYLR® Injectable, Pfizer, New 
York, NY, 5 mg/kg body weight) and analgesic buprenorphine (Henry Schein, 1.2 mg/kg, sustained 
release for 72 hours) were injected into rat subcutaneously. Marcain (Henry Schein, 2 mg/kg body weight), 
a local anesthetic was injected subcutaneously to each shoulder right before skin incision was made.  
Bilateral acute rotator cuff repair was performed on each rat with the transosseus bone tunnel 
method, following a published protocol29. In each rat, the shoulders were randomly selected to be 
repaired using the nanofiber-based biphasic scaffold, the microfiber-based biphasic scaffold, or without 
scaffold. The selection was also randomized such that no rat received the same treatment in both 
shoulders. Briefly, a longitudinal incision was made on the skin of the shoulder region to expose the 
deltoid muscle. To locate the supraspinatus tendon, the coracoacromioal arch was identified and the 
deltoid muscle was cut open alone the arch. A 5-0 prolene suture (Ethicon, Somerville, NJ) was passed 
through the cut deltoid muscle to retract it during surgery. Once the deltoid was exposed, the 
supraspinatus tendon was identified as it passes right underneath the arch. To create an acute rotator 
cuff injury, the supraspinatus tendon was sharply detached from its bony insertion with a surgical blade. 
The fibrocartilaginous footprint of the tendon insertion on the greater tuberosity of humerus was removed 
with a motorized burr. For the transosseus tendon-bone repair, a bone tunnel with 0.5 mm diameter was 
drilled transversely in the anterior-posterior direction on the proximal part of the humerus. The tendon 
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stump was grasped by a 5-0 prolene suture (Ethicon) using a technique similar to the Mason-Allen 
method. For control repair, the suture was passed through the bone tunnel to reappose tendon to the 
anatomic position. For scaffold augmented repair, the scaffold pre-seeded with MSCs was inserted 
between the distal end of the tendon and the cancellous bone, such that its PLGA phase contacting the 
tendon and PLGA-HA phase contacting the bone. Extra attention was paid to ensure the fiber orientation 
of both the nanofiber-based and microfiber-based scaffolds matched with that of the tendon, followed by 
reapposing of the tendon to the anatomic position. Following tendon re-attachment, the deltoid muscle 
was repaired with a 4-0 vinyl suture (Ethicon) and the skin incision was closed by wound clips. Rats were 
not immobilized and allowed for normal cage activity through the duration of this study.  
 
8.2.4 Sample Harvest 
Rats were randomly selected at weeks 5 or 10 post-surgery, and were sacrificed by CO2 
overdose. Shoulders were dissected away from the body, rinsed in phosphate buffered saline (PBS), and 
wrapped in PBS-soaked gauze for end-point analyses.  
 
8.2.5 End-point Analyses 
8.2.5.1 X-ray micro computed tomography analysis 
Immediately after harvesting, each shoulder was scanned with a micro-CT scanner at a voxel 
size of 21µm (VivaCT 40, Scanco, Swizerland) to obtain 2D images along the long axis of humerus. The 
rotator cuff region was selected and contoured on all 2D slices, followed by 3D reconstruction using a 
mineral threshold of 268 mg HA/cm3, a value determined from previous studies24 to visualize the bony 
structures at the healing rotator cuff.  
8.2.5.2 Matrix deposition and organization 
After micro-CT scan, shoulder designated for histology analysis (n=2 at week 5 for comparison 
purpose with other studies) were fixed in 80% v/v ethanol with 1% w/v cetylpyridinium chloride (Sigma-
Aldrich) for 3 days, followed by decalcification in 45 mL of solution consisting formic acid (Thermo Fisher 
Scientific, Waltham, MA), Trizma® HCl (Sigma-Aldrich) and ethylenediaminetetraacetic acid (Sigma-
Aldrich) on a rocker (Roto-Shake Genie, Scientific Industries, Bohemia, NY) for 21 days. Following 
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complete decalcification, the tissues were dehydrated in an ethanol series (70%– 100%), cleared three 
times in xylenes (Thermo Fisher Scientific), and embedded in paraffin (Thermo Fisher Scientific) at 56ºC. 
Samples were sectioned with a microtome (Reichert-Jung RM 2030, Leica, Bannockburn, IL) to obtain 7 
µm thick sections. To assess collagen and GAG distribution, the sections were de-paraffinized and 
rehydrated, and stained with picrosirius red and alcian blue stains, respectively. Collagen fiber alignment 
at the tendon-bone junction was visualized with circular polarized light microscopy of the picrosirius red 
stained slides. All images were taken with an inverted light microscope (Axiovert 25, Carl Zeiss, 
Thornwood, NY).  
8.2.5.3 Mechanical testing 
After micro-CT scan, rat shoulders designated for mechanical testing (n=10) were stored at -80ºC. 
The day before testing, samples were thawed at 4ºC overnight. Gross dissection was performed to 
remove the scapula, infraspinatus, subscapular and teres minor muscles, leaving only the supraspinatus 
muscle and its tendon attached to the humeral head. The muscle was scrapped off and a fine dissection 
was performed to carefully remove the remaining muscle tissue, tendon sheath, and non-load bearing 
scar tissue at the tendon-bone insertion. After fine dissection, to measure the optical strain, Verhoeff’s 
stain lines were placed on the tendon at the insertion, and at 2, 4, and 8 mm away from the insertion, in 
the direction perpendicular to the long axis of the supraspinatus tendon. Tendon cross-sectional areas 
were obtained with a custom device that uses two orthogonal linear variable transformers to measure 
location and a laser to measure tendon thickness by passing through specific locations of the tendon237, 
using the stain lines as references. Following this, the distal portion of the tendon that is above the 8 mm 
staining line was embedded between two pieces of sandpaper with a cyanoacrylate adhesive and the 
distal portion of the humerus was potted in poly (methylmethacrylate) PMMA. The sample was placed in a 
customized clamp and submerged in a 39ºC PBS bath; its uniaxial tendon properties were obtained using 
an Instron 5543 mechanical tester. Briefly, a preload of 0.08 N was applied to the tendon to eliminate 
slack; the tendon was preconditioned for 10 cycles from 0.1 to 0.5 N at a rate of 1%/s. The tendon was 
held for 5 minutes to return to equilibrium, and then loaded to 5% strain at a rate of 5%/s, followed by a 
10-minute relaxation. The tendon was then returned to its initial gauge length and loaded with 0.3% 
strain/s until failure. Video images of the tendon during ramp to failure were captured by a camera and 
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the location of failure was recorded. Mechanical properties were obtained as following: the maximum load 
was read directly as the highest point on the force-displacement curve; maximum stress was calculated 
by dividing the maximum force by the initial tendon midsubstance area. Stiffness was obtained as the 
slope of the linear region of the force-displacement curve. Strain was obtained from stain line 
displacement images using custom tracking software300 and the Young’s modulus was obtained from the 
stress-strain curve. Since the focus of this study is the overall mechanical properties of the repaired 
shoulder, the tendon midsubstance area was used to calculate the Young’s modulus. The viscoelastic 
properties of the tendon were represented by tendon percent relaxation, which was calculated as the ratio 
of equilibrium load to peak load during the stress-relaxation test.  
 
8.2.6 Statistical Analysis 
Results are presented in the form of mean ± standard deviation after outliner analyses were 
perform to remove shoulders that failed pre-maturely during mechanical testing due to sample 
preparation errors such as over dissection and incorrect potting. For each mechanical property, a two way 
analysis of variance (ANOVA) was performed for all pair-wise comparisons to investigate effects of MSC-
laden biphasic scaffold and time on the mechanical properties. All statistical analyses were performed 
using JMP IN 4.0.4. (SAS Institute, Cary, NC) and significance was attained at p<0.05.  
 
8.3 Results 
 Reconstructed micro-CT images demonstrate that the MSC-laden biphasic remained at the 
tendon-bone junction during the entire healing period (Figure 8.1). When MSCs were pre-seeded on the 
aligned, nanofiber-based biphasic scaffold and used to repair acute rat rotator cuff tear, histology analysis 
reveals that similar to the as-fabricated scaffold, fibrocartilaginous tissue that is rich in collagen and GAG 
and consisting aligned collagen fibers were formed at the tendon-bone junction. On the other hand, 
fibrous, disorganized tissue formed in the control shoulder (Figure 8.2). 
 Comparing the mechanical properties over time and between groups, it was found that both the 
maximum load and stress of the MSC-laden scaffold repaired shoulders increased significantly from week 
5 to week 10 post-surgery (Figure 8.3). On the other hand, such change was not observed in the control 
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group. Furthermore, all other mechanical properties measured, including stiffness, Young’s modulus and 
stress-relaxation parameters of the shoulders remain similar, regardless of the treatment or healing time 
(Table 8.1).  
 
8.4 Discussion 
 In this chapter, the aligned, nanofiber-based biphasic scaffold was pre-seeded with allogenic 
MSCs before implantation in rat shoulder. Matrix distribution and organization at the healing tendon-bone 
junction, as well as mechanical properties were determined. 
 Micro-CT images showed that after implantation, the biphasic scaffold remained at the tendon-
bone junction at both weeks 5 and 10 post-surgery. The scaffold should not be confused with ectopic 
bone formation, which was observed when the as-fabricated gradient scaffold was used in the surgery. 
Compared to the ectopic bone, the minerals observed at the tendon-bone junction were more evenly 
distributed, leading to a much lower volumetric mineral density than that of the bone. Furthermore, both 
the size of mineral containing tissue and mineral density at the tendon-bone junction of the MSC-laden 
scaffold repaired shoulder decreased over time, which can be explained by the degradation of the 
scaffold. On the other hand, ectopic bone would either expand or maintain its volume over time. It was 
also interesting to see that when as-fabricated scaffold was used in other studies, micro-CT did not reveal 
the scaffold, while it was clear from histology that the scaffold remained at the tendon-bone junction over 
time. This indicates a slower degradation rate of MSC-laden biphasic in vivo. It is possible that the 
seeded MSCs deposited matrix on the biphasic scaffold and the ECM worked as a barrier to prevent the 
contact of synovial fluid to the scaffold, thus less erosion to the scaffold and a slower degradation rate. 
 When MSCs were pre-seeded on the scaffold, the maximum load and stress of scaffold repaired 
shoulders increased from week 5 to 10. On the other hand, when as-fabricated biphasic scaffold was 
used, these two values remained similar from week 5 to 20. Therefore, it can be seen that one effect of 
the MSC is that they speed up the repair rate of the shoulder, possibly by producing more matrix 
compared to the as-fabricated scaffold. However, it also needs to be noticed that other properties 
remained similar to that of the control and did not increase significantly over time, indicating limited 
enhancement from the MSCs. In this study, MSCs were seeded on the biphasic scaffold without pre-
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differentiation towards the fibrochondrogenic lineage. In a similar study, Gulotta et al. seeded MSCs on a 
fibrin carrier and used it in the same animal model and reported that although these cells were 
metabolically active, they did not improve the structure, composition or strength of the healing tendon192, 
due to the lack of differentiation towards the desired lineage. It is possible that the aligned fibers induced 
tendongenic differentiation of the seeded MSCs236, which deposited collagenous tissue on the scaffold. 
With more connective tissue formation, the maximum load increased over time. However, this tissue was 
not functional for the tendon-bone insertion, thus the intrinsic properties, such as Young’s modulus 
remained unchanged over time.  
 
8.5 Conclusion 
 In this study, allogenic MSCs were pre-seeded on the aligned, nanofiber-based biphasic scaffold, 
and evaluated in the rat model. Results demonstrated that similar to the as-fabricated scaffold, the MSC-
laden scaffold led to the formation of an insertion-like tissue at the healing tendon bone junction. The 
addition of MSCs, without pre-differentiation, increased healing response, as the maximum load and 
stress increased over time in the scaffold repaired group. On the other hand, it is observed that other 
mechanical properties remained similar between groups and over time, possibly due to the lack of pre-
differentiation, thus functional tissue formation from the MSCs. Therefore, although pre-seeding with 
MSCs has some positive effect on the healing response, without pre-differentiation towards the 
fibrochondrogenic lineage, the cells have limited impact on the insertion regeneration. The next two 
chapters will explore potential methods that could be utilized to pre-differentiate MSCs on the biphasic 
scaffold, to further enhancing its in vivo performance.  
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Figure 8.1. Retention of the scaffold at the tendon-bone junction. Micro-CT 3D 
reconstruction of the humeral head with repaired tissue (scale bar=1 mm). At both time points, 
the MSC-laden biphasic scaffold was observed at the tendon-bone junction (circled region), 
indicating it remained in place during the healing period. Less scaffold was seen in week 10 
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Figure 8.2. Matrix formation and organization at tendon-bone junction of MSC-laden 
scaffold repaired shoulders. All groups were stained positive for collagen (picrosirius red stain, 
10x, bar=100 µm) at the tendon-bone junction. Similar to the as-fabricated scaffold, MSC-laden 
scaffold led to the formation of GAG at the heling tissue. Furthermore, organized tissue formed at 
the scaffold repaired tendon-bone junction, while disorganized tissue formed in the control 




































Control 14.8±3.8 4.55±1.8 18.6±6.4 0.94±0.4 69.2±9.2 
Scaffold 12.5±3.4 3.02±0.65 13.4±5.3 0.61±0.3 66.2±10.3 
Week 10 
Control 16.3±1.9 6.26±3.1 35.4±19.2 1.01±0.4 59.0±18.8 
Scaffold 19.4±4.7^ 7.17±1.93^ 29.1±10.4 0.9±0.4 64.8±5.7 
Table 8.1. Mechanical Properties of Operated Shoulders 
























































Figure 8.3. Effect of MSC-laden biphasic scaffold on rat shoulder mechanical 
properties. Both the maximum load and stress of MSC-laden scaffold repaired 
shoulders increased significantly over time from week 5 to 10. These properties of the 
control repaired shoulder remained similar over time. 
(^: significant difference compared to week 5 value, n=10, p<0.05) 
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 In Chapter 8, allogenic, un-differentiated mesenchymal stem cells (MSCs) were pre-seeded on 
biphasic scaffold and their impact on integrative rotator cuff healing was evaluated in the rat shoulder. 
Results showed that although the MSC-laden scaffold led to the formation of an insertion-like tissue at the 
tendon-bone junction, it had limited enhancement on the mechanical properties of the shoulder. It is 
possible that the non-differentiated MSCs only have limited impact on the healing response. Therefore, 
methods for differentiating MSCs towards the fibrochondrogenic lineage, and how they could be 
incorporated into the biphasic scaffold are investigate in this and the next chapter. 
 It is known that external stimulus, such as biomechanical 9;12;167-169 and biochemical 197-201;205;206 
cues all play important roles in rotator cuff development and healing as they could modulate cell response, 
including MSC differentiation, for the insertion fibrocartilage formation. This chapter focuses on the effect 
of biomechanical loading on the formation of fibrocartilage of the MSCs pre-seeded on the aligned, 
nanofiber-based biphasic scaffold. 
 
9.1.1 Background and Motivation 
 In the literature, a significant amount of work has been done to explore the relationship between 
mechanical loading and formation of fibrocartilage, from native fibrocartilage development to in vitro cell 
studies.  
 In a review paper, Benjamin and Ralphs3 reported that fibrocartilage is observed in the region of 
tendon where it wraps around anatomical structure formed by bone or fibrous pulleys, such as the biceps 
tendon insertion on the humeral head. This change in tendon composition is considered as an adaptation 
to compression224;319, since the most fibrocartilaginous tendons are the ones that are permanently bent 
around their pulleys and heavily loaded3. This theory was verified with implant model: Evanko and Vogel 
loaded a fetal tendon explant with compressive loading for 3 days and found increase in large 
proteoglycan protein production, which is consistent with what is expected during the in vivo development 
of fibrocartilage320. Furthermore, Malaviya et al. removed in vivo compressive loading in rabbit flexor 
tendon and found that after 4 weeks of load removal, glycosaminoglycan (GAG) and type II collagen 
content in the fibrocartilage region decreased significantly, indicating a more fibrous morphology321. 
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Collectively, it is demonstrated that compressive loading is critical to the in vivo formation of fibrocartilage. 
Following the in vivo findings, effect of mechanical loading on fibrocartilaginous extracellular matrix (ECM) 
formation has been tested in vitro with MSCs, as they have the ability to differentiate into fibrobastic and 
chondrogenic lineages, which are required for the formation of fibrocartilage. It has been shown that 
tensile loading is important for fibroblastic differentiation of stem cells. For example, when tensile loading 
was applied to aligned scaffold seeded with MSCs, they differentiated into ligament fibroblast-like cells 
with elevated collagen deposition and type III collagen expression322. When tensile loading was applied to 
fibrous scaffold seeded with tendon-derived stem cells, proliferation and tenogenic differentiation of the 
cells were observed220. On the other hand, the correlation between compressive loading and 
chondrogenic tissue formation found in vivo, identified by the elevated expression of aggrecan or 
increased production of GAG, was also observed in vitro. Thomopoulos et al. designed a bioreactor that 
is able to apply cyclic compressive loading to collagen matrix loaded with MSCs, and reported more 
spherical cell morphology and upregulation of GAG expression225. Based on these previous studies, it can 
be concluded that tensile and compressive loadings promote the fibrochodrogenic differentiation of MSCs, 
which lead to increased fibrocartilage production.  
 
9.1.2 Objective 
 This objective of this study is to investigate the effect of biomechanical loading, specifically, 
spontaneous compressive and tensile loading on fibrocartilaginous differentiation of MSCs seeded on the 
scaffold, with a focus on the design of a loading system that is able to provide such stimuli to the cells. It 
is hypothesized that such system can be designed and fabricated. Furthermore, MSCs experiencing 
different loading regimes will show different response. Specifically, cells will remain viable on both the 
tensile only and the compressive/tensile loading regions. However, cells seeded on the tensile loading 
only region will exhibit an elongated morphology, indicating fibrogenic differentiation, while cells seeded 
on the compressive/tensile loading region will show a more spherical morphology, indicating 
fibrochondrogenic differentiation.  
 
9.2. Materials and Methods 
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9.2.1 Bioreactor Design 
 To load the pre-seeded scaffold, a bioreactor that is capable of spontaneously provides tensile 
and compressive loading is needed. Previously, our lab had designed a bioreactor cartridge in which a 
scaffold could be suspended and secured. This cartridge can be connected to a stepper motor, which 
stretches the scaffold horizontally to provide cyclic tensile loading322. Based on this cartridge, a 
compressive component has been created by adding a half cylinder in the middle of the cartridge. The 
height of the cylinder is greater than that of clamps at the two ends. As a result, the scaffold contacts and 
“wraps around” the top of the half cylinder. With this cartridge configuration, when tensile loading is 
applied to the scaffold, it imparts a downward force on the cylinder. The cylinder in term has a counter 
force, which is upward to the scaffold wrapped around it (Figure 9.1). Therefore, cells seeded on this 
region experience spontaneous tensile and compressive loading when the cartridge is loaded by the 
stepper motor. 
 
9.2.2 Estimation of the Compressive Loading 
 The stepper motor provides tensile loading by moving one clamp to a certain distance, which can 
be converted to the strain of the scaffold based on its length. However, magnitude of compressive loading 
cannot be obtained from this method. Since too large a compressive loading could be detrimental to the 
cells, it is important to obtain information about the magnitude of compressive loading when a specific 
tensile strain is applied to the scaffold. 
 Two methods were tested for this purpose: pressure sensitive film and force sensor measurement. 
The Fujifilm Prescale® Tactile Pressure Indicating Sensor Film (Fujifilm, Madison, NJ) was used for 
pressure measurement. This film consists of a donor layer and acceptor layer. The donor layer is 
embedded with microcapsules that contain dye. When loaded, due to the force applied, the dye from the 
capsules of the donor layer is released and transferred to the acceptor layer. The intensity of the color is 
proportional to the force applied. To ensure an accurate estimation of the pressure, the most sensitive 
pressure film (responses to pressure range from 7.2 to 28 PSI) was selected. The film was wrapped 
around the top of the cylinder, followed by securing the scaffold carefully such that it touches the film, 
without imparting any force on it (Figure 9.2). Scaffolds were loaded at 1% and 3% tensile strains (n=3) 
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and the acceptor layer of the pressure sensitive films were collected and analyzed by Fujifilm to create a 
stress map and to calculate the force (Figure 9.2). In the force sensor measurement method, a full bridge 
thin beam force sensor, TBS-0.5 (Transducer Techniques, Temecula, CA) was installed underneath the 
cylinder, around the region where compressive loading is applied (Figure 9.3). This load cell coverts force 
applied into voltage signal, the larger the force, the higher the signal. Therefore, the load cell was 
connected to an oscilloscope, which recorded the voltage change of the load cell. Following a calibration 
in which the relationship between the pre-designed loadings applied and resulting voltage change was 
obtained, the scaffold was placed in the cartridge and loaded with 1% and 3% tensile strain respectively 
(n=3). The voltage change during loading was then converted to force using the calibration curve.  
 
9.2.3 Cell Viability at the Compressive/Tensile Loading Region 
 After the magnitude of compressive loading was estimated, the design of the cartridge was tested 
by observing cell viability on the loaded scaffold. Prior experience indicates that 1% tensile strain is 
needed to induce and maintain the fibrogenic differentiation of MSCs322. Therefore, if when 1% tensile 
strain is applied by the stepper motor and cells remain viable at the compressive/tensile loading region, 
then more cartridges with the same design will be produced and used to determine the effect of 
spontaneous tensile and compressive loadings on fibrocartilage formation from MSCs seeded on the 
scaffold. On the other hand, if at 1% tensile strain, cells are dying at the tensile/compressive loading 
region, it is highly possible that the compressive loading is too high and detrimental to the cells, and the 
cartridge needs to be redesigned, such as decreasing the height of the cylinder or decreasing the 
curvature of the contracting surface, to reduce the compressive load.  
 Since it is a trial study to test out the cartridge, instead of the aligned, nanofiber-based biphasic 
scaffold, aligned PLGA scaffolds were used as they were readily available. Unused PLGA meshes from 
previous studies were cut into 5 x 6.5 cm pieces and treated with ultraviolet (UV) radiation for 15 minutes 
on both sides before assembling in the cartridge. The cartridge components were soaked in 70% ethanol 
for 30 minutes, air dried in sterile biological hood, followed by UV radiation for 15 minutes on both sides. 
The scaffold was inserted into the compressive loading cartridge and vertically split into 5 long strips, 
each measured to be 5 cm x 1 cm in dimension. This cartridge was stored under sterile condition until the 
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day before cell seeding, when pre-soaking medium consisting Dulbecco’s modified Eagle’s medium 
supplemented with 20% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA), 1% antibiotics (10,000 
U/ml penicillin, 10 mg/ml streptomycin), 0.1% antibacterial (gentamicin sulfate) and 0.1% antifungal 
(amphotericin B) was added to the cartridge at a volume that covered the scaffold. The purpose of the 
pre-soaking is to improve the hydrophilicity of the scaffold, as well as allowing the amino acids and 
proteins from FBS to deposit on the scaffold, therefore, enhance cell attachment. Passage 7 sheep MSCs 
were used in this study (isolated from sheep bone marrow). After confluency, MSCs were detached from 
the cell culture plate, centrifuged, counted, and diluted with medium to a concentration of 3x106 cell/mL. 
The pre-soaking medium from the cartridge was aspirated, 10 µL droplets of the cell suspension were 
carefully added on top of the scaffold, such that on each strip, there were 5 droplets evenly distributed 
along its length, which leads to an equivalent cell seeding density of 3x104 cells/cm2 on the scaffold. Cells 
were allowed to attach to the scaffold for 15 minutes, followed by addition of 23 mL fully-supplemented 
medium (same composition as the presoaking medium with only 10% FBS) into the cartridge to ensure all 
areas, included the elevated region due to the loading cylinder were covered by medium. After 6 days of 
static culture, the cartridge was connected to the stepper motor, and loaded with 1% tensile strain at 1 Hz 
for 90 minutes twice daily (10.5 h rest between cycles) based on prior experience with tensile loading on 
MSCs seeded in the original cartridge. Culture medium was changed twice weekly and scaffolds were 
harvested at days 1, 7, and 14 after seeding. Cell viability and morphology (n=2) at the 
compressive/tensile loading region (region 1, Figure 9.3), where the cylinder directly contacted the 
scaffold, and at the tensile loading region (region 2, Figure 9.3), where scaffold was suspended in 
medium, were evaluated using Live/Dead staining (Invitrogen, Carlsbad, CA) following the manufacturer’s 
suggested protocol. The samples were imaged under confocal microscopy (Olympus Fluoview FV1000 
Confocal Microscope, Central Valley, PA) at excitation wavelengths of 488 nm and 594 nm.  
 
9.3 Results and Discussion 
 Both the pressure sensitive film and pressure sensor measurement methods led to force 
estimation at the compressive/loading region (Figure 9.4). Compared to the pressure sensitive film 
method, the pressure sensor method led to a smaller standard deviation in the results, indicating a more 
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consistent measurement between different samples, thus a more reliable estimation. Regardless of the 
methods, the trend is clear that a larger tensile strain led to a larger force at the compressive/tensile 
loading region. At 1% strain, the total force applied to the compressive/tensile region was approximately 
0.5-1 N, at 3% strain, the total force applied to the compressive/tensile region was approximately 2-5 N. 
The cartridge design was successfully tested in vitro, without any medium leakage or contamination. 
Through the duration of the study, cells remained viable on both regions of the scaffold (Figure 9.5). As 
expected, at the tensile loading only region, MSCs had an elongated morphology and at the 




 Collectively, in this study, a bioreactor that is able to provide spontaneous tensile and 
compressive loadings was designed. When MSCs experience both compressive and tensile loadings, 
they are morphologically different from the ones under only tensile loading, indicating a possible 
differentiation toward the fibrochondrogenic lineage. Future work will be to make more of the cartridges, 
and to perform a more compressive study to determine fibrocartilage formation at the tensile/compressive 
loading region, by quantitatively and qualitatively measuring ECM properties, such as collagen and GAG 
content, types I and II collagen and aggrecan distribution. Eventually, pre-cultured aligned, nano-fiber 
based biphasic scaffold with preformed fibrocartilage from the bioreactor will be implanted in the rat 















Figure 9.1. Cartridge design for spontaneous tensile and compressive loadings. The top 
views of tensile loading only cartridge (left) and the compressive/tensile loading cartridge without 
(middle) and with the scaffold(right), showing the positions of the clamps and the cylinder, as 
well as the corresponding region on the scaffold. When in use, scaffold is secured by the two 
clamps and suspended horizontally in the cartridge. The side view of the compressive/tensile 
loading cartridge demonstrates that when the scaffold is horizontally loaded (horizontal arrow), 
the cylinder provides compressive loading to the scaffold (vertical arrows). 
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Figure 9.2. Compressive loading estimation with pressure sensitive film. The top and 
side views demonstrate location of the pressure sensitive film (arrow). After loading, the film 
changed color from transparent to red due to the release of the dye. The images were 












Figure 9.3. Pressure sensor placement and different loading regions of the scaffold and 
cartridge design for spontaneous tensile and compressive loadings. Image on the left 
shows the location of the thin beam pressure sensor (red arrow) and the stem used for 
cylinder placement (yellow arrow). The sensor is placed directly underneath the stem to 
ensure that only the force at the compressive/tensile loading region is captured. Image on the 
right shows the region selection for Live/Dead imaging. Blue arrow indicates the location of the 
cylinder, which is across the width of the cartridge at that location. Scaffolds on region 1 
contact the cylinder and scaffolds on region 2 do not contact the cylinder. Thus, cells seeded 
on region 1 experience both compressive and tensile loadings, while cells seeded on region 2 







































Pressure Sensitive Film Measurement
Figure 9.4. Compressive loading estimation. Both methods showed the trend that higher 
strain results in larger force on the scaffold. The load sensor led to a smaller standard 
deviation, indicating a more consistent measurement with different samples (n=3). 
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Figure 9.5. MSC morphology at the compressive/tensile loading and 
tensile loading regions. Cells remained viable at all time points and 
proliferated over time (Day 1 and Day 7, 10x, bar=200 µm, Day 14, 10x, 
bar=100 µm). The images in the left column (region 1) demonstrate MSC 
morphology when loaded with spontaneous compressive and tensile loadings. 
It can be seen that cells had a more spherical morphology compared to that of 
MSCs experiencing tensile loading only (region 2, right column), indicating 
fibrochondrogenic differentiation. 
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 In Chapter 9, differentiation of MSCs via biomechanical cue was investigated. A bioreactor that is 
able to provide spontaneous compressive/tensile loading to cells seeded on a scaffold was designed and 
tested. Results showed that when MSCs were seeded on the compressive/tensile loading region, they 
exhibited a more spherical morphology compared to those seeded on the tensile loading only region, 
indicating fibrochondrogenic differentiation of the MSCs. 
 In this chapter, differentiation of MSCs towards fibrochondrogenic lineage through another type of 
cue: biochemical factor is explored, with a focus on growth factor incorporation in the scaffold.  
 
10.1.1 Background and Motivation 
 It is known that growth factors play an important role in rotator cuff development and healing. 
Currently for rotator cuff repair, growth factors are usually applied via platelet rich plasma (PRP), as it 
contains a mixture of growth factors that are important for tendon healing209, and is relatively easy to 
prepare. In this approach, after the PRP is obtained via centrifugation of the patient’s blood, it is applied 
to the surgical site either through direct injection213;214 or loaded with a matrix, followed by implantation215-
218. However, in direct injection, there is no guarantee that the PRP will remain at the surgical site. In the 
matrix method, PRP is often burst released immediately following implantation, thus no long term effect. 
Therefore, when a growth factor loading system is designed, it is important that first it will remain at the 
targeted cite, and second, it will enable a sustained, long term release of growth factors.  
 Since the aligned, nanofiber-based biphasic scaffold remains at the surgical cite during the 
healing process as revealed by several studies, it could be an ideal vehicle for growth factor release. The 
growth factor can be mixed with the polymer solutions for electrospinning; as a result, the growth factor 
will be distributed evenly in the scaffold fibers and released as the scaffold degrades, ensuring a 
sustained long term release. In the literature, there are several examples where proteins (which most 
growth factors are) are being incorporated into polymers via electrospinning. For example, Kim et al. 
produced poly (ε-caprolacton) and poly (ethylene oxide) nanofibers loaded with lysozyme and determined 
lysozyme release in phosphate buffered saline (PBS). Results showed a burst release of lysozyme in the 
first 24 hours and sustained release until 180 hours323. Chew et al. incorporated β-nerve growth factor into 
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poly (ε-caprolacton-ethyl ethylene phosphate) using electrospinning and determined its release profile 
over time in serum free medium324. It is noticeable that in Chew’s study, when the growth factor was 
added into the polymer solution, it was added with bovine serum protein (BSA). This is because BSA 
helps to preserve the conformation of growth factor thus its stability325. In addition, usually a very small 
amount of growth factor is added into polymer solution, BSA acts as a vehicle that makes it easier to 
manipulate and helps to load growth factor into the polymer. Therefore, without using growth factors, BSA 
can be used as a model protein to determine the release profile from scaffold. In this chapter, for the 
eventual goal of sustained growth factor release from the scaffold for guided fibrochondrogenic 
differentiation of seeded MSCs, BSA will be incorporated into PLGA scaffold via electrospinning and its 
dynamic release profile in vitro will be determined.  
 
10.1.2 Objective 
 The objective of this study is to incorporate BSA into the scaffold and to determine its stability and 
release profile in plain medium. It is expected that BSA powder can be incorporated into the PLGA 
scaffold by adding the protein into the polymer solution. It is also expected that when the scaffold is 
placed in plain medium, BSA will be burst released, followed by a sustained, controlled long term release 
via scaffold degradation. Furthermore, it is expected that the released BSA will retain its normal structure, 
thus remain bioactive during the whole release process. 
 
10.2. Materials and methods 
10.2.1. Scaffold Fabrication 
 BSA powder (Sigma, St. Louis, MO) was crashed in a mortar for 30 minutes to decrease the size 
of BSA from large flakes (out of the bottle) into fine particles. The PLGA solution was prepared by 
dissolving PLGA (85:15, Lakeshore Biomaterials, Birmingham, AL) in N, N- dimethylformamide (DMF, 
Sigma-Aldrich, St. Louis, MO) and ethyl alcohol at a ratio of 35/55/10 for PLGA (w/v), DMF(v/v), and 
ethanol (v/v). After vortex overnight, a homogenous and viscous solution was formed, into which 250 μL 
of DMF and 87.5 mg of fine BSA powder were added. This gave a final BSA concentration of 5 wt% in the 
PLGA scaffold. 10%w/w BSA PLGA scaffold was fabricated with the same polymer solution that had 175 
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mg of BSA added. Each solution was loaded into a syringe with an 18.5-gauge and dispensed via a 
syringe pump (Harvard Apparatus, Holliston, MA) at 1 mL/h. The solutions were spun at 8-10 kV, and 
fibers were collected on a rotating mandrel, resulting in aligned PLGA scaffold with theoretically 5 and 10% 
w/w BSA incorporated. Plain PLGA scaffold, where no BSA was added into the solution was also 
fabricated via the same protocol. The BSA containing scaffolds were stored in the fridge at 4ºC, until their 
use.  
 
10.2.2 In vitro Release 
 The scaffolds were cut into 1 cm x 2 cm pieces and sterilized with ultraviolet radiation on each 
side for 15 minutes. Each scaffold was placed into 12 well plate with 2 mL of fresh release medium 
(Dulbecco’s modified Eagle’s medium supplemented with 1% antibiotics (10,000 U/ml penicillin, 10 mg/ml 
streptomycin), 0.1% antibacterial (gentamicin sulfate) and 0.1% antifungal (amphotericin B). 1mL of 
medium was collected from each well (n=6) at 30 minutes, 6 hours and 1 day after scaffolds were placed 
into medium and every time when medium was changed (twice weekly). After medium was collected, 
leftover in the well was aspirated off and 2 mL of fresh medium was added. All medium collected were 
stored in -30ºC freezer until the end of study, which is 28 days after the scaffold was added to the release 
medium. In addition to the three scaffold groups, there was an medium group in which each time 1 mL of 
medium in the well was collected, then aspirated and 2 mL of fresh medium added (n=6), following the 
medium change schedule as the scaffold groups. At the end of the study, residual scaffolds were 
collected and dissolved in 1mL chloroform (Sigma, St. Louis, MO). BSA in the scaffold was then extracted 
with 0.5mL distilled H2O and stored in -30ºC freezer until analysis. 
 
10.2.3 BSA Concentration Measurement and Structure Determination  
 The concentrations of released BSA in the spent medium as well as from the dH2O extraction of 
the residual scaffold at the end of the study were determined with Bio-Rad protein assay (Bio-Rad 
Laboratories, Philadelphia, PA) following the manufacturers’ protocol. In this assay, the concentration 
values obtained from BSA containing scaffold groups were normalized by these from the plain PLGA 
scaffold to eliminate any color interference caused by medium and degraded PLGA. The structure of BSA 
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(in medium or in dH2O) was determined with circular dichroism spectroscopy (CD). In CD, 60 μL of spent 
medium or dH2O used for BSA extraction was placed into the gap in between the two pieces of a 0.5 mm 
cuvette. The cuvette was placed into the spectrometer and CD of the solution was measured from the 
wavelength range from 185 nm to 240 nm. To track the change in BSA conformation, the standard CD of 
the BSA powder used in the study before incorporation was obtained: BSA powder was dissolved in dH2O 
at a known concentration. Then CD of the solution was measured. Furthermore, the CD spectrum was 
normalized by BSA concentration and cuvette length following a standard procedure. This normalized 
spectrum was then compared with literature value to confirm the structure of pure BSA powder. Then, 6 
pieces of 2 cm x1 cm as spun 5% BSA scaffold were collected, and each was dissolved in 1mL of 
chloroform and extracted with 0.5 ml of dH2O. CD spectrums of BSA in the dH2O were obtained. The CD 
spectrum of released and residual BSA from the release study was then compared to this one and used 
to determine if the structure of BSA protein changed during the process.  
 
10.3 Results  
 The concentrations of BSA in the spent medium as well as in the residual of the scaffolds used in 
the release study were obtained. This information was used to determine the total actual incorporated 
BSA in the scaffold. Result is shown in the form of percent cumulative release in terms of total actual 
incorporated BSA (Figure 10.1). Results showed that in the first few hours, BSA had a burst release, 
followed by a plateau from day 3 to 18, then the profile changed to continuous release until the end of the 
study. Using this actually value, the incorporation efficiency was calculated as (actual BSA in 
scaffold/added BSA)*100%. For 5% w/w and 10% w/w BSA incorporated scaffold, the actual incorporated 
BSA based on release and residual concentration was calculated to be 27.77 µg BSA /mg of scaffold and 
48.24 µg BSA/mg of scaffold. By day 28, 61.5% of incorporated BSA was released from the 5 % w/w 
BSA/PLGA scaffold and 59.7% of incorporated BSA was released from the 10 % w/w BSA/PLGA scaffold. 
 Normalized CD of BSA solution and CD of BSA extracted from the as-spun scaffold were 
obtained (Figure 10.2). The CD of residual BSA in the scaffold used in release study was also obtained 
and compared to that of the as-sun scaffold extracted BSA (Figure 10.3). It can be seen that the CD of 
BSA in both the as-spun scaffold and in the residual scaffold resembled that of the pure BSA solution. 
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Finally, CD of released BSA in medium was obtained (Figure 10.4), it did not resemble that of the BSA 
solution, in addition, it can be seen that the CD changed from one shape to another at a certain time point, 
indicating a change in protein structure. 
 
10.4 Discussion and Future Work  
 In this chapter, to investigate the feasibility of growth factor loading in the scaffold, thus guided 
fibrochondrogenic differentiation of the seeded MSCs, growth factor incorporation method was tested 
using BSA as a model protein. BSA podwer was added into PLGA solution to fabricate scaffolds with 5 % 
w/w and 10 % w/w BSA incorporated. The BSA release profile was determined up to 28 days in plain 
medium. CD was also utilized to determine the structural change of the BSA, from pure podwer, to in the 
as-fabricated scaffold; to in the spent scaffold used in release study, and finally to released BSA in the 
medium.  
 The BSA release profile obtained in this chapter was interesting. The initial burst release is 
expected since similar behavior was reported in literature for protein release as mentioned in the 
introduction of this chapter. The plateau and later continuous release was somewhat unexpected but 
could be explained. One possible explanation is that when BSA was incorporated; it was either 
incorporated into the nanofibers or dispersed in between fibers. The initial burst release was caused by 
dissolving of the BSA dispersed in between fibers. As the dissolved BSA being removed with medium 
change, less and less “free” BSA was available to be released, leading to the decrease in BSA release, 
thus a plateau region on the figure. At later stage, PLGA fibers degraded significantly in vitro, and BSA 
trapped in the nanofiber was released. Crow et al.326 reported a similar release profile of BSA in PLGA 
fibers. In their study, release was carried in PBS buffer and lasted for 11 weeks. Burst release was seen 
in the first week of release, from week 2 to week 5 the release was seen as plateau, and then there was a 
linear release profile from week 5 to the end of the study. The difference in time scale of each region 
between the two studies was due to the fact that PLGA with a higher PLA ratio was used in their study, 
thus the polymer scaffold has a slower degradation rate compared to the one used in this study.  
 The normalized CD spectrum was compared to reported literature values. To compare the 
normalized CD spectrum, first the general shape of the spectrum was compared. Then, for BSA, the two 
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most important values to look at are the mean residual angles (θMRE) at 209 and 222 nm. These two 
values are supposed to be the same if the BSA being measured has same conformation as the reference. 
A lower value means change in conformation327. Although the shape of the CD looks very similar to that 
reported in literature for BSA powders, the mean residual angle values were a little lower. This indicated 
the BSA used in the study had a slightly changed conformation to start with. Therefore, to determine if 
electrospinning process and the in vitro culturing process change the stability of the BSA, it is more 
reasonable to compare the spectrum of the BSA in the spent scaffold and in the release medium to that of 
BSA solution made in lab instead to the one reported in literature. From the result it is clear that CDs of 
as-spun scaffold and residual scaffold were similar to that of the BSA solution. Therefore, neither process 
significantly changed the conformation of BSA. However, for the released BSA in the medium, the CD 
looked completely different from that of the BSA solution. Therefore, it is possible that the medium 
changed conformation of BSA being released. However, it was also noticed the medium was not 
colorless. Since color will interfere with the CD results, the different CD curves of BSA released in 
medium could simply due to the color interference from medium. Therefore, the next step will be to repeat 
the study with a transport medium.  
 It can also be observed in this study that the BSA incorporation efficiency is low (~50%). This 
needs to be improved before the same method could be used for incorporating the actual growth factor in 
the scaffold. Therefore, future study will also investigate methods to enhance BSA incorporation into the 
scaffold. Following this, actual growth factors will be incorporated into the scaffold, and is effect on 



























BSA Release From PLGA Scaffold
5% BSA
10% BSA
Figure 10.1. BSA release profile from PLGA scaffold. Blue: 5 % w/w  BSA/PLGA scaffold, 
Red: 10 % w/w BSA/PLGA scaffold. Y axis represents percent of accumulated release of the 

















































CD of BSA in As-spun 
Scaffold
Figure 10.2. Normalized CD spectrum of dissolved BSA (left) and BSA in the as-spun 























Figure 10.3. Comparison of BSA conformation in the as-spun and spent scaffold. The 
features of CD spectrum of BSA in the as-spun scaffold (blue) are very similar to that of the 




























Figure 10.4. CD spectrum of released BSA in the medium. The released BSA had 
completely different spectrum compared to that of as-spun or spent scaffold. Furthermore, the 
spectrum was different at different time points. 
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 In the previous chapters, scaffolds with different design parameters were fabricated, 
characterized and evaluated in different animal models. The focus of these studies is to determine the 
structure-function relationship between the scaffold parameters and the healing response in macroscale. 
In the last chapter of this thesis, mechanism of how the biphasic scaffold interacts with cells in vitro will be 
explored to help understand the working principle of the scaffold from the perspective of interaction 
distance between cells seeded on the different phases of the scaffold.   
 
11.1.1 Background and Motivation 
 The native rotator cuff tendon-bone insertion is a heterogeneous fibrocartilaginous tissue can be 
divided into non-mineralized and mineralized regions. The non-mineralized fibrocartilage consists of a 
types I, II collagen and GAG rich extracellular matrix (ECM) populated by fibrochondrocytes, while the 
mineralized fibrocartilage, in addition to types I, II collagen and GAG, also contains type X collagen and 
mineral (hydroxyapatite, HA) in its ECM with the predominant cell type being hypertrophic 
fibrochondrocytes13-15;154. Focusing on the regeneration of the fibrocartilaginous insertion, by incorporating 
the distinct organization and mineral distribution profile in scaffold design, our lab has developed a 
structurally and compositionally biomimetic scaffold that consists of two compositionally distinct yet 
structurally continuous layers: phase A of the scaffold consists of aligned PLGA nanofibers, mimicking the 
non-mineralized fibrocartilage of the rotator cuff tendon-bone interface. Phase B of the scaffold consists 
of aligned PLGA nanofibers loaded with HA nanoparticles, mimicking the mineralized fibrocartilage24. The 
PLGA and PLGA-HA layers provide different cues for cells to differentiate, such that the resulting 
phenotypes will produce fibrocartilaginous and mineralized fibrocartilaginous, respectively. In addition, 
from the cells’ perspective, compared to single-phased PLGA or PLGA-HA scaffolds, the stratified 
structure of this biphasic scaffold decreased cell interaction distance between the two layers, and enables 
interactions between cells seeded on different phases. Since the focus is to determine interface-relevant 
response on the scaffold, instead of mesenchymal stem cells, which need to be pre-differentiated in this 
purpose, primary cells will be used. Due to the difficulty of obtaining insertion fibrocondrocytes; 
chondrocytes, which are similar in most of properties, with a well-established protocol for isolation, 
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expansion and culturing, will be used in this study.  
 
11.1.2 Objective 
 To this end, the objective of this chapter is to investigate the working mechanism of the biphasic 
scaffold from the perspective of cell interactions between the two phases. Specifically, the study in this 
chapter will determine the role of cellular interaction distance on response of cells seeded on the two 
phases, by evaluating interface-relevant cell growth and biosynthesis as a function of distance between 
scaffold phases. It is hypothesized that increasing the distance between scaffold phases will reduce the 
interactive effect observed on biphasic scaffold, leading to different cell proliferation and biosynthesis 
profiles on scaffolds with different phase separation distances. 
 
11.2 Materials and Methods 
11.2.1 Scaffold Fabrication  
 Aligned fibrous scaffod made with PLGA (85:15, Mw= 123.6 kDa; Lakeshore Biomaterials, 
Birmingham, AL), PLGA with HA (diameter: 100-150nm, Nanocerox, Ann Arbor, MI) or a biphasic scaffold 
consists of structurally continuous layers of PLGA and PLGA-HA were produced via electrospinning25. 
Briefly, the PLGA solution was produced by dissolving 35% PLGA (w/v) in 55% N, N- dimethylformamide 
(DMF, Sigma-Aldrich, St. Louis, MO) and 10% ethyl alcohol. Similarly, the PLGA-HA mixture was formed 
with the addition of HA (15% w/v) to the PLGA solution. For electrospinning, each formulation was loaded 
into a syringe with an 18.5-gauge stainless steel blunt tip needle and dispensed via a syringe pump 
(Harvard Apparatus, Holliston,MA) at 1 mL/h. The solutions were spun at 8-10 kV (PLGA) or 11-13 kV 
(PLGA-HA), fibers were collected on a rotating mandrel, resulting aligned nanofiber scaffolds. The 
biphasic scaffold was produced by electrospinning a PLGA layer directly on top of a PLGA-HA scaffold.   
 
11.2.2 Control of the Separation Distance 
To control the separation distance between cells seeded on the PLGA and PLGA-HA phases, 
four scaffold groups were included in this study. The first two groups were PLGA or PLGA-HA only single-
phased scaffolds. In these two groups, cells were seeded on PLGA or PLGA-HA scaffold and cultured in 
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different wells, as such, the separation distance between cells seeded on different scaffold layers can be 
seen as infinite. The third group was the biphasic scaffold, or PLGA/PLGA-HA d=0 mm group, with PLGA 
layer directly deposited on top of the PLGA-HA layer, the separation distance between cells seeded on 
these two phases was 0. The last group was co-cultured PLGA and PLGA/HA scaffolds, or PLGA/PLGA-
HA d =1 mm group. In this group, the PLGA and PLGA-HA layers were cultured in the same well, with a 
separation distance of 1mm. To ensure similar initial scaffold weight, the thickness of scaffolds used for 
single-phased and biphasic groups was controlled to be 0.2±0.01 mm, while for the PLGA/PLGA-HA d = 
1 mm group, two thin scaffolds with 0.1±0.01 mm thickness were used to achieve comparable thickness 
to other groups.  To enable cell seeding on both sides of the scaffold and to prevent scaffold from 
shrinking during in vitro culturing, as-spun scaffolds were cut into 1cm x 2.5 cm rectangles and 
suspended into custom designed clamps.  For the PLGA/PLGA-HA d = 1mm group, an extra separator 
measuring 1mm in thickness was used in the clamp to control separation distance in between the two 
layers of scaffold (Figure 11.1). 
 
11.2.3 Cell Isolation and Culture 
Primary chondrocytes were isolated from three immature bovine knee joints (Green Village, NJ) 
by separating the cartilage from bone328.  Briefly, the joints were opened sterilely, full thickness cartilage 
from the tibia plateau were cut away from the bone and carefully inspected to remove any remaining bone 
tissue. Cartilage was then minced into 3mm x 3mm pieces, samples from all three joints were pooled and 
digested for 16 hours at 37ºC under constant agitation with collagenase type II (310 u/mg, Worthington, 
Lakewood, NJ) in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS, Atlanta Biologicals, Atlanta, GA), 2% antibiotics (10,000 U/ml penicillin, 10 mg/ml 
streptomycin), 0.2% antibacterial (gentamicin sulfate) and 0.2% antifungal (amphotericin B).  The cell 
suspension was then filtered (30 μm, Spectrum, Rancho Dominguez, CA) to isolate chondrocytes.  
Isolated cells were maintained in high-density culture (4 x 105 cells/cm2) with fully-supplemented medium 
(FS medium, DMEM with 10% FBS, 1% antibiotics, 1% non-essential amino acid, 0.1% antifungal and 0.1% 
antibacterial) for 96 h before seeding329. All media supplements were purchased from Cellgro-Mediatech 
unless otherwise specified. 
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Prior to cell seeding, all clamp components were sterilized by soaking in 70% ethanol for 45 
minutes followed by ultraviolet (UV) irradiation. Scaffolds were sterilized with UV irradiation for 15 minutes 
on both sides. Clamps with scaffold were assembled in the cell culture hood and further sterilized with UV 
irradiation for 15 minutes on each side. Clamps were placed into 6-well plates and pre-incubated in FS 
medium supplemented with 10 μg/ml fibronectin (Invitrogen, Carlsbad, CA) at 37ºC and 5% carbon 
dioxide for 16 hours. This allowed fibronectin to adhere on the scaffold, which enhanced cell 
attachment330. For cell seeding, a 10 μL cell suspension containing 6 x 104 chondrocytes was pipetted 
onto the top side of the scaffold and incubated at 37ºC and 5% carbon dioxide for 15 minutes to allow for 
cell adhesion. The scaffold was then flipped and the same seeding procedure was repeated for the other 
side. 5mL of cell culturing media (FS supplemented with 1% ITS premix, 40 mg/mL sodium pyruvate, 100 
mg/mL L-proline, 100μM dexamethasone and 50 mg/mL ascorbic acid) was added into each well and 
changed twice weekly for the duration of the study. Samples were harvested at 1, 14 and 28 days of cell 
culturing. 
 
11.2.4 Cell Viability and Proliferation 
Cell viability and morphology (n=2) were evaluated using Live/Dead staining (Invitrogen, Carlsbad, 
CA) following the manufacturer’s suggested protocol. The samples were imaged under confocal 
microscopy (Olympus Fluoview FV1000 Confocal Microscope, Central Valley, PA) at excitation 
wavelengths of 488 nm and 594 nm. Total DNA content (n=5) was measured using the PicoGreen dsDNA 
assay (Invitrogen). Briefly, at each time point, cultured scaffold samples were homogenized in 0.1% 
Triton-X (Sigma-Aldrich) and subjected to 15s of ultrasonication at 5W. Fluorescence was measured 
using a microplate reader (Tecan, Research Triangle Park, NC) at an excitation wavelength of 485 nm 
and an emission wavelength of 535 nm.  A standard curve was generated and used to correlate DNA 
concentration to fluorescence intensity, and cell number was determined based on a conversion factor of 
8 pg DNA/cell331. 
 
11.2.5 Cell Biosynthesis 
 Total collagen content (n=5) was measured. The assay was performed following a 16 hours 
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sample digestion in Papain (Sigma-Aldrich) to solubilize matrix proteins. Absorbance was measured at 
555 nm using a microplate reader (Tecan). A standard curve was used to correlate total collagen content 
to absorbance. Collagen distribution was visualized using picrosirius red staining of frozen sections (n=2). 
Briefly, after fixation, samples were embedded in 5% polyvinyl alcohol (PVA, Sigma-Aldrich) and 7 μm 
thick sections were obtained using a cryostat (Hacker-Bright OTF model, Hacker Instruments and 
Industries, Winnsboro, SC). The sections were imaged under light microscopy (Axiovert 25, Zeiss). 
Sample glycosaminogylcan content (GAG) was determined with a modified 1,9-dimethylmethylene blue 
binding assay332-334, with chondrotin-6-sulfate (Sigma-Aldrich) as the standard. The absorbance difference 
between 540 nm and 595 nm was used to improve the sensitivity in signal detection. Distribution of GAG 
(n=2) was visualized by alcian blue staining of frozen sections following similar procedure of visualizing 
collagen distribution335.  
Alkaline phosphatase (ALP) activity (n=5), an indicator of mineralization potential, was quantified 
using an enzymatic assay based on the hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol 
(pNP)336. Briefly, after samples were lysed in 0.1% Triton-X solution, pNP-PO4 solution was added and 
allowed to react for 30 min at 37ºC, followed by reaction termination with 0.1N NaOH. Sample 
absorbance was measured at 415 nm.  Distribution of mineral (n=2) was visualized by both Alizarin red 
staining and von Kossa staining of the frozen sections with 5% silver nitrate, followed by 15 min of UV 
exposure337. 
 
11.2.6 Fibrochondrogenic Differentiation  
 The expression of fibrochondrogenic gene markers, such as types I, II, III collagen and aggrecan 
and hypertrophic gene markers, such as collagen X, matrix metalloproteinase-13 (MMP13) and runt-
related transcription factor 2 (Runx2) were measured at days 14 and 28 with reverse transcription 
followed by polymerase chain reaction (RT-PCR, n=3). Briefly, total RNA was isolated via TRIzol 
(Invitrogen) extraction, and reverse-transcribed into cDNA using the SuperScript III First-Strand Synthesis 
System (Invitrogen). The cDNA product was amplified with recombinant Platinum Taq DNA polymerase 
(Invitrogen). Expression band intensities of relevant genes were analyzed semi-quantitatively and 
normalized to that of glyceraldehydes3-phosphate dehydrogenase (GAPDH), which serves as the house-
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keeping gene (primer sequences listed in Table 11.1). 
 
11.2.7 Statistical Analysis 
  Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. Two-way ANOVA was used to determine the effects of scaffold type on cell 
proliferation, matrix deposition and tendon-bone interface related gene expression. The Tukeye Kramer 
post-hoc test was used for all pair-wise comparisons and significance was attained at p< 0.05. Statistical 
analyses were performed with JMP IN (4.0.4, SAS Institute, Inc., Cary, NC). 
 
11.3 Results 
11.3.1 Cell Viability and Proliferation 
 Live/Dead images showed that uniform cell seeding was achieved on both phases of all scaffolds. 
Upon initial seeding, cells remained viable and proliferated during the period of culturing time (Figure 
11.1). Quantitative DNA assay result showed that by day 28, cell number on all groups was significantly 
higher than initial cell seeding density. Furthermore, similar proliferation rates were observed for cells 
seeded on different scaffolds as no significant difference was observed between groups at day 28 (Figure 
11.1). It was found that although different types of scaffolds were used, by controlling their thickness, 
initial scaffold wet weights were controlled to be the same for all groups (Figure 11.2). Although significant 
increase in scaffold weight were observed in all groups by day 28 (stats not shown, since the objective of 
this study is to determine the effect of phase separation distance on different group at the same time point, 
stats regarding comparison of the same group over time will not be shown), no significant difference in 
cell proliferation was observed between groups (Figure 11.2).  
 
11.3.2 Cell Biosynthesis and Fibrochondrogenic Differentiation 
 Although cell proliferation rate was not impacted by the type of underlying scaffold or their phase 
separation distance, other responses, such as cell biosynthesis of fibrochondrogenic ECM were 
modulated by the scaffolds. In terms of collagen production, all groups showed increased collagen 
production from day 0 to day 28. By day 28, collagen production in the PLGA/PLGA-HA d = 1mm group 
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was suppressed compared to all other groups (Figure 11.3). This was visualized in histology as the 
scaffolds of PLGA/PLGA-HA d = 1 mm group were stained less intense with picrosirius red compared to 
other groups. GAG production had similar trend: GAG deposition on the scaffold increased overtime for 
all groups. By day 28, GAG production in the PLGA/PLGA-HA d = 1mm group is lower than that of the 
PLGA-HA group, which is visualized in the histology. 
Further investigation of tendon-bone interface related fibrochondrogenic gene markers showed 
that they were also modulated by the scaffold and the trend matches with cell biosynthesis (Figure 11.4). 
At day 14, expression of type I collagen was down regulated in the PLGA/PLGA-HA d = 1 mm group 
compared to both PLGA-HA and PLGA/PLGA-HA d = 0 mm groups; aggrecan was down regulated in the 
PLGA/PLGA-HA d = 1mm group compared to that of the PLGA-HA group. This down regulation in gene 
expression was reflected in fibrochondrogenic ECM production at a later time point as mentioned in the 
previous paragraph. By day 28, the expression level of interface related genes showed a general 
increasing trend for all groups compared to day 14 and similar levels of expression were observed in 
different groups. 
 
11.3.3 Mineralization  
 In addition to fibrochondrogenic ECM production, mineralization potential of chondrocytes, which 
is important for the regeneration of mineralized fibrocartilage, was also modulated by the scaffold phase 
separation distance. The ALP activity of PLGA-HA scaffold peaked at day 28, both overtime and 
compared to other groups (Figure 11.5). For hypertrophic gene markers, at day14, expression of MMP13 
was down regulated in the PLGA/PLGA-HA d = 0 mm group compared to that of PLGA-HA group. By day 
28, similar expression levels were observed in all groups. 
 
11.4 Discussion 
In this study, the working mechanism of the biphasic scaffold was explored by investigating the 
effect of phase separation distance on bovine chondrocyte cell response on the scaffold. The separation 
distance between the two phases was controlled to be either 0 or 1 mm. For control purpose, PLGA or 
PLGA-HA only single phase scaffolds were also used in this study.  
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Primary bovine chondrocytes were seeded on both sides of all scaffolds and cultured over a 
period of 28 days. Uniform initial cell seeding density was observed across all groups and cell 
proliferation rate remained comparable between groups over time.  While not changing cell proliferation 
rate, it was observed that the separation distance between PLGA and PLGA-HA phases modulated other 
cell response such as matrix production and interface-relevant gene expression. Specifically, collagen 
production remained the same when chondrocytes were seeded on single-phased or PLGA/PLGA-HA d = 
0 mm group, but suppressed significantly when chondrocytes were seeded on the PLGA/PLGA-HA d = 1 
mm. Similarity, GAG production was suppressed on the PLGA/PLGA-HA d = 1 mm group. One 
reasonable explanation is that cell biosynthesis involves both paracrine and cell-cell interaction. For the 
paracrine effects, it is known that spent medium from chondrocyte cell modulates chondrocyte ECM 
production338 and the macromolecules and growth factors entrapped in ECM affect chondrocyte behavior1. 
Therefore, it is possible that chondrocyte seeded on the PLGA or PLGA-HA phase secreted paracrine 
factors that has the inhibits ECM production of cells seeded on the other phase, as it is reflected by 
suppression of both collagen and GAG production in the PLGA/PLGA-HA d = 1 mm, where both phases 
were cultured in the same well and paracrine interaction enabled. Biosynthesis is also controlled by cell-
cell interaction, since the suppression in ECM production caused by paracrine factors was not observed 
in the PLGA/PLGA-HA d = 0 mm group, and the only difference between this and the PLGA/PLGA-HA d 
= 1 mm group is that in this group, cell-cell interaction is enabled. This is further confirmed by the DAPI 
stain of the PLGA/PLGA-HA d = 0 mm group at day 28 (results not shown), despite that cells were initially 
only seeded on the surface of scaffold, by day 28, cells were seen to penetrate and distribute through the 
thickness of the scaffold.  
It was also found that the mineralization potential of the cells were modulated by the separation 
distance: it is known that HA increases ALP activity329, but out of all three groups that contained HA, ALP 
activity was only enhanced in the PLGA-HA groups. This enhancement was not observed in the 
PLGA/PLGA-HA d= 0 mm group and ALP activity was even suppressed in the PLGA/PLGA-HA d = 1 mm 
group when compared to the PLGA-HA group.  It can be concluded from this result that the cells seeded 
on PLGA phase suppressed ALP activity on the PLGA-HA phase through paracrine interaction. This was 
confirmed when a different separation distance, 40 mm between PLGA and PLGA-HA scaffolds was used 
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and the same ALP suppression was observed (results now shown). Similar to that of ECM production, 
cell-cell interaction in the PLGA/PLGA-HA d = 0 mm helped to mitigate some of the negative impact 
brought by paracrine factors. 
Since in the biphasic scaffold, the two phases with distinct compositional features were in direct 
contact with each other, the separation distance between cells seeded on the different phases was 0, and 
both paracrine interaction and direct cell-cell contact were enabled for these cells.  By changing the 
separation distance between the different phases to 1 mm, direct cell-cell contact between them was 
disabled, but paracrine interaction was maintained. When cells were seeded on single phase scaffolds, 
where the separation distance between cells seeded on the different phases was effectively infinite, the 
paracrine interaction was further disabled. Through this study, the working mechasim of cells on the 
biphasic scaffold was investigated. It was evident that by modulating interaction distance between 
chondrocytes seeded on different phases, their response could be modulated. The biphasic scaffold, 
which has a separation distance = 0 mm, led to the best overall in vitro response of chondrocyte, which is 




Collectively, this study explored the biphasic scaffold working mechanism by investigating 
homotypic cell interaction of chondrocytes co-cultured on different phases of a stratified scaffold and it 
was found while cell proliferation rate remained the same, both paracrine interactions and cell-cell 
interaction between homotypic cells are important for the biosynthesis and mineralization potential of 
bovine chondrocytes. While the paracrine interactions suppresses matrix production and mineralization 
potential, by culturing cells on different phases of a stratified biphasic scaffold enable cell-cell interaction, 
which rescued the negative effect brought by paracrine interactions.  
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Table 11.1. List of Primers Used for RT-PCR  
 
Gene Sense Anti-Sense Blast Product Size (bps)
GAPDH 5’- GCTGGTGCTGAGTATGTGGT -3’ 5’- CAGAAGGTGCAGAGATGATGA -3’ 108
Col I 5’- CTTCTGGAGCAAGTGGTGAA -3’ 5’- GATCCTTCAGCACCAGGAG -3’ 108 
Col II 5’-GCATTGCCTACCTGGACGAA-3’ 5’-GAACCTGCTGTTGCCCTCAG-3’ 100
Col III 5’- CCGTTTGGAGAATGTTGTGC -3’ 5’- CCTTGAGGTCCTTGACCATT -3’ 79
Col X 5’- TGGATCCAAAGGCGATGTG -3’ 5’ GCCCAGTAGGTCCATTAAGGC -3’ 82
Aggrecan 5’-GTGAATCCCAAAACGCCACT-3’ 5’-CGGCGTAGCACTTGTCCAG-3’ 80
MMP-13 5’-ACATCCCAAAACGCCAGACAA-3’ 5’-GATGCAGCCGCCAGAAGAAT-3’ 109
Runx2 5’-AATCCTCCCCAAGTTGCCA-3’ 5’-TTCTGTCTGTGCCTTCTGGGT-3’ 82
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Figure 11.1. Clamp design and cell viability. Scaffold configuration and cell viability on 
the scaffold over time. Top and bottom views show cell seeding on both sides of the 
scaffold. Side views show scaffold composition in PLGA,PLGA-HA and PLGA/PLGA-HA d = 
0 mm groups and scaffold as well as spacer arrangement in PLGA/PLGA-HA d = 1 mm 
group. Live/Dead images show that cells remained viable and proliferated over time on all 
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Figure 11.2. Cell proliferation on the scaffold. Results showed that 
uniform wet weight and cell proliferation rates were maintained in all groups 



















































PLGA/PLGA-HA d = 0 mm
PLGA/PLGA-HA d = 1 mm
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Figure 11.3. Extracellular matrix formation. Histology of cellular scaffolds at day 28, showing 
collagen (left, Picrosirius red) and GAG (right, Alcian blue) deposition on the scaffold (10x, bar=100μm) 
PLGA, PLGA-HA, PLGA/PLGA-HA d = 0 mm groups stained strongly for both collagen and GAG. 
Quantitative assays show that at day 28, for collagen production, PLGA/PLGA-HA d = 1 mm group had 
the lowest production in all groups. For  GAG, PLGA/PLGA-HA d = 1 mm group had lower GAG 
production compared to PLGA-HA group.  
(#: significant difference compared to all other groups at the same time point, *: significant difference 



















































































PLGA/PLGA-HA d = 0 mm







PLGA/PLGA-HA d = 0 mm




d = 0 mm          
















































Figure 11.4. Fibrochondrogenic gene expression. Semi-quantitative PCR show 
that at day 14, type I collagen was down regulated in PLGA/PLGA-HA d = 1 mm group 
compared to PLGA-HA and PLGA/PLGA-HA d = 0 mm groups; aggrecan was down 
regulated in PLGA-PLGA-HA d = 1 mm group compared to PLGA-HA group. At day 
28, aggrecan was up regulated in PLGA/PLGA-HA d = 0 mm group compared to 
PLGA group. 
(*: significant difference between groups, n=3, p<0.05) 
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Figure 11.5. Mineralization potential. Histology of cellular scaffolds (n=2) at day 28 showing mineral 
distribution of the scaffold and newly formed matrix (left: Alizarin red; right: von Kossa, 10x, 
bar=100μm). PCR of hyperthrophic gene expression at day 14. show that MMP13 was down regulated 
in PLGA/PLGA-HA d =  1 mm group compared to PLGA-HA group. At day 14, no difference between 
groups was observed. Quantitative assay showed that ALP activity of PLGA-HA group peaked at day 
28 both overtime and across all groups. 
(#: significant difference compared to all other groups at the same time point, *: significant difference 
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CHAPTER 12: SUMMARY AND FUTURE DIRECTIONS 
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12.1 Thesis Summary 
The objective of this thesis was to identify key parameters that contribute to the in vivo efficacy of 
a scaffold designed for integrative rotator cuff tendon-bone repair. This thesis is guided by the working 
hypothesis that the in vivo regeneration of the tendon-bone insertion is the result of certain key 
parameters, either dependent or independent of the scaffold design. It is anticipated that when a key 
parameter is altered, the tendon-bone healing will be less effective, as a fibrous, unorganized scar-like 
tissue will form at the tendon-bone junction, instead of the formation of a fibrocartilaginous, organized 
insertion-like tissue. This hypothesis was tested through two specific aims. Aim 1 focused on determining 
the effects of scaffold-dependent properties on rotator cuff tendon-bone healing in a rat model. An ideal 
tissue engineered scaffold should be biomimetic of the native insertion in terms of its structure and 
composition. Therefore, the effects of two structural properties, scaffold fiber alignment (Chapter 2), and 
diameter (Chapter 3) on in vivo rotator cuff tendon-bone insertion healing were evaluated. The effects of 
two compositional properties, mineral distribution through the thickness of the scaffold (Chapter 4), and 
polymer composition (Chapter 5) were also determined. Results showed that a scaffold consists of 
distinct non-mineralized and mineralized layers consisting aligned nanofibers, and made from poly 
(lactide-co-glycolide) (PLGA) led to the best healing response. Given the in vivo nature of this thesis, Aim 
2 focuses on determining the effects of scaffold-independent factors on rotator cuff integrative healing, 
using the optimized scaffold from Aim 1. The effects of healing time (Chapter 6) and animal model 
(Chapter 7) were evaluated. Results demonstrated the aligned nanofiber-based biphasic scaffold 
improved certain mechanical properties of the repaired shoulder compared to the control in the short 
term, and did not decrease mechanical properties in the long term. Finally, the efficacy of the biphasic 
scaffold was independent of animal model, as it led to the formation of a fibrocartilaginous, organized 
tissue at the tendon-bone junction in both the rat and the sheep models. Following these studies, where a 
foundation is laid for a scaffold that has the potential for clinical application, work in more exploratory 
nature is done in Chapters 8-11 to investigate if the scaffold performance can be further improved, and 
the mechanism of cell interactions on the biphasic scaffold.  
The major findings of each chapter are briefly highlighted below. 
12.1.1 Effects of Scaffold-Dependent Properties on Rotator Cuff Tendon-Bone Healing 
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 In Aim 1, the in vivo effects of scaffold structural and compositional properties on rotator cuff 
tendon-bone healing were evaluated. In each chapter, one properties of the scaffold was changed, and 
the scaffold was used to repair acute, full-thickness rotator cuff tear in a rat model. The healing tissues 
were assessed predominately with histology. A scaffold design parameter was considered to be critical 
for integrative rotator cuff repair if it led to the formation of tissue at the tendon-bone junction with the 
following properties: 1) it stains positive for both collagen and GAG for the formation of fibrocartilaginous 
tissue, 2) matrix exhibits organized morphology as assessed through polarized light microscopy, 3) it 
stains positive for both types II and X collagen for the formation of non-mineralized and mineralized 
fibrocartilage, and 4) it  does not lead to ectopic bone formation. 
 It was reported in vitro, fiber alignment of electrospun PLGA scaffold guided cell morphology and 
matrix deposition of human rotator cuff fibroblasts25. While elongated cells producing aligned collagen 
were observed on scaffolds with aligned fibers, polygonal cells producing scar tissue-like extracellular 
matrix (ECM) were observed on scaffolds with unaligned fibers. Therefore, in Chapter 2, the in vivo effect 
of scaffold fiber alignment was evaluated. Biphasic scaffolds with unaligned fibers were fabricated by 
collecting electrospun fibers with a stationary plate. Results demonstrated the in vitro effect of fiber 
alignment was translated in vivo, as the alignment parameters of the healing tissue followed that of the 
as-fabricated scaffold in the aligned scaffold-repaired shoulders. While a fibrocartilaginous tissue 
consisting organized collagen fibers was formed in the aligned scaffold-repaired shoulders, a fibrous, 
scar-like tissue was formed in the unaligned scaffold-repaired shoulders. Therefore, a scaffold for 
integrative rotator cuff repair should contain aligned fibers.  
 It was reported in vitro that nanometer-sized PLGA fibers led to higher cell number, total collagen 
and proteoglycan (GAG) production of human rotator cuff fibroblast, while microfibers promoted the 
expression of fibroblast phenotypical markers30. Therefore, Chapter 3 investigated the in vivo effect of 
scaffold fiber diameter on integrative rotator cuff tendon-bone healing. Microfiber-based scaffolds were 
fabricated by increasing the polymer to solvent ratio of the electrospinning solution. Results demonstrated 
that the microfibers did not stimulate healing response, as minimal matrix deposition was observed at the 
tendon-bone junction compared to that of nanofiber scaffold repaired shoulders.  
 The biphasic scaffold mimics the native insertion by incorporating a non-mineralized layer and a 
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mineralized layer. Chapter 4 investigated effect of mineral distribution within the scaffold on integrative 
tendon-bone repair. First, the biphasic scaffold was used to repair rat rotator cuff with reversed order: 
PLGA phase contacting bone and PLGA-HA phase contacting tendon. This scaffold led to the formation 
of unorganized fibrous tissue. Therefore, correct phase-specific cues from the biphasic scaffold were 
needed for integrative tendon-bone healing. In this chapter, a scaffold with a more gradual change in 
mineral content through its thickness was fabricated by spinning four equal-thickness layers, PLGA, 
PLGA-HA (5%), PLGA-HA (10%) and PLGA-HA (15%) from top to bottom to form a gradient scaffold. 
This scaffold was considered more biomimetic compared to the biphasic scaffold, as the native rat 
insertion has a gradual, almost linear change in mineral content from its tendon to bone end17;32. 
However, when used in vivo, this gradient scaffold did not lead to the formation of aligned 
fibrocartilaginous tissue. Ectopic bone formation was observed in one shoulder repaired by the gradient 
scaffold. It is possible that the thicker PLGA layer in the biphasic scaffold acted as a barrier to prevent 
ectopic bone formation, and the biphasic structural is better for integrative rotator cuff tendon-bone 
healing compared to the gradient scaffold.   
In tissue engineering approach, the scaffold degrades over the healing period to provide space 
for new tissue deposition and penetration. In Chapter 5, the effect of scaffold polymer composition was 
investigated by fabricating an aligned, nanofiber-based scaffold using a poly (ε-caprolactone) 
(PCL)/PLGA blend, which has a slower in vitro degradation profile compared to PLGA266. Results showed 
that the PCL/PLGA scaffold degraded slower in vivo, and prevented the formation of insertion-like tissue 
at the rat rotator cuff tendon-bone junction.  
Collectively, results from Aim 1 demonstrated that a PLGA-based biphasic scaffold consisting 
aligned nanofibers is needed for integrative rotator cuff repair in rat, as it led to the formation of an 
organized, fibrocartilaginous insertion-like matrix at the tendon-bone junction by week 5 post-surgery. 
This scaffold was used in Aim 2 to determine the effect of scaffold-independent properties on integrative 
rotator cuff repair.  
 
12.1.2 Effects of Scaffold-Independent Parameters on Rotator Cuff Tendon-Bone Healing 
Aim 2 focuses on determining the effects of scaffold-independent parameters on rotator cuff 
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tendon-bone healing. In Chapter 5, the effect of healing time was evaluated by comparing tensile 
mechanical properties of rat shoulders repaired with or without the biphasic scaffold at weeks 5 and 20 
post-surgery. The biphasic scaffold improved ultimate tensile load of the repaired shoulder compared to 
the control at week 5, and led to similar tissue percent relaxation compared to the native tissue at both 
time points. These results agreed with the histological findings from Chapter 2, in which the biphasic 
scaffold led to the formation of an organized fibrocartilaginous tissue, while unorganized fibrous tissue 
was formed in the control repair without scaffold. The performance of the biphasic scaffold did not 
decrease with time, as comparable mechanical properties were observed between scaffold and control 
repaired shoulders at week 20 post-surgery.  
The ultimate goal is to use the biphasic scaffold in clinical setting. Specially, the biphasic scaffold 
will be implanted at the tendon-bone junction, following an “inlay” configuration with the double-row 
suture-bridge technique that is widely used in rotator cuff repair surgeries76. This requires the use of a 
large animal model that could accommodate this procedure and to confirm the repair efficacy of the 
aligned, nanofiber-based scaffold in this model. A sheep model was selected for this purpose due to the 
similarity in rotator cuff tendon dimensions between human and sheep34;74. In Chapter 7, the biphasic 
scaffold was successfully implemented at the sheep tendon-bone junction with the double-row suture-
bridge technique. Results demonstrated the biphasic scaffold was biocompatible, led to the formation of 
an organized fibrocartilaginous tissue consisting types I, II collagen and GAG, and actively controlled the 
mineralization at the sheep rotator cuff tendon-bone junction. 
 
12.1.3 Exploratory Work 
 In Chapter 8, the effect of MSC pre-seeding on the aligned, nanofiber-based biphasic scaffold 
was explored, by seeding MSCs on the scaffold, followed by evaluation in rat model. Results showed that 
although MSCs led to improvement in certain mechanical properties over time, they did not provide much 
additional benefits, possibility due to the lack of pre-differentiation towards the fibrochondrogenic linage 
that is related to insertion healing. In Chapters 9 and 10, two possible methods to differentiate MSCs on 
the scaffold were explored by designing a bioreactor that is capable of providing spontaneous 
compressive/tensile loading to the scaffold, and incorporating a model protein in the scaffold for growth 
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factor loading purpose. Both chapters result in positive preliminary work that would lead to the eventual 
formation of a system in which biomechanical or biochemical loading to the scaffold can be controlled for 
fibrochondrogenic differentiation of MSCs. Lastly, in Chapter 11, the mechanism of cell interaction on the 
biphasic scaffold was explored, results showed that by changing the separation distance between cells 
seeded on different phases of the scaffold, the resulting response can be modulated. The biphasic 
scaffold, with a phase separation distance of 0, led to the best overall cell response, where 
fibrocartilaginous tissue is formed without external stimulus.  
 
12.2 Future Directions 
Collectively, results from this thesis demonstrated that an electrospun PLGA-based biphasic 
scaffold with a non-mineralized layer and mineralized layer consisting of aligned nanofibers led to 
integrative rotator cuff tendon-bone repair. However, several areas of further studies are needed for its 
clinical application.  
 
12.2.1 Mechanical Test in Sheep Model 
 The ultimate goal of integrative repair is to enable biological fixation between tendon and bone 
through the regeneration of the tendon-bone insertion. Mechanical properties can be used to quantify the 
degree of biological fixation. Therefore, tensile mechanical test will be performed in the sheep model to 
evaluate the functionality of the healing tissue with and without the scaffold, following published 
methods205;315 
 
12.2.2 Degenerative Animal Model 
 In this thesis, repair efficacy of the biphasic scaffold is evaluated with an acute injury model in 
which the tendon is sharply detached from its bony insertion and repaired immediately29. Although this 
method has been widely used and provides valuable healing information, a chronic model, in which the 
injury is created to allow tendon degeneration for a period of time before repair, is more clinical relevant, 
as most of rotator cuff tears are caused by chronic tendon degeneration35;39-41. Chronic rotator cuff tears 
have been successfully established in both rat339 and sheep models340. 
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12.2.3 Use of Stem Cells and Growth Factors 
 The biphasic scaffold used in this thesis is acellular, therefore, the healing capacity is dependent 
on the host cells. To further enhance its performance, the biphasic scaffold could be pre-cultured with 
autologous mesenchymal stem cells for a period of time for the initial deposition of insertion-like matrix 
before its use in rotator cuff repair. Furthermore, since certain growth factors, such as the TGF-β isomers 
are known to play an important role in insertion healing158-160, they could be incorporated into the scaffold 
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